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Abstract
Palmitoylation is a post-translational modification that involves the addition of the fatty
acid palmitate onto specific cysteine residues. Recently, several members of a family of
transmembrane proteins containing a zinc finger and a DHHC motif, have been shown to
be palmitoyl transferases in yeast and mammalian cells.
The recessive hair loss mutant, dep, contains a spontaneous mutation (del-233F) at the C-
terminal of Zdhhc21. Wild-type Zdhhc21 has been shown to enhance palmitoylation of
several specific substrates in a transfected cell assay. Zdhhc21 localises to the cis-Golgi,
whereas the mutant protein is mislocalised and is inactive in palmitoylation. We verified
the candidacy of Zdhhc21 by transgenic BAC rescue.
Dep is characterised by progressive hair loss, hyperplasia of the sebaceous glands, the
interfollicular epidermis and the outer root sheath. In-situ hybridisation and
immunohistochemistry show that both wild-type and dep mRNA and protein are present in
the inner root sheath (IRS).
Phenotypic characterisation using molecular markers in cell culture and on skin sections
reveals abnormalities that suggest a lack of correct hair shaft differentiation in dep. We
speculate that dep may have a direct or indirect effect on 4 members of the Wnt family -
essential regulators of hair shaft differentiation - because of their co-expression in the IRS
and because dep exhibits a Wnt-deficient phenotype.
This hypothesis may provide an example of how local signalling centres may be established
to allow for spatiotemporal gene expression. Furthermore, dep is the first mouse model that
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Chapter 1 - INTRODUCTION
1.1. Use of Mouse Models to dissect gene functions
1.1.1. Reverse Genetics - Manipulation of Gene expression in Mouse
The most powerful and straightforward approach to study gene function, is by mutating a given
gene and determine the phenotypic outcome in a model organism. The laboratory mouse (Mus
Musculus) is considered one of the best species for such manipulation because unlike other
model organisms such as flies and worms, they are closely related to human in evolutionary
terms and thus share many of the physiological and developmental properties with humans.
Therefore, it is reasonable to assume that the same gene in mouse is likely to provide similar
function in humans, so the study of gene function in mice may allow us to predict the role of
genes in human development and disease. Another reason why mouse is the most popular
model in biomedical research is because of the abundant genomic resources that allows them to
be genetically manipulated in a highly precise manner using gene knockout and transgenic
technology (Peters et ah, 2007; Rosenthal and Brown, 2007).
Generation of Transgenic Mice
DNA segments of a gene of interest may be introduced to a mouse by pronuclear
microinjection so that the segment may incorporate randomly into the germline, and result in
transgenic offspring with extra copies of the transgene (Hanahan et ah, 2007). The transgene is
most often engineered to express in a spatially specific manner by using tissue-specific
promoter, this is usually applied to overexpression of a target gene. For example, the role of
Wnt signaling in hair follicles has been studied by using the keratin 14 (K14) promoter to drive
expression of genes of the Wnt pathway, such as Wnt3a, Dvl2 (Millar et al, 1999), Lefl and
Tcf3 (Merrill et al 2001) in the hair follicle outer root sheath (ORS) specifically.
The transgene may also be modified so that its expression may be inducible with certain drugs.
Alternatively, to study the contribution of a candidate gene to a certain phenotype, a transgene
cloned in a large DNA segment such as BAC may be injected into mutant embryos to speculate
whether the expression of the transgene is able to rescue a given phenotype.
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Gene Targeting
In gene targeting, the target gene is altered in its original genomic location by homologous
recombination in embryonic stem (ES) cells. Mutant ES cells that have undergone the rare
recombination event can be selected by drug (resistance or sensitivity), and injected into a
blastocyst which is then implanted into a recipient mother to give chimeric offspring. If the
mutant ES cells were incorporated into germ cells, the altered DNA will be passed on to
subsequent offspring (Muller, 1999; Smithies etal., 1985). Currently, this manipulation ofES
cells is used in several mutagenesis approaches which produce either 'knockouts' to inactivate
a gene completely, or 'knockins' to replace a gene with a mutant version.
For example, using the mouse keratin 6 (MK6) knockout mouse that was generated by
homologous recombination in ES cells, it was shown that although MK6a~~ mice have normal
hair and skin, they show a delay in reepithelializaton from the HF. This indicates that even
though MK6a may not play a major role in keratinocyte proliferation or migration, it has a role
in the activation of HF keratinocytes after wounding (Wojcik et ah, 2000).
Conditional Gene Targeting
Gene targeting is powerful in studying gene function by generating loss-of-function mutations.
However, although the conventional approach is ideal in disrupting role of genes in
embryogenesis, it has limited application in studying their functions in adulthood. For example,
a protein may have an early role in embryogenesis, but also has other roles in development. In
this case, a complete knockout in ES cells would not allow the study of the later phenotype.
Furthermore, given the complex temporal and spatial specificity of gene expression, and
possible functional redundancy of proteins, the loss of a protein function may contribute to a
human phenotype in a temporally and spatially specific manner. To induce gene activation /
inactivation specifically, the Cre-loxP-induced site-specific recombineering recombination
(Nagy, 2000) and tamoxifen-inducible systems (Hayashi and McMahon, 2002) may be
employed in ES cell manipulation for conditional gene targeting.
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Typically, conditional gene targeting involves crossing 2 genetic modified mice; one carries a
Cre recombinase gene controlled by a tissue specific promotor, the other one carries the
conditional (floxed) gene. Upon expression ofCre recombinase in the resulting offspring, the
target DNA is removed at the loxP sites that are recognized by Cre, thereby inactivating the
gene in a tissue-specific manner. The transgenic mouse strain carrying the tissue-specific Cre
expression may be crossed with strains that carry other transgene targeted by loxP, and vice
versa (O'Neal and Agah, 2007). A list of existing targeted gene mutations is maintained by the
Jackson Laboratory1.
As an example, the Cre/loxP technology has been used to generate a conditional mutation of (J-
catenin during embryogenesis and stem cell differentiation in adult skin (Huelsken et al., 2001).
It was shown that P-catenin is required for placode formation, but it also essential for fate
decisions of skin stem cells.
Over the past few years, several large-scale mutagenesis screens have been initiated on an
international scale to study gene function. In collaboration with the Wellcome Trust Sanger
Institute (WTSI), the European Conditional Mouse Mutagenesis programme2 (EUCOMM) and
the Knockout Mouse Project3 (KOMP) aim to generate a collection ofmouse mutants to include
all genes encoded by the mouse genome (Friedel et al., 2007). This involves the construction of
conditional gene targeting vectors and the production of targeted ES cell lines that will be
available to the public when completed. Not only is this approach cost- and time-effective, it
also enables high-throughput generation of knockout mutants in a standardized and systematic
way.
The phenotype of the mutant lines derived from ES cells are initially assessed by the European
Mouse Disease Clinic4 (EUMODIC) which is build upon a comprehensive database of
standardized phenotyping protocols called the European Mouse Phenotyping Resource of
Standardised Screens5 (EMPReSS) (Brown et al., 2005).
1









1.1.2. Forward Genetics - Identification of mutant alleles for certain phenotypes
While the reverse genetic approach or knockout technology is straightforward and essential, it
is complemented by forward genetics, the first tools available to geneticists, where the
observation of a phenotype is followed by the identification of the responsible genes, leading to
discovery of many novel genes and their functions. Often, a mutagen such as radiation or other
chemical substrates may be used to accelerate the mutagenesis process (Rinchik et al., 1990).
Spontaneous Mutations
Before the development of transgenic technology and gene targeting, many spontaneous mouse
mutants have already been characterized and studied by geneticists. To date, the sequencing of
the mouse and human genomes are completed and are frequently being updated and manually
annotated for better quality of the finished genome sequence. The abundance in genomic data
and availability of genetic markers has facilitated the identification of causative genes in
spontaneous mutants.
Induced Mutations
Although spontaneous mutations are productive, they represent only a small number of all
possible mutations, and they occur at an extremely low rate. To facilitate the study of gene
function, new mutations may be induced by several methods such as radiation, chemical, and
transposon insertion.
Early mutagenesis screens includes the specific locus test (SLT), which uses visible markers
such as coat colour and ear morphology to recover chemical- and radiation-induced
chromosomal deletions at defined genomic locations (Davis and Justice, 1998). The deletions
lead to a loss of the genes within those regions, as well as the marker gene. One of the loci
studied was the brown (b) locus, at which 30 deletions were initially recovered and will be
described in Chapter 2. By complementation analysis against the panel of b-del
chromosomes, several classical mutations have been mapped, including a hair loss mutant
called depilated (dep). The identification of the responsible gene will be described in Chapter
3.
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More recently, other mutagenesis strategies have been used that generate mutations in a more
precise and unbiased manner. N-ethyl-N-nitrosourea (ENU) is a powerful alkylating mutagen
that induces point mutations in mice, generating a range of effects including loss-of-function,
gain-of-function and dominant-negative mutations (Justice et ah, 1999). Unlike the gene
targeting approach, ENU induces mutations in regulatory elements as well as known coding
genes, and it does not require any knowledge or presumption of protein function. ENU
mutagenesis screening is powerful both in isolating new alleles of a gene of interest and to
confirm the functional identity of candidate gene (called gene-driven screens) (Coghill et al.,
2002), and in identification of novel genes and pathways by screening for a certain phenotype
(phenotype-driven screens) (Thaung et al., 2002). To date, several large-scale ENU
mutagenesis programs exist worldwide, including the Baylor College ofMedicine, MRC
Mammalian Genetics Unit (Quwailid et al., 2004) and the Riken GSC Institute (Sakuraba et al.,
2005).
Other induced mutagenesis alternatives include 'gene-trapping', which refers to the random
insertion of a reporter that disrupts a gene locus in ES cells, followed by PCR-based gene
identification techniques. The advantage of this approach is that the new allele can be tagged
with a known marker that facilitates the identification of responsible gene in a phenotype. A list
of characterized gene trap insertions in ES cells are available from the International Gene Trap
Consortium (IGTC) (Nord et al., 2006).
DNA transposons can also be used to generate new mutants based on the principles of gene
trapping, these include the reconstructed mariner element Sleeping Beauty (Dupuy et al., 2006)
and piggyBac, a functional transposon from insects that also works in mammals (Cadinanos
and Bradley, 2007). Due to the ability of transposons to mobilize within the genomes, they
insert randomly into the genome and maintain the capacity to relocate and integrate at different
genomic sites. Recently, an inducible version of the mouse codon-optimized piggyBac
transposase was engineered by fusing with an oestrogen receptor ERT2, making it a highly
active and regulatable transposase that is ideal for transposon-based mutagenesis for
characterizing genes.
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1.2. Using mice to study hair follicle and hair cycle
In addition to the aforementioned advantage of using mouse models, mouse is an excellent
system for studying the hair cycle and hair follicle development for several reasons (Porter,
2003).
In mice, the hair cycle progresses as waves of synchronized growth among the follicles for the
first 2 cycles following birth. After that, the cycle in different follicles becomes progressively
unsynchronized. This makes it possible to discriminate certain stages from other stages and
allows detailed characterization of each cycle stage within the first 2 cycles. In human, hair
follicles mainly function independently of their neighbors, at least by the time when it is
ethically possible to collect biopsies (Randall et al., 2003).
A complete murine hair cycle takes about 3 weeks, whereas in human, even the unpigmented,
short vellus hairs take several months to complete a cycle. The pigmented, terminal hairs can
take several years due to a prolonged anagen. The short hair cycle in mice allows us to access
skin samples of specific time points easily during the first 2 cycles when follicles are
synchronized (Porter, 2003).
One of the current challenges in mouse genetics is describing the phenotype of individual
mutants. In order to recognize subtle abnormalities, each key stage of the mouse hair cycle have
been systematically sub-divided and standardized based on morphologic differences, onset and
progression of melanogenesis, and characterization with several other markers (Muller-Rover et
al., 2001). The dep mutant was finely characterized by histology and use of hair-related
markers, which will be presented in Chapter 5.
Originally, knowledge of hair follicles came from culture of specific cell type isolated from
human follicles. Hair follicle cell types that have been cultured include the dermal papillae cells
(Jahoda et al., 1984), ORS cells (Limat et al., 1993), connective tissue sheath cells (Reynolds et
al., 1999). The major advantage is that primary cell culture allows individual cell types to be
studied in detailed and to be manipulated in vitro. It also allows study of the interaction
between individual cell types. The major disadvantage is that cycling hair follicles can only be
maintained for a short length of time in primary culture, and that cells are not subjected to
normal cellular interactions, physical constraints and their natural environment that supplies
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nutrients and regulatory factors (Randall et al., 2003). The studies of spontaneous, transgenic
and targeted mice thus represent a better model of hair follicle function and behavior in reality.
1.3. Thesis Outline.
In this thesis, the nature of the dep hair loss mutation is investigated. The identification of the
candidate gene, Zdhhc21, will be described in Chapter 3, which includes the use ofBAC
transgenic rescue, ENU mutagenesis screen and RNA interference to verify the candidacy of
Zdhhc21.
Zdhhc2l is one of the 23 mammalian proteins originally identified by its cysteine-rich zinc
finger Dhhc-containing motif by protein sequence homology analysis. Subsequent functional
assay have identified this class of proteins to be protein acyl-transferase (PAT). During the
course of the project, the involvement of Zdhhc2l in palmitoylation has been verified in cell
culture assay by several groups. However, no mammalian model is currently available to show
a direct consequence of under-palmitoylation of a given substrate. The possibility that the dep
phenotype is a result of a defective PAT function was investigated in Chapter 4. The
identification of Zdhhc21 mutation in dep may represent the first mammalian model of PAT
activity.
Detailed phenotypic characterization of the mutant skin (presented in Chapter 5) reveals a
defective hair shaft formation during the rapid growth phase. In combination with the detailed
phenotypic characterization, and phenotypic comparison with existing mutants in the literature,
we explored the possibility that the Wnt signaling pathway may affect the epidermal
homeostasis in dep (Chapter 6).
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Chapter 2 - Study of the brown deletion (b-del) interval and mapping of
the b-del chromosomes
2.1. Introduction
2.1.1. The brown deletion complex
The mouse brown (Tyrpl) deletion complex is one of the most characterized regions of the
mouse genome defined by a collection of 25 independent deletions of various sizes, spanning
~22Mb (~8.5cM) on mouse chromosome 4. Each deletion chromosome loses one copy of the
coat colour gene, tyrosinase- relatedprotein 1 {Tyrpl), which encodes a melanocyte enzyme
required to produce dark eumelanin, without which a homozygous mouse will have brown coat
(Bennett et ah, 1990).
The set of deletions was generated as part of the specific locus test (SLT) carried out at the Oak
Ridge National Laboratory (ORNL, Tennessee) over the last 50 years (Davis and Justice, 1998;
Rinchik et ah, 1990). Wild-type mice treated with a potential mutagen (radiation or chemicals)
were crossed with the Oak Ridge test stock (T stock), which is homozygous for 7 recessive
mutations affecting visually recognizable traits, including the brown mutation (b) of Tyrpl.
Five other loci also affect coat phenotype, they are: nonagouti [a, Chr.2], chinchilla at albino
[cch , tyrosinase (Tyr), Chr.7], dilute [d, myosin Va (Myo5a), Chr.9], pink-eyed dilution \p,
Chr.7] and piebald-spotting [5, endothelin receptor type B (Ednrb), Chr. 14]; and one other
locus that controls ear morphology, short-ear [se, bone morphogenetic protein 5 (Bmp-5),
Chr.9], which is also visually detectable. These other 6 loci are also well-characterized.
After mutagen treatment, the efficacy of the treatment was assessed in the resulting F, progeny
(Figure 2.1): a brown coat phenotype indicates a newly induced allele at the Tyrpl locus. A
deletion will remove Tyrpl, along with varying amount of the genome flanking the locus. All
the deletions generated must be hemizygous viable to be recovered. Homozygotes or
'compound heterozygotes' between individual b-del chromosomes confer a phenotype, most of
which are prenatal lethal, indicating the presence of essential genes flanking the Tyrpl locus
removed by the deletion.
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Originally, genomic probes and sequences were not available, so the knowledge on the deletion
chromosomes was limited. Nevertheless, the b-del complex had been utilized as a very
powerful tool for mapping genes within the interval and investigating their functions. There
were several ways ofwhich informative data may be obtained: (1) By crossing overlapping
deletions of different extent (at Tyrpl), it is possible to identify recessive phenotypes within the
region and their candidate genes. (2) By complementation analysis of existing mutations
against the b-del panel.
Using this approach, several phenotypic loci within the region were defined. At the proximal
end was the spontaneous circling, head tossing and deafmouse whirler (wi) (Fleming et al.,
1994; Lane, 1963). Another interesting locus was the baf mutant (brown-associated fitness),
which has been mapped very closely on either side of Tyrpl (section 2.1.4). Near the distal end
of the b-del interval, was the spontaneous hair loss mutation, depilated (dep) (Green, 1970),
which will be the focus of this thesis (Chapter 3 to 6). In addition, 3 lethal mutants were
identified by Gene Rinchik using complementation analysis (Rinchik et. al., 1994) (Figure 2.2).
Over a decade ago, our lab generated a genomic map which defines the endpoints of the b-del
chromosomes using a set of 34 molecular markers scattered across the interval (Bell et al.,
1995). Each deletion chromosome has either a C3H or 101 origin, and were crossed with the
wild-derived inbred strain Mus spretus which allows us to define the deletion endpoints and the
extent ofeach deletion using polymorphic markers (Bell et al., 1995; Rinchik et al., 1994;
Simpson et al., 2000). This information had supplemented the preliminary molecular map and
allows more precise isolation of the genes that lie within the interval.
2.1.2. The brown interval - Genomic Features
In collaboration with the UK Mouse Genome Sequencing Consortium and the Wellcome Trust
Sanger Institute, the brown interval was sequenced and manually annotated using a 172-BAC
contig encompassing the interval of about 21Mb. The brown deletion annotated sequence in the
reference strain C57BL/6 is available from the Vertebrate Genome Annotation (VEGA)6
browser (Ashurst et al., 2005; Loveland, 2005). Unlike other genome browsers which are
6
Vertebrate Genome Annotation (VEGA) browser: http://vega.sanger.ac.uk
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automated, data in the Vega browser is annotated by hand, which makes it more accurate at
identifying splice variants, pseudogenes, non-coding transcripts and complex gene structures.
Intriguingly, the brown interval is unusually gene poor containing only 39 protein-coding genes
that can be identified with confidence, in that they have human orthologues or encode known or
predicted proteins (Smyth et al., 2006). This may explain why the large deletions are viable
when heterozygous. There are 14 additional transcripts that are encoded by more than one exon
and which contain a predicted open reading frame (ORF) of between 110 to 354 residues but
lack homologues in other species. In addition, the interval harbors 74 recognizable pseudogenes
and 28 spliced transcripts which do not contain any significant ORF nor homologues in other
species (Smyth et al., 2006).
The overall gene density across this region is less than 2 genes/Mb, in contrast with the genome
average of 10 genes/Mb. In addition, these genes are not evenly distributed across the region
since there are 7 stretches of 1.0-2.5Mb regions that are completely absent of any protein-
coding transcripts but however contain substantial number of non-coding segments that are
highly conserved among mammalian species (presented on the ECR browser7 Figure 2.3). If
functional, these sequences may represent cis-regulatory elements, unknown protein-coding
exons, non-coding RNA genes (ncRNAs) or unknown functional non-coding sequences (Smyth
et al., 2006).
2.1.3. Identification of Deletion Phenotypes
The first part of this thesis involves refining the endpoints of these deletions and defining the
location of essential genes deleted or disrupted by the breakpoints (Figure 2.4A).
Combinations of deletions within the interval have identified two early-acting embryonic lethal
[ l(4)lRn and l(4)3Rn ] and one neonatal lethal [ l(4)2Rn ] phenotypes. 1(4) 1Rn is mapped to a
2Mb region containing protein tyrosine phosphatase receptor type D (Ptprd), jumonji domain
containing 2C (Jmjd2c) and an uncharacterized gene, which is the mouse orthologue of human
C9orfl23 (Smyth et al., 2006). Homozygous deletion of the l(4)lRn locus results in embryonic
death, most likely around postimplantation stage (Rinchik, 1994). Ptprd has previously been
7
Evolutionary Conserved Region (ECR) browser: http://ecrbrowser.dcode.org/
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knocked out, and the Ptprd' is viable with a runting syndrome and mild neurological defects
(Uetani et al., 2000). The C9orfl23 orthologue is only 11 laa in length but contains 2
transmembrane domains that are conserved in humans, so it is likely to be a functional gene
although nothing is known about it. Therefore, Jmjd2c and the C9orfl23 orthologue are both
candidates for 1(4) lRn.
l(4)2Rn is mapped to a small region which contains only one gene: nuclear factor 1 B-type
{Nfib). Deletion of the l(4)2Rn locus causes death in the late gestation/ neonatal period. Nfib has
been knocked out, and the Nfib" mice die after birth but prior to weaning due to pulmonary
hypoplasia (Grunder et ah, 2002), which is similar to the phenotype observed in l(4)2Rn. It is
therefore reasonable to conclude that Nfib underlies the lethal phenotype.
l(4)3Rn is mapped to a larger region containing 6 genes: Frasl related extracellular matrix
protein 1 (Freml), the small nuclear RNA activating complex (Snapc3), basonuclin2 (Bnc2),
the PC4- and SF2-interacting protein 1 (Psipl), also known as lens epithelium-derived growth
factor (Ledgf) and two uncharacterized genes which are the mouse orthologues of human
C9orf52 and C9orf93. Ledgf is a chromatin-associated protein that has been implicated in
transcriptional regulation, mRNA splicing, and cell survival in vitro. Recently, an embryonic
stem cell clone with disrupted Ledgfwas identified in a gene trap screen. The homozygous
mice displays a range of phenotypes, and the majority of them died perinatally (Sutherland et
ah, 2006). Since lethality of 1(4)3Rn occurs much earlier in pre-implantation stage, Ledgf is
unlikely to be a candidate of l(4)3Rn.
Dep is a hair loss mutant (Figure 2.4C) that has been mapped to a very small region; its
candidate genes will be discussed in Chapter 3.
The TyrplHW allele contains an inversion with breakpoints at Tyrpland basonuclin 2 (Bnc2),
inverting about 5Mb of the chromosome (Javerzat and Jackson, 1998). RT-PCR shows that the
Tyrpl-Bnc2 fusion transcript expressed not only in melanocytes but also in kidney, liver, ovary
and testis. It is speculated that the ectopic expression of fusion transcript results in melanocyte
death and loss of hair pigmentation, which characterizes the phenotype.
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2.1.4. Brown-Associated Fitness (baf) - small mouse with increased mortality
All of the brown deletions are prenatally lethal when homozygous; however, some of the
crosses between individual blelhal deletions were able to rescue the lethal phenotype, resulting in
a runting syndrome evident during postnatal development (Rinchik, 1994). These mice are
smaller in body size with increased mortality and usually die before weaning. Since this
phenotype is recessive and lies very close to Tyrpl, all the viable mice also display a brown
coat. Because of this, the locus is called brown-associatedfitness (baf).
A large number of pairwise crosses between individual b'elhal deletions have been made in the
ORNL, which is reported in Rinchik (1994). Later, it was found that some compound
heterozygotes that deleted a minimal region around Tyrpl were viable and normal
(unpublished, Eleanor Simpson and Ian Jackson). Part ofmy project was to try to identify the b-
region whose deficiency results in the reduced fitness observed in baf
2.1.5. Regional ENU mutagenesis screen (Baylor College of Medicine)
Deletions spanning the brown interval have been used as the basis for a regional ENU
mutagenesis screen for recessive phenotypes at the Baylor College ofMedicine (Figure 2.5A).
The basic idea is to use the brown deletions with known endpoints to isolate novel ENU-
induced mutations that lie within the deleted region. The mutation is immediately localized to a
specific chromosomal location, sidestepping the need to map a mutation.
About 550 chromosomes were tested over the largest proximal brown deletion (b-11R30M) and
360 were tested over the largest distal deletion (&-13R75M). As a result, more than 26 mutant
phenotypes have been isolated, including 6 lethal, 10 neurological and 7 with craniofacial/
skeletal defects, one with hearing defect and another with eyes open at birth (Table 2.1, Figure
2.5B).
Table 2.1. ENU mutants isolated by regional ENU mutagenesis
The 2-generation recessive scheme has isolated a number ofENU mutants of various
jhenotypes, using the largest proximal and distal brown deletion chromosomes.
Lethal Neurological Craniofacial/ Skeletal Other
b-\ 1R30M 1 9 5 2 (e.g. deafness)
A-13R75M 5 1 2 1
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Collaboration has been established with the Wellcome Trust Sanger Institute to sequence all of
the known and predicted exons in protein-coding and highly conserved non-coding elements
within brown interval in the 26 mutant animals derived from the screen. Assuming that most
mutant phenotypes are unigenic and are caused by an ENU mutation in a protein-coding gene,
the sequencing approach would be time and cost effective in comparison to the
complementation analysis. Currently, the sequences are being analyzed to flag mutations, and
to distinguish any signal from noise.
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Figure 2.1: The Specific Locus Test (SLT) carried out at Oak Ridge National Laboratory
Wild-type mice were exposed to radiation to induce mutations in germ cells, and then crossed with
a special T stock which is homozygous for several recessive visible mutations. From this, new
mutations at any of those 7 loci of the treated parent can be detected easily in the F l progeny. In
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Figure 2.2. Complementation analysis of the b-del complex
(Diagram from Simpson et al, 2000)
The deletions represented by the black lines are lethal when homozygous, but when compound
heterozygous, some of them exhibit the Arz/'phenotype. The b-del deletion panel has been
exploited this way in developing correlated physical and functional maps of the interval. For
example, l(4)2Rn was mapped to between the distal endpoints ofA and D based on the
observation that deletions of type A complement l(4)2Rn but deletions of type D do not.
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Figure 2.3. Conservation across different species within the b-del interval
An overview of the b-del interval showing conservation across different species. The diagram was drawn
in the ECR browser (Ovcharenko et al., 2005), which is a convenient tool for quick visualisation of
multiple genome alignments. With the mouse genome being the reference sequence, the whole interval
was aligned with corresponding regions in fugu, chicken, rat, dog and human. However, only human data
is complete. The other species have some data missing. Individual peaks represent presence of<100bp
long sequences that have over 75% identical w ith the mouse sequences. The blue are conserved seqs in
coding exon, the pink are conserved seqs in introns, and the red are just any sequences that meet the
criteria. The 7 gene deserts are highlighted with green lines, within which lies a considerable amount of
conserved regions between human and mouse. The interval is very gene-poor especially the region of
over 2Mb that is completely devoid of genes.
Blue bar - coding exon; yellow bar - UTR; pink bar - intron; red bar - intergenic element.
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Figure 2.4: Mapping of mutants using complementation analysis against the b-del complex
[A] Several mutant loci (!4Rnl, l4Rnl, l4Rnl, bqfand dep) were defined by complementation analysis
against the b-del complex, and subsequent fine-mapping of the endpoints of informative b-del
chromosomes (grey bars) using polymorphic markers. These markers distinguish between the C3H/101
and M. spretus backgrounds in the b-dell spretus heterozygotes. The mapped loci contain (or overlap
with) candidate genes that may underlie the phenotype. The largest proximal and distal deletions, b-
11R30M and 6-13R75M respectively (pink bars), were used for the regional ENU mutagenesis screen
described in section 2.1.5. Fine mapping has also revealed that the further proximal and distal deletions
of the b-del complex are b-11R30M and />-8Pub respectively. Only informative genes are shown.
[B] The bafmutant compared against wild-type control, showing that the bafmutant is obviously smaller
in size in comparison with a wild type control littermate.
[C] Homozygote dep mutant showing the regional hair loss, although the phenotype is heterogenous in



































Figure 2.5: Regional ENU mutagenesis screen
[A] A simple two-generation scheme for isolating recessive phenotypes. Wild-type mice were treated
with ENU before crossing with a brown mouse that carries homozygous brown mutation (Tyrplhb). The
ENU-mutagenised chromosomes were then placed over 2 specific brown interval deletion by crossing
with mouse carrying a known deletion. The resultant offspring are phenotypically screened for
abnormalities.
[B] Three examples of ENU mutant generated by the regional ENU mutagenesis screen. Out of the 26




Deletion (e.g. b- \ 1R30M)
White-based brown
M/Bu(carrier) b! del b/ B"
[B]
Short Scrunched Hunchback Pinhead
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2.2. Results
Some of data presented in this section were published recently (Smyth et al., 2006). Here 1
describe my contribution to the work (details ofmy contribution are available in Appendix IA),
which mainly involves refining deletion endpoints that define a mutation, so as to include or
exclude certain genes of interest. In short, my major findings include:
- Out of 2 sub-groups of proximal and distal deletions, the furthest proximal and distal deletions
were identified to be b-11R30M and 6-8Pub respectively.
- The extent of the b-del interval was thus defined.
- The furthest proximal deletion chromosome, b-11R30M does not include Rgs3.
- The involvement of brown interval gene 1 (Bigl) in bafwas excluded.
- The involvement ofmultiple PDZ domain protein (Mpdtz) in bafwas excluded.
- The dep region was reduced to 160kb which includes zinc finger DHHC domain containing
21 (Zdhhc21), Cerberus 1 (Cerl) and only part ofFreml.
In addition, an RT-PCR expression profile of the brown interval was generated, which will
serve as a useful resource for future studies of the interval.
2.2.1. Study of the brown interval and mapping of b-del deletions
(i) Gene Annotation of the b-del interval
To define the extent of the b-del interval, the endpoints of the furthest proximal deletion and the
furthest distal deletion were refined by using polymorphic markers that define the endpoints. To
date, the furthest proximal and distal deletions were confirmed to be Tyrpl"R30M and Tyrpf"B
respectively, and the brown interval is approximately 22Mb in physical length (Table 2.2.).
The b-del chromosomes have a C3H/101 background, and is maintained by crossing with Mus
Spretus. Mus spretus is a wild-derived inbred strain that is evolutionarily distant from Mus
musculus, from which common inbred strains such as C3H and 101 are derived. Therefore any
short sequence in the (C3H/101) x Spretus mice is likely to contain several single nucleotide
polymorphisms (SNPs).
These SNPs can be detected by comparing amplified sequences from Mus spretus and the Mus
musculus-derived inbred strains. Informative regions were then amplified from the b-del mutant
in question and analysed using sequence analysis software. At individual SNPs, a double peak
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would indicate that the C3H/101 chromosome is retained; whereas a single peak (of Spretus
origin) would indicate that the C3H/101 chromosome is deleted at that point. An example is
shown in Figure 2.6.
All deletion endpoints that define the loci being studied (i.e. l(4)lRn, 1(4)2Rn, l(4)3Rn, dep and
baf) were refined by further markers. The data is summarized in Table 2.2. Mapping data of
individual b-del chromosomes and sequences of primers are included in Appendix IA and IB.
Sequences of primers used for mapping key chromosomal endpoints can be found in
supplementary table 2 and 3 in Smyth et al (2006).
Table 2.2. Relative location of Oak Ridge deletion endpoints that defines the mutants





Just distal to (deletes) regulator ofG-
protein signaling 3 (Rgs3)
Lies about 300kb distal ofmultiple
PDZ domain protein (Mpdz).
Furthest distal: b-
8Pub
Cuts between Ptprd exon 9 and 10. Loss at Bnc2-3'.
Baylor's furthest
distal: 6-13R75M
Lies within a gene desert between toll¬
like receptor 4 (Tlr4) and 'deleted in
bladder cancer 1' (Dbccrl).
The R/L region* includes Snap,
Psipl and 3 novel genes.
1(4) lRn
Proximal end of b-1 lPu: cuts Jmjd2c
(exon 18 to 3')
Proximal end of 6-8Pub [as above]
l(4)2Rn Distal end of b-11R30M [as above]
Distal end of 6-9R75VH: cuts Nfib
(5' to exon4)
l(4)3Rn Distal end of />-46UTHc: cuts Freml. Distal end of 7>-8Pub [as above]
dep (depilated)
Distal end of b-IOZ: does not disrupt
Zdhhc21.
Distal end of b-46UTHc [as above]
Baftbrown-
associated fitness)
Proximal end of Z>-46UTHc and b-IOZ:
lies within gene desert between Ptprd and
Tyrpl
Distal end of 6-37DTD, MTHO-IV,




Tyrpl intronl, 105bp from exon2 splice
acceptor site.
15kb upstream of Bnc2, distal of
deletion complex.
* 'R/L region': the distance between the two markers that are 'retained' and Toss' at that point respectively.
A Please refer to Appendix IA for the markers that define the endpoints, and Appendix IB for primer sequences.
(77) Generation of an RT-PCR expression profile for the brown interval
Gene expression patterns across the whole interval were characterized by RT-PCR for the 39
known genes and 14 putative coding transcripts within the interval. RNA was extracted from
BALB/c for the following tissues: brain, ES cells, eye, heart, kidney, liver, lungs, ovary, spleen,
testis, E9.5, E12.5 and E16.5 embryos. Most genes are widely expressed; some have alternative
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splice forms (Table 2.3). This provides resources for gene identification in mutant mouse
strains within the b-del interval. RT-PCR showing multiple bands were repeated and cloned for
sequencing to confirm the expression of gene. They were also checked in VEGA for alternative
splice sites that may have resulted the multiple band appearance.
The RNA expression profile may serve as a useful resource for studying the Baylor mutants
isolated from the regional ENU screen once their mutations are identified.
2.2.2. Mapping the distal baflocus
More than half of the pairwise crosses between individual bk,ha' deletions results in the baf
phenotype, and less than half of them are prenatally lethal (Rinchik, 1994). In addition, there
were a few combinations that result in phenotypically normal mice. These combinations delete
a minimal region around Tyrpl, and include the following: Tyrpl'oz/37DTD, Tyrpl46UTHc/ 330,
Tyrpl46urHa 37D"\ and Tyrpl46irrHc' ,rHO~lv (E.M. Rinchik, unpublished) (represented in Figure
2.8.).
Combining the pairwise complementation crosses and our mapping data, bafhas been mapped
to 2 positions, one of which is Ptprd (the proximal baf) based on the observation that minimum
proximal bafdeletions delete the 5' end of Ptprd. On the other hand, combinations that do not
delete Ptprd but delete distal DNA still exhibit a baf-\ike phenotype. Therefore, a second baf
locus distal to Tyrpl must exist.
My involvement of this project was to investigate this second locus. To map the distal baf the
endpoints of the £>a/-associated deletions were further refined using additional polymorphic
markers (C3H/101x Spretus). The orthologue of human C9Orfl50, which we termed the brown
interval gene (Bigl hereafter), is an uncharacterized gene that lies 70kb distal of Tyrpl. Using
polymorphic markers, the involvement ofBigl is ruled out based on evidence that Bigl is
deleted in 2 non-bafdeletions (i.e. b-33G and &-37DTD in Figure 2.7B).
Mpdz involvement is also considered less likely based on a previous finding that Mpdz is
retained in two distal ^/-associated deletions including &-173G and 6-47DthWb (Simpson et
al., 1999b). When both deletions were crossed to deletions that contain intact Ptprd (e.g. b-
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46UTHc) respectively, the offspring still have the bafphenotype (Rinchik, 1994). The &-173G
deletion retains exon2 ofBigl (see Appendix 1, 'Bigl-ex2'), which is 320kb from the 3' of
Mpdz. The 6-47DthWb deletion is retained at a marker that is 152kb from the 3' ofMpdz
(Appendix 1, '395J04-10k'). This indicates that an intact Mpdz is unable to rescue baf, and so
Mpdz is unlikely to underlie baf.
Therefore, we conclude that the distal bafmust be between Mpdz and Bigl. A summary of the
final mapping of baf is presented in Figure 2.8. Details of the mapping of baf-associated or
complementing deletions and sequences of the marker primers can be found in Appendix IB,
and the major primers are published as supplementary data (Smyth et al., 2006).
To date, the distal baf locus is further refined to a 179Kb region (between markers 395J048 and
s79.489) that is about 2.7Mb distal ofPtprdl; and 73Kb proximal to Mpdz. When blasted
against the human and dog genomes in the ECR browser (Ovcharenko et ah, 2005), this region
was found to harbor several highly conserved elements with stringency of at least 500bp and
about 80% identity (e.g. 87% of 412bp, 93% of 155bp with human).
8 395J04 primers: 5'GGGTTGTGGGTTCTCAGTG-3'(F) and 5'CTAGCTAGCGTTTCGTGCAG-3'(R)
9 S79.48 primers: 5' GTGAGTGTGTGGGGGACTTT -3'(F) and 5' TCCCTGCTCCTATTGCATCT -3'(R)
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CO LU X * -J -J o c/> cn K LU LU LU LU LU LU UJ
Ambp 249 + + + + + + + + + + + + + + + + + +
Kif12 169 - + - - + + - - - + - - + - + + - +
Col27a1 275 + + + + + + + + + + + F + + + + + +
Orm1 223 - - + + + + + F + + - F - - - + + +
Orm3 222 - ? - - - + - - - - - - - - - F F F
Orm2 216 - - - F - + - + + - + + - +
Akna 182 F + + + + + + + + + + + + + + + + F
Whrn 198 + + + + + + + + + + + F + + + + + +
Atp6 168 + + + + + + + + + + + + + + + + + +
C90rf91 205 + + + + + + + + + + + + + + + + + +
Tnfsf15 207 - F - F + + + + ? - - - F F F F F F
Tnfsf8 250 - - + + + + + - F + - + - - - + + -
Trie 416/260 - + F F F - - + + - - - + +
Pappa 173 + + + + + - + + + + + + + +
Astn2 344 + - + + + + + + F + + F + + + + + +
Trim32 140 + +
Tlr4 499 + - + + + + + + + + F + - +
Dbccr 277 + - + ? ? ? + - - - + - + + + + + +
Cdk5rap2 172 + + + + + + + + + + + + + + + + + +
Egf15 262 + F + + + + + + + + + F + + + + + +
Tle1 242 + + + + + + + + + + + + + +
Rasef 198 - + + F + + + + + + + + + + + + + +
Frmd3 207 + + + + + + + + + + + + + + + + + +
Jmjd2c 284 + + + + + + + + + + + + + + + + + +
NM025849 271 + + + + + + + + + + + + + + + + + +
Ptprd 257 + + + + + + F + + - + F + +
Tyrpl 285 + - + + + - - + +
Big1 178 + - F F + + + + +
Mpdz 518/224 + + + + + + + + + + + + + +
Nfib 244 + - F F + + - + + - F - + +
Zdhhc21 239 + + + + + + + + + + + + + + + + + +
Cer1 420 -
Freml 235 + F + + + + + + + + + + + + + + + +
C90rf52 332 + + + + + + + + + + + + + + + + + +
Snapc3 295 + + + + + + + + + + + + + + + + + +
Ledgf 503 - + - + + + - + - - + + + +
C90Orf93 230 + + + + + + + + + + + + + + + + + +
Bnc2 238 + + + + + + + + + + + + + + + + + +
Transcripts > 1 exon, contains ORF.




*ts68.8 246 + + + + + + + + + + + + + + + + + +
ts76.8 148 ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
Gapdh




'F' faint band (but may be expressed);
'?' RT-PCR result was inconclusive, may represent multiple bands that are yet to be verified.
Blank - not completed.
* 'ts68.6' and 'ts68.8' are specific RT primers for amplifying the 10-fold repeat transcript (Smyth et. al.,
2006).
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Figure 2.6: Deletion Mapping
At the nucleotide base where C3H/101 (base A) and spretus (base T) are polymorphic, the double peak in
Deletion A (base T/A) shows that both C3H/101 and spretus DNA are present at this genomic location,
meaning that the chromosome is not deleted at this point. Whereas Deletion B only has a single peak
(base T), showing that the C3H/101 -derived chromosome is deleted at this point, and that the observed
sequence is derived from spretus.
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Figure 2.7: The involvement of Big1 is ruled out in baf
[A] The relative location of Tyrpl, Bigl and Mpdz (VEGA browser). The distal /^/region was mapped
within this region (Each bar line represents a 20-kb interval).
[B] Sequence traces showing that Bigl is not related to buf. The three b-del mutants A-ITHO-IV, b-
37DTD and A-33G that carry a spretus chromosome are all normal (non-buf). How ever, each one of them
deletes, disrupts or retains Bigl respectively, showing that the presence or the loss ofBigl does not alter
the Aa/phenotype and must therefore be unrelated to baf
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Figure 2.8. Final mapping of baf to two positions on either side of Tyrpl
The proximal haflocus is defined by a non-fo//deletion A-46UTHc and a tar/deletion /?-9R75VH. The
179-kb distal baflocus is defined by the furthest distal non-for/ deletion 6-1THO-IV and the furthest
proximal bafdeletion b-\73G. Green bars represent the distance between the two markers that are
'retained' and Toss' at that point respectively. The vertical black line indicates the 179-kb region of
highly conserved elements where the distal haf is now mapped. Fine map of the deletion endpoints are
































2.3.1. Mapping of baf
In this study, the bafdeletion was finely mapped by refining the deletion breakpoints of the b-
del chromosomes using sequence polymorphisms. As a result, 2 loci were identified.
The proximal locus is likely to be Ptprd because some of the non-complementing (baf)
deletions lose part of the coding Ptprd and results in the bafphenotype. This is supported by
previous literature that Ptprd'' mice have neurological defects that is consistent with those
observed in many of the ia/deletions (Uetani et al., 2000). Therefore, the disruption ofPtprd is
likely to underlie baf. However, in some cases, even though the coding region ofPtprd is intact
in the b-del chromosomes; they do not complement baf. Therefore, we conclude that a second
locus must exist within the mapped region.
Initially, Bigl and Mpdz have both been considered candidates of the distal baf region,
however, the involvement of both genes was ruled based on: (1) Bigl is deleted in two
complementing (non-baf) deletions; and (2) Mpdz is retained in two non-complementing (baf-
associated) deletions. This is consistent with previous findings in our lab that Bigl does not
rescue bafphenotype completely although it seems to rescue the male hypogonadism to a
limited extent but with varied phenotypes (Andrew Childs, unpublished data).
Using further markers, the distal region is now reduced to a 179kb region, which contains
several highly conserved elements. These elements do not encode known or predicted genes.
Therefore, it is conceivable that they may represent potential regulators of Ptprd, separated
from its target gene by Tyrpl (and Bigl). This is consistent with the fact that, although the
effects of the bafmutation are heterogeneous, individual bafmutants of the proximal and distal
6-deletions can not be distinguished from each other. So the proximal and distal loci may be in
the same expression pathway, thus have similar effect as deleting Ptprd itself.
Nevertheless, we do not rule out the possibility that the distal deletion may delete regulatory
elements for other genes, such as Mpdz, or a distant gene on the chromosome (Kleinjan and van
Heyningen, 2005). But given the above data, this possibility seems less likely. To assess
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whether the 179-kb segment contains elements that underlies baj\ the region could be deleted
with a simple deletion to observe the consequence of it.
2.3.2. Expression Patterns of genes across the b-del interval
The RT-PCR results (Table 2.3) indicate the presence of transcripts in the selected tissues;
however, it is not informative for determining the level and specific location of expression. In
addition, there are alternative ways of looking at expression patterns that are readily available
in the following databases:
-NCB1 (Jax/ Unigene) cDNA
-EMAGE database http://genex.hgu.mrc.ac.uk/Emage/database/emageIntro.html (mouse)
-SAGE data http://5sage.gi.k.u-tokyo.ac.jp (human line)
-Microarray http://www.mged.org/index.html
-MPSS (massively parallel signature sequencing) http://mpss.licr.org/ & http://sgb.lynxgen.com
-EURExpressII http://www.eurexpress.org/ee/intro.html (mouse embryos RNA in-situ)
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Chapter 3 - Molecular analysis of dep
3.1. Introduction
3.1.1. Mapping of dep interval
The original background on which the dep mutation arose was an offspring of a cross between a
mouse that was T/tufted(tf) and a mouse that was C57BL/10 (Green, 1970). The T/tf line was a
stock used for study of the T-complex on mouse chromosome 17, and is heterozygous for
Brachyury (on one chromosome 17) and tufted (on the other chromosome 17). According to the
information supplied by the Jax® database10, dep was subsequently crossed to various strains
including CBA/Ca, Sec/1 and C3H, before it was crossed to C57BL/6 for 85 generations. Since
the re-derivation of the strain at the MRC, dep has been maintained by homozygote crosses
until recently, dep was crossed once to C57BL/6, and subsequently maintained by heterozygote
crosses for the purpose of obtaining age-matched controlled littermates for homozygotes.
Over the past 50 years, a panel of 30 chromosomal deletions within the 22Mb brown (b, Tyrpl)
interval has been generated at the Oak Ridge Laboratories as part of the specific loci test (SLT)
(Davis and Justice, 1998). Dep was initially mapped to the b-del interval by a 3-point cross for
studying the linkage of dep with brown (Tyrpl) and pintail (Pt) on chromosome 4 (Mayer et al.,
1976). The recombination frequency for the brown-dep was estimated to be 1.93, meaning that
the chance of the two loci being segregated is low, and thus the 2 loci are likely to be closely
linked.
In combination with the sequence data generated from BAC contig, the brown deletion
endpoints have been utilized to define the dep interval, which has been mapped to a very small
region at the distal end ofmouse chromosome 4.
This is defined by complementation analysis of dep against the b-del deletion panel. Out of the
30 deletion chromosomes, b-dell0Z is the furthest distal deletion that when crossed to dep, the
offspring exhibit the hair loss phenotype. b-def6UT c is the furthest proximal deletion that yield
10
Breeding history of dep available from: http://jaxmice.jax.org/strain/003020_3.html
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offspring with normal appearance when crossed with dep (Rinchik, 1994). This indicates that
the mutation of dep most likely lies within the genomic difference of these 2 deletions, defined
by the distal breakpoints of both b-dell0Z and b-del46mHo (Figure 3.1A). The endpoints of these
deletions were further refined by polymorphic markers, and from this the region has been
reduced to about 160kb which contains 3 genes that lie at the distal end of the b-del complex;
Zdhhc21, Freml and Cerberusl (See Table 2.2. and Figure 2.4.).
Nevertheless, there may also be a possibility that a regulatory element of a distant gene is
deleted or disrupted in dep. However, our subsequent data shows that Zdhhc21 is most likely to
be affected in dep.
3.1.2. Zdhhc21 is the most probable candidate for dep
Despite its expression in developing hair follicles, previous literature has shown that Freml is
associated with 2 ENU-induced alleles and the classical mutation head blebs (heb) which is
characterized by the formation of embryonic subepidermal blisters, leading to subsequent
eyelid and limb defects after birth (Smyth et al., 2004). Furthermore, complementation analysis
between a Freml mutant (bfd) and dep gives normal mice (unpublished data, Monica Justice),
suggesting that Freml involvement in dep is unlikely. In addition, no Freml mutations were
found in DNA of dep mice. Cerl has also been knocked out previously but the null mutants do
not exhibit dep phenotype (Shawlot et al., 2000; Simpson et al., 1999a). All known exons of
both genes have been sequenced in dep but no mutations were found. Having ruled out the
involvement of the other 2 genes, Zdhhc21 remains most likely candidate for dep.
3.1.3. Functional domains of Zdhhc21
The mouse Zdhhc21 (zinc finger, DHHC containing protein 21) encodes a 31.2kDa protein of
265a.a. that has 4 predicted membrane-spanning domains and a cysteine-rich domain (CRD)
containing a conserved DHHC (Asp-His-His-Cys) motif. The entire protein is encoded by 7
exons, each of which encodes part of a functional motif predicted in Ensembl (Figure 3.1C).
The orthologous gene is located on 9p22.3 in human; and 23 DHHC members have been
identified in human and mouse genome.
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The DHHC-type zinc finger domain (Znf^dhhc), was first isolated in the Drosophila putative
transcription factor DHZ1 (Mesilaty-Gross et al., 1999). The Znf_dhhc domain is highly
conserved among all other DHHC-family proteins, however, the rest of the sequences share
little or no homology beyond this consensus domain (Mitchell et al., 2006). However, it is
predicted that mutation within the Znf dhhc domain in different family members may disrupt
similar cellular function even though the resulting phenotypes may be diverse. The function of
the Dhhc family as a palmitoyl acyl transferase (PAT) will be discussed in Chapter 4.
3.1.4. Zdhhc21 (del-233F) mutation in dep
On sequencing the 7 exons in Zdhhc21, a 3-bp deletion was identified" in dep by comparing to
the wild-type sequence (Figure 3.1 B). The mutation deletes one single phenylalanine amino
acid at residue 233 (del-233F). The phe233 residue lies in the C-terminal tail, downstream of
the 4 transmembrane (TM) domains but does not lie within any functional domains predicted in
Ensembl (Figure 3.1 C). Nevertheless, the C-terminal may encode a function that has not yet
been recognized. Bioinformatics predictions using online structural prediction algorithm12
predicts the functional Dhhc motif and the C-terminal of the protein to be intracellular on the
basis of in-out structure (represented in Figure 3.1C).
11
dep mutation: the Zdhhc21-del233F was identified previously by Ian Smyth.
12
Transmembrane topology was predicted by TMHMM (http://www.cbs.dtu.dk/services/TMHMM-2.0/)
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Figure 3.1: The dep mutation
[A] Mapping of the dep interval against the b-del complex. When dep is crossed with the deletion of b-
IOZ (bars indicates extent of deletion), the offspring exhibit the hairloss phenotype, but w hen crossed
with A-46UTHc, the dep phenotype disappears, indicating that the dep mutation must lie within the
genomic difference of the distal breakpoints of the 2 deletions.
[B] Sequence trace showing a 3-bp deletion in Zdhhc21 found in dep. The deletion of the 3 nucleotides:
TCT lie in exon 7 ofZdhhc21, which has not been predicted to encode any functional domain. The
deletion is not in-frame but as a result deletes one single amino acid residue at a.a.233, Phenylalanine (F).
[C] The location of dep mutation in Zdhhc21. The dep mutation is at the C terminal of the Zdhhc2l,
which is not within any of the predicted functional domain. The seven exons are indicated by alternating
pink and purple bars. The red dotted line indicates the proposed transmembrane topology ofZdhhc2l as
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3.1.5. Molecular study of Zdhhc21 candidacy for dep
To verify the involvement of Zdhhc21 in dep, 3 main approaches were used to answer firstly,
whether wild-type Zdhhc21 has an effect on dep phenotype; secondly, whether other Zdhhc21
mutants resemble the dep phenotype; and thirdly, the effects of knocking down Zdhhc21
expression with RNAi.
To address the first approach, we used a BAC transgenic rescue experiment to ask whether a
normal copy of Zdhhc21 is able to rescue dep. So far, one rescued line has been generated that
shows the rescued phenotype robustly. The second approach is to screen the candidate gene in
an archive of DNA samples from individual ENU-mutagenised mice. One missense mutation
has been isolated so far (L91F). A new screen on the Riken ENU-archive is also under way and
may isolate some new alleles. The third approach to study Zdhhc21 function was by mean of an
siRNA knockout experiment using pDECAP vector (Shinagawa and Ishii, 2003) to examine the
effect of knocking down Zdhhc21 expression in transgenic mice. Despite some potentially
interesting findings, this approach lacks consistency and a robust marker for assessing RNAi
transgene expression is required.
(i) BAC transgenic rescue experiment for dep
Utilisation of BAC to rescue a phenotype of interest
Bacterial artificial chromosomes (BACs) are DNA vectors that are capable of holding large
DNA inserts of up to 300kb. They are essential tools for mapping the genomes ofmost
organisms. Recently, BAC inserts have been used to generate transgenic mice in high-
throughput mutagenesis programme (e.g. EUCOMM). The advantage ofBAC transgenesis is
its convenience of propagation and DNA preparation, and the ease of modifying genomic DNA
by recombineering (Sparwasser and Eberl, 2007).
Recently, highly efficient phage-based E.col'x homologous recombination systems have been
widely used to enable large fragments ofDNA such as BACs to be modified and subcloned by
the use of recombination functions that are encoded by phages, without the need for restriction
enzymes or DNA ligase (Copeland et al., 2001; Warming et ah, 2005). Also because of its
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ability to incorporate large genomic regions, BAC transgenesis allows potential regulatory
regions to be included with the targeted gene.
Rescue of dep phenotype using BAC containing Zdhhc21
Given the evidence that suggests Zdhhc21 to be the candidate of dep, the introduction ofwild-
type Zdhhc2\ expression may reverse the mutant effects in vivo. To test this hypothesis, a BAC
transgenic rescue experiment was carried out by introducing a normal copy of Zdhhc21 into
mutant embryos to see if it is able to rescue the dep phenotype. To date, one transgenic line has
been successfully generated by an unmodified RP23-76J17 BAC construct. This indicates that
the BAC has been properly incorporated into the genome and that the transgene was
successfully expressed. Most importantly, it confirms that Zdhhc21 is indeed the causative
protein of dep.
(ii) Gene-driven Approach for isolating Zdhhc21 allelic series
To isolate an allelic series of Zdhhc21, a gene-based screen of two Zdhhc21 exons was carried
out on an archive of-5300 DNA samples from individual F1 ENU-mutagenised mice [BALB/c
(ENU) X C3H], The archive was generated by a dominant genome-wide mutagenesis screen at
the MRC Mammalian Genetics Unit at Harwell (Figure 3.2). Individual exons of the target gene
may be chosen for high-throughout genotyping in the archive. Each of these DNA samples is
paralleled with a frozen sperm sample that can be used to reconstitute stocks by a number of
assisted reproductive technologies including artificial insemination, IVF and intracytoplasmic
sperm injection (ICSI) (Justice et ah, 1999). Live births resulted from the backcross may
subsequently be used for functional analysis and for comparison with dep.
The gene-driven approach is reported to be very powerful in generating a variety of alleles with
potentially different phenotypic outcomes resulted from different mutations of the same gene
(Quwailid et ah, 2004). The target gene is selected and screened for ENU-induced point
mutations in an archive of genomic DNA samples paralleled by frozen genetic material such as
sperm, embryos and ES cells. Once an allele is identified, the mutant line can then be recovered
in live animals for detailed phenotypic analysis.
ENU is an efficient mutagen which induces point mutations at random throughout the genome
at a rate of 1.5- 1.6 mutations per locus per 1000 mutagenised offspring (about 1 in 600)
depending on dose and mouse strain (Justice et ah, 1999). Quwailid and colleagues (2004)
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reported a mutation rate of 1 in 1.01 Mbp of which 1 in 1.82 Mbp were potentially functional.
In addition, approximately 64% of ENU mutations are reported to cause nonsynonymous
mutation. Using this approach, series of alleles of candidate genes can be isolated, which will
greatly facilitate the investigation of gene function (Justice et al., 1999).
(iii) Knocking out Zdhhc21 using siRNA technology (pDECAP-Zdhhc21J
To study the gene function of Zdhhc21 in vivo, the most direct way is to knock out gene
expression in ES cells and determine the functional consequence in mouse. However, a
possibly easier alterative such as RNA interference (RNAi) may be used to silent gene
expression specifically. RNAi aims to introduce double-stranded DNA (dsDNA) into the cell,
where it induces degradation of complementary mRNA and thereby suppresses gene expression
(Hannon, 2002).
To achieve this, the pDECAP [Deletion ofCap structure and poly(A)] vector was used in
attempt to knock down Zdhhc21 expression in C57BL/6 by RNAi mechanism. Using the
pDECAP expression vector, Shinagawa and Ishii reported a successful knockout of the
transcriptional corepressor Ski (Sloan-Kettering viral oncogene homolog) in the transgenic mice
embryos by expressing long dsRNA for Ski from the pDECAP vector. The transgenic embryos
exhibited phenotypes that were similar to those of the ^/-deficient embryos, including defects
of neural tube closure and eye formation (Shinagawa and Ishii, 2003).
The pDECAP vector expresses mRNA from the cytomegalovirus (CMV) promoter that lacks 7-
methylguanosine (m7G) cap structure at its 5' end and a poly(A) tail at its 3' end that normally
facilitates dsRNA export to the cytoplasm, where interferon synthesis may be induced. The
interferon response would otherwise lead to a block in translation and sequence-nonspecific
mRNA degradation, and should therefore be avoided.
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Figure 3.2. Gene-driven approach for isolating ENU allelic series for a given gene
The Harwell archive consists of~5300 DNA samples from individual Fl ENU-mutagenised mice,
paralleled with frozen sperm samples. The mice were all phenotypically screened and potentially carry a
dominant mutation. The archive can be screened for a particular gene using high throughput method, to
isolate an allelic series of that gene. The corresponding sperm samples may then be used to generate
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3.2.1. Genotyping the mutation
Based on the 3-bp difference between wild-type and mutant Zdhhc21, the del-233F mutation
can be rapidly genotyped on the ABB 10. PCR products of exon 7, where the mutation resides,
were amplified using 5'FAM fluorescence-tagged primers and loaded onto the ABB 10
(Materials and Methods). The genotype ofwild-type, heterozygote and homozygote can be
robustly read out by the size reading of individual peaks. Heterozygotes appear as double peak
that are 3-bp apart (Figure 3.3).
3.2.2. The F233 residue is conserved across mammals
The potential effects of the del-233F on Zdhhc21 function was assessed by comparing amino
acid conservation at this position in paralogs and orthologs within and across species.
The Zdhhc21 transcripts of different species were aligned in Clustal W (EMBL-EBI) and the
del233F mutation is conserved across mammalian species including Rattus norvegicus (rat),
Bos Taurus (bovine), Canis familiaris (dog), Pan troglodytes (chimpanzee), and Homo Sapiens
(human). However, the residue is not conserved to Fugu rubripes (Fugu) (Figure 3.4). The
alignment suggests that the 233F residue is likely to be important and the deletion of it is likely
to have a molecular consequence.
Although the Dhhc21 protein is conserved across mammalian species, the del-233F is not
conserved across other Dhhc family members (data not shown). However the residue lies 3 a.a.
upstream of a 3-residue ' VFG' motif which is conserved among several members of the DHHC
family, including Dhhc-2, 3, 4, 7, 15 and Dhhc21. In vitro assays currently suggest that this
'VFG' motif may be important for a function in post-translational lipid modification (Fukata,
personal communication, Chapter 4).
The deletion of the 3 base pairs results in a single residue deletion in dep, as a result,
subsequent codons are in frame, and the mutant protein is likely to express normally in dep.
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3.2.3. Testing expression of Zdhhc21 using RT-PCR
RT-PCR shows that the Zdhhc21 transcript is present in C57BL/6 embryos atE9.5, E12.5 and
E16.5, and a range of tissues including brain, eye, spleen, kidney, liver, lungs, ovary and testis
(Figure 3.5). RT-PCR on dep skin RNA (1-week) shows that Zdhhc21 is expressed in dep\ the
expression ofmutant transcript is confirmed by the cDNA sequences. Based on the presence of
the mutant transcript, the mutant protein is likely to be expressed (as proved by Western
blotting in Figure 4.2. and 4.4.). Therefore, we would expect the mutant protein to be defective.
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Figure 3.3: Rapid genotyping of del-233F on ABI310
The heterozygous genotype is represented by the double peak, which has size reading of'245' and '248'











Figure 3.4: The 233F phenylalanine residue is conserved across mammalian species
The del-233F residue is conserved across mammalian species including rat, dog, human, chimpanzee and
bovine, but not fugu. Asterisk (*) denotes position at which all aligned sequences share the same residue;
colon (:) and dot (.) indicate strong and weak conservation respectively.
[dep! IEKMSNCCEEISRPRKPWQQT-SEVFGTPWKILWFIPFPQRQPLRVPYHFANHV
Mis wsculus IERMSNCCEEISRPFKPWQQTFSEVFGTRWKILWFIP FPQP Q P LPVPYHFANHV
Sattas norregicns IEKMSNCCEE ISRPRKPWQQTFSEVFGTRWKILWFIPFRQRQPLRVPYHFANHV
Canis famlians IEKMSNCCEEISRPRKPWQQTFSEVFGTRWKILWFI PFRQRQPLPVPYHFANHV
Hoto sapiens IEKMSNCCEDISRPRKPWQQTFSEVFGTRWKILWFIPFRQPQPLPVPYHFANHV
Pan troglodytes IEKHSHCCEDI SRPRKPWQQTFSEVFGTRWKILWFIP FRQRQ PLRVPYHFANHV
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Figure 3.5: RT-PCR of Zdhhc21 across tissues
Zclhh21 transcript is present in wide range of tissues including ES cells, testis, brain, eye, ovary, spleen,
kidney, liver, lungs and various stages of embryos. For each RNA sample, RT-PCR ofGAPDH was run
in parallel as a control (data not shown).
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3.2.4. Investigating Zdhhc21 candidacy for dep
(i) Transgenic BAC rescue
Pep phenotype is rescued by Zdhhc21
Using an unmodified BAC, a rescue line of dep, r/e/?/<7e/?-Tg(RP23-76J 17)1 Jkn, was
successfully generated. A BAC containing an intact copy of Zdhhc21 (Figure 3.6A) was
microinjected directly into 85 homozygous dep embryos, 36 ofwhich were transferred into a
pseudo-pregnant CDl recipient13 (Figure 3.6B); from there 5 were born, of which 4 had the dep
phenotype and 1 a wild-type phenotype. This animal was identified as transgenic by PCR using
3 markers that are specific to the BAC construct, including the chloramphenicol resistance
(CmR) marker specific to the carrier vector, and the proximal and distal end of the genome-
specific region amplified with the T7 and SP6 primers flanking the BAC region respectively
(Figure 3.6B, 3.7). Alternatively, the transgene can be genotyped robustly by electrophoresis
analysis described in Section 3.2.1.
Genotyping with the transgenic markers expectedly corresponds to the rescued phenotype. The
dep/dep-Tg{RP23-l6i\l) \ Jkn mouse has a smooth and shiny dorsal hair coat that is
comparable to wild-type, whereas the hair coat of non-rescued littermates remains greasy and
disorderly (Figure 3.8). Later the non-transgenic mutant littermates lose their hair, whilst the
transgenic mouse retains its hair.
The transgenic founder was backcrossed to a homozygote female, and to date, 10 out of 17
pups also exhibit the rescued phenotype (Figure 3.9). The wild-type copy of Zdhhc21 supplied
by the transgene can be reflected by the peaks that resemble the dep/+ genotype (Figure 3.10).
Skin sections of the dep!dep-Tg(K?23-l6i 17)1 Jkn rescue mice show normal histological
appearance comparable to wild-type, confirming that the dep phenotype is adequately rescued
(Figure 3.11).
In the same litter as the transgenic founder, another mouse was also found positive for the 3
transgenic markers but its dep phenotype was not rescued. It is possible that even though the
transgene germline transmission was successful, the transgene was not expressed.
Alternatively, this animal may be a mosaic in which only some populations of cells contain the
13 The microinjection and embryo transfer were carried out by Margaret Keighren.
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transgene which were insufficient to rescue the phenotype. This possibility was investigated by
backcrossing the transgenic non-rescued mouse to a dep homozygote. If it is a mosaic, a
proportion of the offspring would be expected to show a rescued phenotype given that the
transgene is successfully passed on and expressed.
However, none of the 10 post-weaning offspring from the backcross is rescued, indicating that
it is unlikely that the lack of rescued phenotype is due to mosaicism. Alternative, the animal
might be a mosaic and that the transgene has incorporated into the genome, but was not
expressed. The expression of the transgene is yet to be tested in these animals.
Deletion of Cerl by BAC recombineering
The BAC clone that was selected for transgenic rescue of the dep phenotype, RP23-76J17, is
202Mb in length and contains an intact copy ofCerl that lies ~40kb upstream to Zdhhc21
(Figure 3.6A). This clone was selected because it contains minimal amount of known coding
DNA other than the target gene. Nevertheless, to circumvent any effect of the Cerl gene, the
BAC clone was modified to ensure that it only contains an intact copy of Zdhhc21, and that any
rescued phenotype is the sole result of the expression of candidate transgene.
The deletion of Cerl is targeted by means of a double homologous recombination system in
E.coli strain EL250 (For details, see Figure 7.1 in Materials and Methods), which involves 2
steps: First, the targeted region ofCerl was replaced with a zeocin resistance gene (ZeoR)
flanked by 2 FRT sites. Secondly, the zeoR gene and one of the FRT sites were removed by
treatment with the FLP recombinase. As a result, about 2kb of the Cerl-coding region distal to
Zdhhc21 was deleted, and was replaced with 85bp of foreign DNA. The resulting construct was
checked for rearrangement by restriction digestion, and the transgene was sequenced for
possible mutation.
The ACerl BAC construct was injected into heterozygous embryos and subsequently
backcrossed to dep (see below section). Altogether, 25 animals were born and 2 were typed
positive for the transgenic markers. However, neither the founder nor their transgenic offspring
exhibit a rescued phenotype. With the first line, the transgene was not intact as evident by a
lack ofwild-type sequence across the del233F mutation.
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With the second line, the transgene was intact but was not expressed based on RT-PCR data
using Zdhhc21-specific primers and sequencing data as described below.
Generation of the ACerl-B/KC transgenic line
As efficiency of transgenesis into some background is poor, the modified BAC construct was
microinjected into heterozygous embryos from a cross between dep and an F1 superovulated
female, which is a standard established line for microinjection. The embryos were then
transferred into a pseudo-pregnant recipient to give a heterozygous litter (dep/+), which was
genotyped for a transgenic founder. The transgenic founder (depl+ [Tg]) was further crossed to
a dep homozygote to yield a litter that may contain a transgenic carrier that is homozygote
(idepldep [Tg]). If the transgene is correctly passed on and expressed, the phenotype should be
rescued in this animal (Figure 3.12).
This method is complicated because of the difficulty in distinguishing Zdhhc21 expression
from the C57/CBA hybrid, dep and the BAC background (C57BL/6J). As a result, we were
unable to distinguish between homozygote and heterozygotes robustly by amplifying across the
del233F mutation or using polymorphic markers within the region. Therefore, markers outside
the BAC genomic regions were designed.
A program called 'SPUTNIK' (see Materials and Methods) was used to develop markers of
pentanucleotide repeats (simple sequence repeats, SSRs) that can be visualised on the ABI310
based on fragment size difference (Figure 3.13). The proximal and distal sputnik markers are
0.2Mb and 0.5Mb from the dep mutation respectively, and so if they both match, the result
should be reliable unless there were 2 or more occurrences of recombination within such
limited genomic distance, which is highly unlikely (Figure 3.6B - showing relative location of
sputnik markers).
At the proximal sputnik marker, the transgenic animal has 2 peaks that resembles that of Fl-
CBA/C57 but different from the deptC57 heterozygote, showing that the transgenic animal has
a CBA background. This is confirmed by the distal sputnik marker at which the transgenic
animal has a single peak, and is of same size to CBA and dep. Therefore, CBA and dep share
the same polymorphisms, but C57BL/6 is different at both sputnik markers. It means that if the
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transgenic founder has a CBA (instead of C57BL/6) background, these markers would not be
able to distinguish homozygotes from heterozygotes (Figure 3.13).
To overcome this problem, the transgenic founder with CBA background (fifejo/CBA[Tg]) was
crossed to a C57BL/6 mouse to switch the background onto C57BL/6 (<7ep/C57[Tg]). The
subsequent cross to dep homozygote can then be effectively genotyped by the sputnik markers
that distinguish homozygote (dep/dep [Tg]) from heterozygote (c%?/C57[Tg]) (Figure 3.12).
However, this strategy is extremely tedious and time-consuming, so alternatively, polymorphic
markers between CBA and dep may be designed to distinguish between heterozygotes and
homozygotes.
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Figure 3.6: The BAC transgenesis rescue experiment
[A] The BAC clone RP23-76J17 harbours intact genomic sequence ofZdhhc21 and Cerl. It contains an
intact copy ofZdhhc21 and about 40kb upstream of it which may contain regulatory elements for
Zdhhc21. Each bar line represents a 20-kb interval.
[B] Summary of the BAC rescue experiment. The purified BAC construct is microinjected into dep
embryos and transferred onto pseudo-pregnant female to produce a transgenic founder, which can be
genotyped by the CmR marker, and the proximal and distal end of the genomic BAC region with T7 and
SP6 that are flanking the BAC region. The position of the 2 sputnik markers were indicated [see Section
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Figure 3.7: Genotyping for the BAC transgene
Three transgenic markers were used for genotyping
the successful incorporation of transgene into the
genome. The relative positions of the marker are
represented in Figure 3.6B.
Figure 3.8: The dep phenotype is rescued
[A] By 3 week of age. a significant difference can be observed in the rescued homozygote by the smooth
and shiny dorsal hair coat, comparing to the non-rescued littermate, which exhibits the typical matted and
disorderly pattern and sparse hair around the eyes. [B] The difference remains apparent at week 6.
Figure 3.9: Offspring of the transgenic founder
Backcross litter between the original transgenic founder (dep/dep-Tg(RP23-76J 17)1 Jkn) and dep
homozygote, in which 2 out of 4 are rescued. Altogether, the original rescued founder has generated 10
out of 17 rescued mouse, showing that the transgene is robustly incorporated into genome and
successfully passed on to the next generation.
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Figure 3.10: Alternative genotyping for the transgene
The presence of a wild-type Zdhhc21 copy may be tested
robustly on the ABI310 as described in Section 3.2.1. The
presence of the wild-type peak, labeled '248', would
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Figure 3.11: H&E sections of rescue and non-rescue littermate
At the same age, the rescue and non-rescue mice are in mismatched hair stage. The anagen follicle in the
non-rescued mouse (arrow) appears to be abnormally small.
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Figure 3.12: Alternative breeding scheme for generating BAC transgenic rescue animal
The BAC construct was microinjected into heterozygous embryos which were then transferred into a
pseudo-pregnant recipient to give a heterozygous litter (dep/+). The transgenic founder (depl+ [Tg]) was
further crossed to a dep homozygote to yield a litter that may contain a transgenic carrier that is
homozygote (dep/dep [Tg]). If the transgene is correctly passed on and expressed, the phenotype should
be rescued in this animal (red box). The transgene may be genotyped by markers ofCmR and the
proximal and distal BAC ends. Homozygotes and heterozygotes are distinguished by using markers
Hanking the BAC region to avoid the effect of the BAC transgene (Figure 3.6B).
CBA and dep share the same polymorphism at both BAC-flanking markers, whereas C57 is
polymorphic. Since the heterozgoous transgenic animal will have 50% chance of inheriting either CBA
or C57 background, they were genotyped before backcrossing to dep. Animal w ith a CBA background
were transferred onto a C57 background before backcrossing to dep (blue box). Tg, transgenic.
F1 C57/CBA y
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Figure 3.13: Markers flanking genomic BAC region
At the proximal marker, depl+[Tg] has 2 peaks similar to that ofCBA/C57 but is different from dep/C57,
showing that the mouse has a CBA background. At the distal marker, dep/+[Tg] has a single peak, which
is the same size of that ofCBA and dep. Therefore, CBA and dep share the same polymorphism at both
markers, and that this animal has a CBA background. For distinguishing homozygotes from
heterozygotes, the animal must have a C57 background.
Proximal sputnik Distal sputnik























(ii) Isolating new Zdhhc21 mutations from Harwell ENU archive
One Zdhhc21 allele (L91F) is isolated
The MRC Mammalian Genetics Unit has an archive ofDNA samples from mutagenised mice,
matched with frozen sperm from the same animals. I screened the DNA from this archive for
new mutations in Zdhhc21. Altogether, about 5300 samples from the Harwell ENU-archive
were successfully screened in exon 3 and exon 4 of Zdhhc21 by heteroduplex analysis, which
involves the denaturation of dsDNA and subsequent formation of heteroduplex, followed by
detection of loops and bubbles in heteroduplex regions where the two DNAs differ.
Exon 3 encodes part of the Znf_Dhhc domain which is highly conserved across species;
whereas exon 4 encodes part of the same domain and part of the third transmembrane domain.
When a shift was detected by the fluorescent signal on the ABI3100 machine, the 4 DNA
samples within the pooled sample were individually amplified by PCR and repeated by CESE
(Section 8.6.1. in Materials and Method). Any samples still showing the shifted peak were then
sequenced using both 5' and 3' primers to identify the mutation14.
In total, about 1,33Mb coding sequence was screened15 and one ENU mutation was isolated16.
It is a C->T substitution at base 479 (Figure 3.14A), which convert a leucine (CTC) residue into
Phenylalanine (TTC) at residue 91 where the Znf_dhhc domain lies (479C->T Leu91Phe). Both
amino acids are neutral, the L91F mutation results in the R-group '-CH2' of leucine being
replaced by a benzene ring in phenylalanine. This could have a phenotypic effect if the size of
the group is important even though both groups are neutral.
The L91F allele is conserved across species
The L91F residue is conserved across multiple species (Figure 3.15) including Rattus
norvegicus (rat), Bos Taurus (bovine), Canis familiaris (dog) and Homo Sapiens (human) and
also to Takifugu rubripes (pufferfish), Gallus gallus (chicken) and Tetraodon nigroviridis
(Tetraodon). But despite the shared zinc finger cysteine-rich DHHC domain, the residue is not
14 After the initial screen on AB3100, 21 (exon 3) and 14 (exon 4) PCR samples were re-run on AB310, but none of
them showed a shift; this may be due to discrepancies in the operating temperature (32'c on ABI3100 and 60°c on
ABI310). To confirm, all samples that showed a shift on the ABI3100 were sequenced (6x4 for ex3 and 3x4 for ex4).
15 About 1.33Mb coding sequence was screened: [(exon3: 112bp) + (exon4: 139bp) * 5300 samples] = 1,33Mb
16
Etiology plate 21 well A2.
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conserved among other Dhhc family members. Nevertheless, the L91F mutation may be
important because it lies immediately next to one of the 2 CXXC motifs upstream to the
consensus core of the Dhhc finger (Figure 3.15).
The isolated mutation disrupts a restriction site in Zdhhc21
The 479C->T mutation disrupts a Sac\ restriction site, which normally cut the screened PCR
product once at GAGCTAC and divide this 257bp fragment into about 174bp and 83bp with 3'
overhang. The mutant fragment remains uncut. This method allows rapid genotyping to
distinguish between wild-type, heterozygote and homozygote mice for the Harwell allele
(Figure 3.14B).
Re-derivation of L91F allele by 1CS1 and IVF
The frozen sperm from the BALB/c ENU-treated male was obtained from MRC Mammalian
Genetics Unit, Harwell. Several attempts using in vitro fertilization had failed due to low sperm
density and poor quality possibly as a result of sperm samples not being properly cryo-
protected, stored or transported. After several attempts, the allele was re-derived by Brendan
Doe (MRC Transgenic Unit) using a revised ICSI protocol.
The resultant litters were found to segregate according to Mendelian frequencies confirmed by
PCR and restrictive digestion genotyping. Since the sperm and egg are both haploid, half of the
offspring typically carries the mutant allele and the other halfwere wild-type.
The L91F mutation complements dev
The heterozygote L91F carrier was crossed to a dep to answer whether the two mutations are
allelic to the observed phenotype. The compound heterozygote between the Harwell allele and
dep (Zdhhc21F9XFI^) does not exhibit a phenotype, indicating that the L91F copy of the gene
must be either fully functional, or at least has a sufficient function to complement the dep allele.
To purify the L91F mutation from other ENU mutations in the genome, the allele was
backcrossed to C57BL/6 three times to ensure that the resultant mouse carries minimal amount
of other ENU mutations. A homozygote of the L91F allele was generated (Zdhhc21L9lFll9lF) by
a het x het cross, which has a brown hair coat (Figure 3.16A). However, the brown color coat is
due to the linked Tyrpl mutation that is 2Mb from Zdhhc21. This mutation originated from the
BALB/c mouse that carries mutation at Tyr and Tyrpl. The Tyrpl mutation disrupts a TaqI site
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and was readily confirmed by restriction digestion (Figure 3.16B). Furthermore, skin sections
of Zdhhc21L9lFl L9IF from different time points confirms that the L91F homozygote is normal
(Figure3.16C).
Collaboration with R1K.EN Genomic Science Centre in Japan
Despite the negative result from the Harwell-ENU archive screen, a collaboration has been set
up with Dr. Yoichi Gondo from the Riken Genomic Science Centre in Japan. The Riken ENU
archive consists of 10,000 samples and uses multiplex PCR for high-throughput genotyping.
The PCR conditions of Exon 1, 2, 3, 4 and 7 were optimised, and the 5'FAM-tagged primers
were sent to the Riken group.
Comparing the amount ofDNA that will be tested in total by the end of the screen (6.38Mb), it
will be 5 times as much of the Harwell screen. Since one single mutation in the Harwell ENU
archive was isolated, it is estimated that at least 5 ENU mutations will be isolated from the
Riken-GSC ENU archive. Currently, exon 2 and exon 4 of Zdhhc21 has been screened in part
of the archive (together represents about ~1.7Mb coding genome), from which several ENU
mutations have been isolated. This includes 2 mutations from the coding region, P79P and
LI38V. Although LI38V is a non-synonymous change, it probably has little effect based on the
mild nature of the amino acid change.
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Figure 3.14: Isolation of a new Zdhhc21 allele from the Harwell ENU archive
[A] The Harwell ENU DNA archive was screened by high-throughput genotyping from which a shift in
the peak was identified. Peaks that contain genuine mutation tend to appear as a subtle but detectable
shoulder, instead of an extra/ separate peak. Subsequent sequencing reveals the 479C->T substitution.
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Figure 3.15: The L91F allele is conserved across species
The L9IF mutation lies immediately upstream to the cysteine-rich DHHC consensus core (highlighted in
green), which is also conserved across all DHHC members (data not shown).
re so n 180 no lie
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Figure 3.16: The re-derived Harwell homozygote has no phenotype
[A] Comparison between 7.5wk wild-type and L91F homozygote littermates. The homozygote has no
visible hair loss phenotype. The coat colour is brown due to a linked Tyrpl mutation carried by the
BALB/c strain that disrupts a Taql site. [B] PCR products of Tyrpl amplified from DNA of a het x het
litter are digested with Taql. The Taql site of L9IF homozygote is disrupted and therefore remains uncut
(224bp), whereas wild-type fragments are completely cut (I03bp and 121 bp). [C] H& E sections from 2-







(iii) Knocking out Zdhhc21 by siRNA using pDECAP vector
The construction of pDECAP-Zdhhc21 expression vector involves the incorporation of the
target cDNA into the vector (456bp), and another copy in the opposite orientation (Figure
3.17). It is aimed that the transgenic mice will express a 456bp hairpin dsRNA from this vector
and induce degradation of Zdhhc21 RNA17. Using the pDECAP-Zdhhc21 fragment, several
transgenic lines have been generated. The transgenic founders were typed by PCR
amplification of the insert in both directions. The transgenic founder is then crossed to
C57BL/6 and half of the litter was expected to carry the intact transgene.
Abnormally folded skin in the abdomen ofE17.5 embryos
In another transgenic experiment with the DECAP-Zdhhc21 construct, a litter of fifteen El 7.5
embryos was collected. Some embryos were positive for the forward insert, and some were
positive for the reverse insert. No unusual phenotype were observed in the litter, however, 3 of
the embryos appear to have highly wrinkled skin on the ventral side of the abdomen (Figure
3.18). This may be due to the mere positioning of the embryo in the placenta, where the
wrinkled embryos might be forced into gesture that may result in the observed folds.
Unfortunately, it was proved difficult to correlate this observation with the genotyping data
because all 3 embryos exhibiting the wrinkly appearance are only positive for the reverse insert.
On the other hand, the embryos that are positive for both inserts are normal. However, the
expression of the transgene was not tested, so it is not sure whether the Zdhhc21 dsRNA was
successfully transcribed in these animals or whether it is able to silence Zdhhc21 expression.
Furthermore, the genotyping data is not consistent, so this finding remains essentially
inconclusive.
pDECAP-Zdhhc21 generates a hair loss phenotype
In one of the transgenic lines, 3 out of 6 pups were typed positive for both inserts of the hairpin
(Figure 3.19A), this includes 1 female and 2 males. Interestingly, the transgenic female exhibits
a hair loss phenotype at about 12-week (Figure 3.19B), however, the other 2 transgenic males
appear normal. Intercross between the hair loss female and one of the transgenic males was set
up to increase the transgene dosage. If Zdhhc21 expression was successfully knocked down, a
17 The pDECAP-Zdhhc21 vector was designed by Peter Budd and Ian Smyth.
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quarter of the litter would be expected to exhibit the hair loss phenotype. However, none of the
offspring shows a hair loss phenotype even though they all carry both inserts of the hairpin
transgene. This suggests that the transgene had passed on successfully, but it was unsuccessful
in knocking down Zdhhc21 expression.
The phenotype of the hair loss female persists until it was culled. Like dep, the pDECAP-
Zdhhc21 transgenic female loses hair on the dorsal hair coat, as well as on the face. However,
there are subtle differences in the texture, distribution of hairless patches and the onset of hair
loss. In addition, the dep mutant typically exhibits depigmentation of the ventral hair coat,
which is not observed in the pDECAP transgenic female. Therefore, it is speculated that the
hair loss phenotype seen in the DECAP-Zdhhc21 female, may be due to factors other than the
transgene.
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Figure 3.17: Structure of the 2-kb Bgl2-BamM pDECAP-Zdhhc21 fragment
The vector contains the CMV promoter, Ribozyme and MAZ site. The gene-specific targeting sequence
was cloned between the ribozyme cassette and the MAZ site as an inverted repeat separated by a 12-bp
spacer containing a Kpn I cut site.
jr*
CMV ribozyme •<fFrag1 p~| Krag2 | MAZ
(1)DECAPFraglf AWH001: AAGAATTCAAACATCAGTGCATAGCAAG
EcoRl





Figure 3.18: E17.5 embryos from oocytes injected with pDECAP-Zdhhc21
Pictures ofEl 7.5 embryos from a litter derived from oocytes injected with pDECAP-Zdhhc21. Highly
wrinkled skin can be seen in pictures (b) and (d), whereas (b) and (d) are normal. The vibrissae follicles
(e) are normal in all embryos observed (x2 objective).
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Figure 3.19: pDECAP-Zdhhc21 generates a hair loss phenotype
[A] Genotyping for the forward and reverse insert of the pDECAP-Zdhhc2l construct (upper and lower
panel respectively). Animal T, '4' and '6' and positive for both inserts, whereas animal '2' and '3' are
only positive for the forward insert. [B] The transgenic female that is positive for both inserts (Animal
'1' of [A]) exhibit a hair loss phenotype that is comparable to that of dep.
[A]
1 2 3 4 5 6
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3.3. Discussion
3.3.1. Transgenic rescue experiment using BAC
The generation of a rescued line by BAC transgenesis confirms that Zdhhc21 is likely to be the
candidate gene for dep. However, the BAC construct used in the successful rescue experiment
was unmodified and thus contains Cerl. Therefore, it may be argued that the rescued phenotype
is due to Cerl expression. However, this is unlikely to be the case because coding region of
Cerl is intact in dep, and Cerl null mutants have no phenotype. Based on the same arguments,
an additional copy of Cerl is thus unlikely to have any effect on dep phenotype.
To date, no rescue line has been generated from the modified ACerl BAC constructs. Although
2 transgenic founders were generated using this construct, in the first case, the transgene is not
intact, and with the second line, the transgene is intact but not expressed (shown by RT-PCR).
Since the BAC recombineering strategy involves transferring vectors into a different bacterial
strains and inducing recombinations between vectors, the construct might be rearranged during
the process and result in a disruption in the transgene.
With transgenic rescue experiments, the chromosomal integration site may often silence the
transgene. This may explain why some of our transgenic lines contain intact transgene that is
not expressed. However, this happens much less often with BACs, whose longer length seems
to protect them from silencing.
There may also be a possibility that a transgenic animal contains an intact transgene that is
expressed, but the phenotype is not rescued. In this case, it may be possible that deleting Cerl
(which is only 20Kb upstream to Zdhhc21) may disrupt a regulatory element of Zdhhc21,
which may render the BAC unable to rescue dep.
3.3.2. ENU-mutagenesis approach
Quwailid et. al. (2004) reports successful recovery of sperm from ENU mutants. However, with
our isolated allele, several attempts of IVF and ICS1 had failed due to low sperm density and
poor quality possibly as a result of sperm samples not being properly cryo-protected, stored or
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transported (Brendan Doe, personal communications). Nevertheless, the mutant line was
recovered by 1CS1 at the end.
One criticism of the ENU mutagenesis approach is that the outcome of the screen is not
targeted, and the rate of success is not guaranteed. On screening 1.33Mb coding DNA, only one
missense mutation was found and even though comparative sequence analysis suggest that it
may have a functional importance, the re-derived animal does not exhibit a phenotype. Out of
the 1.7Mb DNA screened so far, 2 coding mutations were found, but only one ofwhich is non-
synonymous.
The efficiency of ENU mutagenesis was predicted to be 1 mutation/locus per 600 mice. And
since the mouse genome is currently estimated to have 24,000 coding genes, each mutagenised
mouse will have approximately 40 functional ENU mutations. The coding part of the genome is
currently estimated to be ~37.5Mb in size, so there should be approximately one change every
1.875Mb (37.5Mb/ 40mutations). This agrees well with Quwailid's reported functional
mutation rate of 1 in 1.82 Mb.
Given the currently reported genome size of 2,500Mb and the reported ENU mutation rate of 1
in 1.01Mb, we would expect about 2500 mutations per mouse, most of which would be non¬
functional, and about 37 will hit a coding region. Furthermore, about 20 (1/1.875 x 40) of them
will be functional.
3.3.3. The pDECAP vector for siRNA knock down
The siRNA experiment using pDECAP vector technique was attempted by several groups in
the MRC Human Genetics Unit but there has been no success. In some cases, although both
copies of inserts are present in the transgenic animal, the animal always failed to exhibit the
founder mutant phenotype. This may be due to the dsRNA not being generated as expected for
directing the degradation of the target protein. The low rate of success may also be due to
inefficiency of the dsRNA to knockdown the target expression in a transgenic animal.
Since Zdhhc21 is believed to have a role in hair follicle development, the pDECAP construct
may be tested in keratinocyte culture, since the efficiency of knocking down Zdhhc21
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expression may be more readily detected in cell culture. If pDECAP-Zdhhc21 successfully
knock down Zdhhc21 expression in cell line, it may be tested in vivo with better confidence.
Apart from the low success rate, there is also a lack of robust genotyping for the transgene due
to difficulties in amplifying across the hairpin structure. This may be improved by digesting the
vector at the hinge of the hairpin before PCR amplification. Over all, the genotyping results
have not been consistent and robust enough to conclude the presence of the transgene at the
genomic level.
In our experiment, transgenic mice were crossed with C57BL/6, and the heterozygote progeny
were genotyped for brother-sister mating. The subsequent progeny would have a quarter chance
of inheriting 2 copies of the transgene that may increase the chance of knocking down Zdhhc21
expression.
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Chapter 4 - Functional Studies of Dhhc21
4.1. Introduction
4.1.1. DHHC proteins are palmitoyl-acyl transferases (PATs)
Assuming that Zdhhc21 is the causative gene for dep, the most interesting question would be
how a loss of protein function gives rise to the dep phenotype. Over the past few years, several
DHHC proteins have been found to promote palmitoylation in yeast and mammalian cells,
suggesting that Zdhhc2l is likely to be a palmitoyl-acyl transferase (PAT) and that a loss in its
activity may result in the dep phenotype in vivo. Functional studies of Zdhhc21 could
contribute to the evidence that the del-233F mutation underlies the dep phenotype.
4.1.2. What is palmitoylation?
Palmitoylation (or S-palmitoylation, protein S-acylation) is a posttranslational lipid
modification, which involves the addition of the fatty acid palmitate onto specific cysteine
residues through thioesterification (Smotrys and Linder, 2004). The PATs share a common
feature in that they all contain a cysteine-rich domain (CRD) with a characteristic Asp-His-His-
Cys (DHHC) motif, which is required for PAT activity.
Post-translational lipid modifications such as myristoylation, prenylation and palmitoylation
generally serve to tether proteins to the cytoplasmic surfaces of cellular membranes. But unlike
the other 2 modifications, palmitoylation is reversible and thus allows for membrane tethering
to be regulated. Palmitoylated proteins are often key proteins in membrane trafficking (Hayashi
et ah, 2005), cell signalling, synaptic transmission (Fukata et ah, 2004; Yanai et ah, 2006), and
are affected in the progression of diseases such as cancer (Acconcia et ah, 2005).
4.1.3. Palmitoyl transferase and identification of substrates
Although the genes encoding PATs can be easily identified by the shared CRD-DHHC domain
consensus sequence, identification of specific substrates are problematic. This is due to the lack
of consensuses for predicting palmitoylation from sequence using bioinformatic tools.
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The finding that DHHC proteins are PAT was first discovered in Saccharomyces cerevisiae by
forward genetic screens. The two identified yeasts PATs are Erf2/Erf4, which palmitoylates
prenylated Ras2 (Lobo et ah, 2002); and Akrl, the PAT for the yeast casein kinase 2 (Roth et
ah, 2002). Deletion of Erf2/4 or Akrlp prevents palmitoylation ofRas2 or Yck2 respectively,
indicating that they confer PAT activity for the yeast proteins. Since Erf2 and Akrl p share a
conserved CRD-DHHC domain, based on these findings, it was first predicted that DHHC
members might be a PAT family.
Based on the CRD-DHHC domain consensus sequence, it was predicted that there are 7 yeast
DHHC proteins and 23 DHHC proteins in mouse and human genome (Linder and Deschenes,
2004; Smotrys and Linder, 2004). The first mammalian DHHC protein that was associated with
a palmitoylated substrate, was the Golgi-specific DHHC zinc finger protein (GODZ, or
DHHC3), which is shown to enhance palmitoyl transfer to the GABAa receptor y2 subunit in
heterologous cells. This mechanism is proposed to be important for regulated trafficking of
these receptors in the secretory pathway (Keller et ah, 2004).
In another study, a subset of 4 mammalian DHHC proteins was found to enhance
palmitoylation of the neuronal scaffold protein PSD-95 at cysteine residues 3 and 5 in cultured
cells. These 4 proteins, Dhhc2, 3, 7 and 15, are closely related within the Dhhc family (Figure
4.1), which reflects a correlation between structure and enzyme specificity for PSD95
palmitoylation. It has also been shown that individual DHHC clones are specific for its
substrates, suggesting the possibility that other limbs of the tree are specific for palmitoylating
another class of proteins (Fukata et al., 2004).
Other DHHC proteins that have demonstrated a PAT function includes the yeast protein
Erf2/Erf4, Pfa3p, Swfl p, and the human proteins DHHC9/ GCP16 and HIP 14. H-Ras and N-
Ras are palmitoylated by Erf2 in complex with Erf4 in yeast, and are also palmitoylated by the
human PAT complex DHHC9/ GCP16 in a substrate specific manner (Swarthout et al., 2005).
In another study, the yeast DHHC-CRD proteins Pfa3p and Swflp were found to palmitoylate
Vac8p in vitro and in vivo, and play a role in vacuole fusion (Smotrys et al., 2005). The
Huntingtin-interacting protein (H IP 14, or DHHC17) palmitoylates a number of specific
neuronal substrates including SNAP25 and PSD95, thus regulates their trafficking and synaptic
functions (Huang et al., 2004).
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Very recently, several mutations in human ZDHHC9, PAT ofNRAS and HRAS, were found to
cause X-linked mental retardation associated with Marfanoid Habitus (Raymond et ah, 2007).
In another case, a balanced reciprocal translocation between chromosomes X and 15 that causes
a breakpoint in ZDHHC15, was found in a patient with severe nonsyndromic mental retardation
(Mansouri et ah, 2005). Furthermore, a SNP variant ofZDHHC8 was found to associate with
risk of schizophrenia, and that Zdhhc8-knockout mice have decreased exploratory activity in a
new environment, and decreased sensitivity to the locomotor stimulatory effects of a
psychomimetric drug (Mukai et ah, 2004). These findings suggest that other PATs may be good
candidates for causing other mental syndromes. However, in neither cases ofDHHC8 or
DHHC15 a palmitoylated substrate has been suggested.
Endothelial Nitric Oxide Synthase (eNOS) is a substrate ofZdhhc21.
The palmitoylation of the endothelial NO synthase (eNOS) is enhanced by a set ofDHHC
proteins including Dhhc2l. However, only the inhibition of Dhhc21 by siRNA reduces eNOS
palmitoylation, suggesting a regulatory role of Dhhc21 in governing eNOS function
(Fernandez-Hernando et ah, 2006). It was also shown that palmitoylation-deficient mutants of
eNOS release less nitric oxide in endothelial cell culture. However, although eNOS-deficient
mice have vasoconstriction due to reduced nitric oxide release, they have no reported skin or
hair phenotype (Shesely et ah, 1996), suggesting that the dep phenotype is unlikely to be eNOS
mediated, and therefore Zdhhc2l must have another target for palmitoylation that is specific to
the observed hair loss phenotype.
4.1.4. Identification of palmitoyl substrates for individual DHHC proteins.
Traditionally, palmitoyl proteins were identified through in vivo [3H]palmitate labeling, which
is limited by the long exposure time and its requirement for known protein substrate. Recently,
a new proteomic methodology called the acyl-biotin exchange chemistry method (ABE, or
Biotin switch) for purifying and identifying palmitoyl proteins was used to characterize the
palmitoyl proteome of yeast (Roth et ah, 2006). From the screen, over 30 new palmitoyl
proteins were identified, including SNARE proteins, amino acid permeases (AAP), and
participants in cellular signaling and membrane trafficking (Roth et ah, 2006).
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The ABE protocol developed by Drisdel and Green (Drisdel and Green, 2004) involves 3 major
chemical steps. First, any free thiols that are not palmitoylated can be blocked by N-
ethylmaleimide (NEM), which forms a stable covalent linkage with the free thiols; secondly,
thioester linkages of palmitoylated cysteine thiols are cleaved by hydroxylamide. And finally,
these cysteinyl thiols are exposed to a thiol-specific biotinylation reagent. The biotinylated
proteins were affinity purified by streptavidin agarose and subjected to Western blotting.
The samples are then compared with proteins that were not treated with hydroxylamide to
ensure that the bands observed are due to palmitoylation alone because some proteins become
non-specially labeled with biotin independent of the hydroxylamine treatment or some proteins
may adhere to the streptavidin resin nonspecifically, leading to misinterpretation of the data
(Linder and Deschenes, 2007).
The ABE protocol is not only more sensitive and time-efficient, another advantage is that it
does not require the use of radioactivity, but instead uses palmitate as a specific pull-down.
This provides the potential to isolate substrates of the DHHC protein in question, and the
potential to identify novel substrates by mass spectrometry sequence analysis.
Using the ABE protocol, PSD-95 palmitoylation by DHHC-15 and DHHC-3 in HEK cells was
specifically detected (Masaki Fukata, personal communication). This alternative protocol may
be used to assess PAT activity of the Dhhc21 protein and identify potential substrates that give
rise to the hair loss phenotype. It does not require any knowledge or presumptions on the
substrates, and so it will allow us to identify other substrates of Zdhhc21 that may not be hair-
loss related e.g. eNOS and Lck.
4.1.5. Functions of Palmitoylation
Like other lipid-modification, palmitoylation is involved in membrane association. However, it
is better described as a secondary signal as other primary signals (e.g. myristoylation) must
bring the protein to the membrane to allow access to the membrane-bound PAT enzymes.
Protein-protein interactions, or prenylation/ myristoylation provide a weak or transient
membrane interaction, whereas palmitoylation gives a more stable anchor to the membrane.
Nevertheless, palmitoylation also occurs on proteins that are already in tight association with
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the membrane such as transmembrane proteins (e.g. AMPA), suggesting that the palmitoylation
is more than just a membrane tether.
(i) Protein trafficking
Paimitoylation may regulate membrane retention and protein sorting by modification of
specific cysteine sites. Indeed, palmitoylation of different cysteine sites of the same proteins
often have distinct effect of trafficking (Greaves and Chamberlain, 2007).
The ligand-gated cation channel, a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) receptor have 4 subunits (GluRl -4), each of which is palmitoylated on 2 specific
cysteine residues in their transmembrane domain (TMD) and in their C-terminal region.
Palmitoylation of the TMD site is enhance by GODZ (Dhhc3) and leads to an accumulation of
the receptor in the Golgi and a reduction of plasma membrane expression. This is consistent
with previous findings that the overexpression of several PAT-Dhhc members (such as Dhhcl5
and Dhhc21) also have similar effect on the trafficking of their substrate (PSD-95 and eNOS)
(Fukata et ah, 2004; Huang et ah, 2004; Keller et ah, 2004). Whereas palmitoylation at the C-
terminal site causes the protein to retain in the cytosol via interaction with the cytoskeletal
protein 4. IN (Hayashi et ah, 2005). The differential fate of specific site palmitoylation may
underlie the important role of palmitoylation in receptor trafficking and synaptic plasticity.
(ii) Protection from ubiquitination
Palmitoylation has also been reported to play a role in prevention of ubiquitination of the
palmitoylated protein. In yeast, palmitoylation of Tlgl by the Dhhc protein Swfl, ensures that it
is retained on the trans-golgi/ endosome membranes. When Swfl is mutated or inactivated,
Tlgl is unpalmitoylated and recognized by the ubiquitin ligase Tlul, resulting in targeting to
the vacuole for degradation (Valdez-Taubas and Pelham, 2005). On the other hand, cysteine
mutants ofTlgl have similar distribution to wild-type when ubiquitin ligases were inactivated,
implying that palmitoylation is not required for membrane targeting of Tlgl, but to prevent
ubiquitination specifically (Greaves and Chamberlain, 2007; Valdez-Taubas and Pelham,
2005).
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Figure 4.1. Dhhc family members show specificity for palmitoylation substrates
The Dhhe members that enhance PSD95 palmitoylation (P-PATs) include 4 closely related members in
the Dhhc family. This may reflect a correlation between structure and enzyme specificity for PSD-95
palmitoylation. Other branches of the phylogenetic tree may be specific for targeting other substrates.
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4.2.1. Palmitoylation assay - dep mutation is inactive for palmitoylation in vitro
(Collaboration with Masaki Fukata)
Considering the previous literature suggesting that DHHC members are palmitoyl transferases,
it is likely that Zdhhc2l is responsible for palmitoylating a set of substrates in vivo, and that the
proteins that are under-palmitoylated as a result, may have a defective function that gives rise to
the dep hair loss phenotype. Nevertheless, the first question is, whether the dep mutation affects
palmitoylation at a molecular level.
To answer this, I set up a collaboration with the author of the PSD95 paper, Masaki Fukata
from the National Institute of Longevity Sciences in Japan (moved to National Institute for
Physiological Sciences from 01.06.07). To examine whether dep has palmitoyl transferase
activity, 2 substrates were used based on their recent findings, including eNOS and the
lymphocyte-specific protein tyrosine kinase (Lck). eNOS has been proposed to be a specific
target of Zdhhc21 (Fernandez-Hernando et ah, 2006). Lck was found to be robustly
palmitoylated by DHHC-21 among the 23 DHHC members (Yuko Fukata and Masaki Fukata,
unpublished data).
Lck knockout mice exhibit a marked thymic atrophy, with a dramatic reduction in the double-
positive (CD4"CD8 ) thymocyte population, and a complete absence of the mature, single-
positive thymocyte population (Molina et ah, 1992), indicating that a defective Lck is likely to
have an effect on thymocyte development. However, apart from the phenotypes described in
Chapter 5, dep does not show any thymus-related phenotype under unchallenged conditions in
the laboratory.
To test the PAT activity of the mutant protein, Dhhc21 constructs of wild-type, dep and another
mutant construct C120S (a mutation in the conserved Dhhc motif, DHHS, Fukata) were
individually transfected into HEK293 cells together with eNOS and Lck respectively. The
palmitoylation of eNOS and Lck were assessed by metabolic labelling with [3H]palmitate. The
experiments showed that the wild-type DHHC21 protein increased incorporation of
["'Hjpalmitate into eNOS, whereas the dep and C120S mutant proteins have no effect on eNOS
palmitoylation, indicating that they are inactive for palmitoylating eNOS. The same pattern
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applies to Lck being the substrate, suggesting that both mutations are likely to abolish PAT
activity completely (Figure 4.2; the experiment was carried out by Ryouhei Tsutsumi and
Masaki Fukata as a collaboration).
In a separate experiment, Fukata and colleagues found that the short region of the C-terminal
cytoplasmic region of DHHC-15 is required for the enzyme activity, and that mutations ofVFG
(273-275aa) in DHHC-15 impairs the enzyme activity (Masaki Fukata, personal
communications). The VFG motif corresponds to 236-238 a.a. in DHHC-21, and is conserved
among all P-PATs and also to DHHC-4, 7 and 21. The VFG motif is only 3 bp upstream of the
dep deI233F mutation, suggesting that the mutation may affect Dhhc21 function at the VFG
motif.
This data is potentially exciting, because if the dep hair loss phenotype were due to the mutant
protein being inactive for palmitoylation, the in vitro result would be the first direct evidence
that the enzymatic activity of DHHC family is involved in a mammalian mutant condition.
4.2.2. Acyl-biotin exchange chemistry (ABE) - an alternative to [3H]palmitate
labeling
Generation of DHHC-21 mutant constructs by site-targeted mutagenesis
To assess the functional significance of individual mutations, I made a set of Dhhc21 mutant
constructs for overexpression of the corresponding mutant proteins in cultured cells. The dep
mutation was subcloned by replacing wild-type cDNA from the original construct with a dep
cDNA carrying the single amino acid deletion.
A construct containing the missense mutation isolated from the MRC Harwell ENU archive,
was also generated by site-targeted mutagenesis using the wild-type construct provided by
Masaki Fukata as a template. This is to assess whether the L91F mutant retains its PAT activity
in culture, since the re-derived animal does not exhibit any phenotype. In addition, 2 other
mutant constructs were made on the cysteine residues within the cysteine-rich DHHC domain
(Figure 4.3). The integrity ofmutant constructs was tested by sequencing.
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Auto-palmitoylation - dep and some other mutants are defective in auto-palmitoylation
Using the biotin switch protocol, it was shown that there is a difference between wild-type and
dep activity in auto-palmitoylation. The set of constructs generated by site-targeted mutagenesis
were transfected into HEK293 cells and subjected to ABE chemistry, streptavidin pull-down
and Western blotting. The result shows that the wild-type Dhhc21 and the Harwell L91F
mutant are pulled down in greater quantity, in comparison to dep and the other 2 mutants C95S
and C106S (Figure 4.4), indicating that the wild-type and L91F mutant are active for auto-
palmitoylation, whereas dep and the other 2 mutants are unable to self palmitoylate. As the
Harwell L91F mutant appears to retain its cellular function as a PAT of its own, this data is
consistent with the fact that the re-derived animal of the Harwell L91F mutation does not
exhibit a phenotype.
4.2.3. Cellular nature of Zdhhc21 - dep is mislocalised in the ER
Having established the fact that dep has a cellular defect in palmitoylation, the expression of
individual constructs were visualized in cultured cells to investigate any obvious phenotype that
is associated with the dysfunction since a mislocalisation may contribute to the mutant's
inability to palmitoylate its substrate. The set of constructs used for the auto-palmitoylation
assay was over-expressed in NIH3T3 cells, and visualised by immunohistochemistry with
antibody that targets the HA tag of the Dhhc21 constructs, together with cellular markers such
as the cis-Golgi marker Gm 130.
It was found that the wild-type Dhhc2l protein localizes to a highly specific ribbon-like
structure in the cytoplasm, which co-localises with the cis-Golgi marker Gml30, whereas the
dep mutant is completely delocalised and dispersed in the cytoplasm, and does not co-localise
with Gml30 (Figure 4.5). The localization of the Harwell L91F mutant resembles that ofwild-
type, which is consistent with the fact that the re-derived animals do not exhibit a phenotype
and that the mutant L91F protein retains its auto-palmitoylation activity. The C95S and C106S
mutants are both mislocalised, although the C95S mutant appears to partially retain the
structure as a globe of protein in the cytoplasm where the Gml30 localises. In the future we
may initially test the cellular localisation of an isolated ENU mutant before considering to re-
derive the mutant line by in vitro fertilization.
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The wild-type and dep constructs were further transfected into keratinocyte culture by Ian
Smyth, who also showed that the wild-type protein colocalises with the cis-Golgi marker
(Figure 4.6A), but not the trans-Golgi marker (data not shown). And instead of the cis-Golgi,
the dep mutant protein seems to co-localise with the endoplasmic reticulum marker PDI
(protein disulfide isomerase) (Figure 4.6B).
Taken together the above findings, it looks as though the wild-type Dhhc21 protein localizes to
the cis-Golgi, but the dep mutant fails to associate with the cis-Golgi and gets trapped in the ER
(Figure 4.7).
4.2.4. Zdhhc21 involvement in dep and in eNOS function
Given that eNOS is a reported substrate of Zdhhc21, and that a Zdhhc21 mutation demonstrates
a loss of PAT activity in dep, the following 2 parallel questions may be asked:
Do eNOS knockout mice have a hair phenotype?
Although eNOS knockout mice have no reported hair loss phenotype, the mutant skin had
never been carefully examined. Recently, a regulatory role in melanogenesis has been
suggested for the NOS isoforms including eNOS and neuronal NOS (nNOS) and inducible
NOS (iNOS) (Sowden et al., 2005). Since dep exhibits a hair loss phenotype, this piece of
evidence may be relevant to the contribution of unpalmitoylated eNOS in melanogenesis in
epidermis and HF keratinocytes. Normally, eNOS is highly expressed in melanocytes in the
epidermal basal layer. Although eNOS is not expressed in melanogenically active melanocytes
of anagen hair bulb, it shows a preferential restriction to melanocyte dendrites in
undifferentiated melanocytes in the ORS and melanocytes that have survived HF regression.
This may reflect a role for locally produced NO in the maturation and transport of
melanosomes along the cell dendrites (Sowden et ah, 2005).
To test the possibility that eNOS deficiency is associated with the hair loss phenotype, we could
look at the skin of eNOS knockout mice, which are available from Dr. Rob van T'Hoff
(University of Edinburgh). These mice have superficially normal hair. More detailed
histological analysis might show hair-related defects but this has not yet been done.
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Do dep mice show an eNOS-related phenotype?
(Collaboration with Dr. Tom van Agtmael)
On the other hand, eNOS may still be a substrate for Dhhc21 in vivo even though it may be
unrelated to the hair loss phenotype. Based on the eNOS substrate specificity for Zdhhc21 in
cellular assay demonstrated by Fernandez-Hernando and colleagues (2006), it is speculated that
the eNOS substrates in dep may be under-palmitoylated and have a functional defect in
releasing nitric oxide, which may lead to vasoconstriction as a result. To test this hypothesis, a
collaboration has been set up with Dr.Tom van Agtmael (University of Edinburgh) to
investigate eNOS activity by asking whether the aorta of dep and wild-type differ in the degree
of vasodilation under treatment with acetylcholine (Ach) which activates eNOS to release nitric
oxide. To date, preliminary data shows a significant difference between wild-type and dep in
Ach response, and that the difference is due to a reduction in eNOS function (data not shown).
So far, it is established that eNOS is a specific substrate of Dhhc21 in cell culture assay. Since
eNOS knockout mice do not resemble the dep hair loss phenotype, eNOS can not be a mediator
of dep. Therefore, we conclude that there must be another substrate that contributes to the dep
phenotype.
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Figure 4.2. Assessing PAT activity of dep (Masaki Fukata)
(Experiment carried by Masaki Fukata and colleagues as a collaboration)
Individual Dhhc21 clones ofwild-type, dep and C120S (mutation of the Dhhc motif) were individually
transfected together with eNOS and Lck into HEK293 cells. After metabolic labelling with
[3H]palmitate, proteins were separated by SDS-PAGE and subjected to fluorography (upper panel).
Arrows indicated the position of eNOS and Lck respectively. Increased incorporation of [3H]palmitate
into eNOS and Lck is clearly observed when co-transfected with the wild-type Dhhc21 construct,
indicating an enhancement of eNOS and Lck palmitoylation by DHHC21. The dep mutation and the
mutation of the Dhhc motif (del-233F and C120S) clearly blocked eNOS and Lck palmitoylation.
Immunoblots against Lck and the eNOS tag protein Myc (middle panel), and the HA tag protein for the
DHHC21 clones (lower panel) are shown as controls. The mobility of palmitoylated Lck is shifted by
wild-type Dhhc21 (indicated by an asterisk).
Substrate: Lck eNOS
r ■x ' ^
Dhhc21: yjj dep C120S - WT dep C120S - WT dep C120S
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palmitoylation



















Figure 4.3. Relative location of mutations targeted by cloning or mutagenesis
The dep mutation lies at the C terminal of DHHC21; all other mutant constructs used in this project lie
within the cysteine-rich DHHC consensus core. The L91F construct was generated because of an isolated
ENU mutation from the MRC Harwell ENU archive.
(Harwell) (Fukata)






Figure 4.4. Auto-palmitoylation of Dhhc21 proteins using the ABE protocol
Individual Dhhc21 constructs were transfected into NIH3T3 cells and were left to grow overnight. The
lysates were then subjected to ABE chemistry, and subsequently pulled down by streptavidin agarose
beads and resolved by SDS-PAGE. The result shows that the wild-type and L9IF proteins were pulled
down at a greater quantity than dep, C106S and C95S (right panel), comparing to the portions that are not
pulled down (left panel). This indicates that wild-type and L91F proteins are active for auto-
palmitoylation, whereas the other mutants are unable to autopalmitoylate.
Not pulled down: Pulled down by Streptavidin:
WT dep L91F C106S C95S WT dep L91F C106S C95S
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Figure 4.5. Cellular localisation of the Dhhc21 constructs
HA-tagged Dhhc2l cDNAs (wild-type, dep, L91F, CI06S and C95S) were over-expressed in NIH3T3
cells, and were stained by anti-HA antibody (red); the degree of co-localisation with the cis-Golgi marker
Gm 130 (green) was assessed. Wild-type and L9IF (Harwell) Dhhc21 localises to a specific tubular,
ribbon-like structure in the cytoplasm, which co-localises with Gml30, whereas the dep mutant is
completely delocalised and dispersed in the cytoplasm, and does not co-localise with Gml30. The C95S















Figure 4.6. Wild-type and dep Dhhc21 over-expressed in keratinocyte culture
(experiment carried by Ian Smyth as a collaboration).
[A ] Wild-type Dhhc2l protein co-localises specifically with Gml30, a marker of the cis-Golgi network,
but not with the trans-golgi marker Tgn38 (data not shown).
[B] Instead of the cis-golgi, dep mutant protein seems to localise to the ER, as shown by its co-






Figure 4.7. Cellular localisation of wild-type and dep proteins
Based on immunocytochemistry, wild-type Dhhc21 seems to localise to the cis-Golgi network, whereas
the dep mutant is trapped in the ER. It is speculated that the del-233F mutation at the C-terminal may
affect protein folding, leading to the trapping ofprotein in the ER.
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4.3. Discussion
4.3.1. Dep mutation may lead to protein trapping in the ER
Based on the immunocytochemistry assay on cellular localization, it is observed that the wild-
type Dhhc2l protein localizes to the cis-Golgi. This is consistent with previous literature which
shows that other Dhhc members also localise to the cis-Golgi (Fernandez-Hernando et ah,
2006; Fukata et ah, 2004). According to the predicted transmembrane topology, the Dhhc
functional motif is intracellular and is therefore facing the cytosol (Figure 3.1C), so
paimitoylation is likely to take place in the intracellular space. The dep mutant protein, on the
other hand, is unable to target specifically to the cis-Golgi and appears to be trapped in the ER.
If the C-terminal is in the ER lumen then it seems that the mutation may hinder protein folding
which may subsequently lead to trapping of the mutant protein in the ER (represented in Figure
4.7).
This is the case with the most common mutation of cystic fibrosis (del508F CFTR), which is
also a single deletion of Phenylalanine. Previous literatures had shown that correct localisation
of the CF mutant is restored by growing the cells at a lower incubation temperature (Denning et
al., 1992). Based on this finding, it may be reasonable to anticipate that the mislocalisation of
dep protein may also be rescued by overexpressing the mutant at a lower temperature.
In combination with the palmitoylation assay, this experiment may answer whether the lack of
PAT activity of dep is due to the mislocalisation, or an inactivity of PAT, which may result in
the unpalmitoylated protein not being unable to localise specifically. In the case of the cysteine
mutations (C106S, C95S and C120S), the lack of PAT activity may be due to both a
mislocalisation and the PAT being inactive.
If the mislocalisation of dep is rescued at a lower incubation temperature, the same lysate may
be used for palmitoylation to assess if the PAT activity is also rescued. If the PAT activity is
then rescued, it suggests that the loss of palmitoylation is due to mislocalisation of the mutant
protein, and that the site of palmitoylation is likely to be the cis-Golgi.
However, if palmitoylation is not rescued despite correct localisation, it may suggest that the
PAT activity ofdep is abolished and that its mislocalisation is independent of the loss of PAT
activity. It may also suggest that the cis-Goigi is not necessarily the site of palmitoylation.
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Zdhhc21 may target several palmitoyl proteins unrelated to hair loss
Previous data shows that Zdhhc21 is able to enhance palmitoylation of a range of substrates in
cell culture, including PSD95, eNOS and Lck (Fernandez-Hernando et ah, 2006; Fukata et ah,
2004). In the case of eNOS, even though the five Dhhc proteins seem to share a functional
redundancy in eNOS palmitoylation, the inhibition ofZdhhc21 alone in endothelial cell culture
reduces eNOS palmitoylation, indicating that Zdhhc21 may be indispensable for this function.
Although the effects of lack of eNOS palmitoylation in dep is yet to be determined, it suggests
the possibility that Zdhhc21 may have a regulatory role in governing palmitoylation of a range
of substrates. The dep mutation may potentially affects substrates other than the one specific for
the hair loss phenotype. This is supported by the RT-PCR data which shows that Zdhhc21 is
widely expressed across a range of tissues (Figure 3.5, chapter 3).
The dep mutants are often smaller in body size at an early stage (up to 4 weeks of age, Chapter
5), which may be caused by the lack of palmitoylation of a substrate other than the hair-loss-
related substrate. Furthermore, the dep mutation may potentially give rise to other phenotypes
may be repressed under controlled, unchallenged laboratory environment.
4.3.2. The role of auto-palmitoylation
While the lack of PAT activity in dep may be due to mislocalisation of dep-Dhhc21, it is not
clear whether the mutant protein is functional. Our ABE assay has shown that the dep mutant,
and the cysteine-targeted mutants (C106S and C95S) are inactive for auto-palmitoylation. This
implies that the PAT activity of dep is abolished by the mutation, but it is also possible that
mislocalisation affects the protein conformation required for auto-palmitoylation.
The function of auto-palmitoylation is not clear. It is a very rapid process that occurs before
palmitate transfer to a substrate (Swarthout et ah, 2005), and has been suggested that it serves
as a covalent acyl-enzyme intermediate required for the PAT reaction (Mitchell et ah, 2006). So
it is conceivable that the loss of auto-palmitoylation function prevents the PAT activity on the
targeted substrates.
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Chapter 5 - Phenotypic and Molecular characterization of dep
5.1. Introduction
5.1.1. The skin
The skin is the largest organ in the body and serves a wide range of functions such as physical
protection, temperature regulation and social signaling. It is composed of an epithelial and a
mesenchymal compartment joined together by the basement membrane (BM). The epithelium
includes the interfollicular epidermis (IFE) and the hair follicles (HF), and the mesenchyme
includes the dermal papillae (DP), dermis and the subcutis. The IFE is composed ofmultiple
layers of keratinocytes at successive stages of differentiation, from undifferentiated,
proliferative keratinocytes attached to the BM in the basal layer, to terminally differentiated,
cornified cells in the suprabasal layers as they migrate up the IFE layers (Fuchs and Raghavan,
2002).
The epidermis primarily consists of differentiating keratinocytes which makes up 95% of the
skin layer, but other functional cell types can also be found in the epidermis, including
melanocytes, Langerhans cells and Merkel cells and melanocytes. Langerhan cells play a role
in the immune defense of the body, and Merkel cells are involved in sensory reception.
Melanocytes are derived from neural crest progenitors (melanoblasts). They are the skin
pigment cells that are located between keratinocytes in the epidermal basal layer and are also
present in the hair follicles. Melanocytes synthesize melanin and deposits into cytoplasmic
organelles (melanosomes) that are transferred to the keratinocytes via their dendrites. Melanin
functions to provide protection against UV irradiation, photo-carcinogensis and photoaging.
Individual melanocytes are able to associate with multiple keratinocytes via their multiple long
dendritic projections.
The basement membrane is a complex layer of tissue that is composed of a series of elaborately
interconnecting extracellular matrix (ECM) proteins including collagen IV, laminin and
fibronectin. The main role of the BM is to separate the epidermis and the dermis and act as a
diffusion barrier for nutrients and growth factors between them. Another role of the BM is to
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ensure that the proliferating keratinocytes are attached to the basal layer through an anchoring
complex composed of the hemidesmosomes and anchoring filaments.
The dermis is a thick skin layer located beneath the epidermis that provides support to the skin.
The layer predominantly consists of fibroblasts that form a supporting matrix made of collagen
and elastin, which gives the skin its strength and flexibility. The dermis also harbors an
extensive vascular network which supplies the skin with nutrients and oxygen. The dermis also
contains other cell types such as endothelial cells and mast cells, and plays a part in immune
defense.
The subcutis is a layer of tissue beneath the dermis and is composed of protein fibres and
adipose tissue. The adipocytes store energy as triglycerides and release the energy as free fatty
acids and glycerol during starvation. They are also important in temperature insulation and
provide a cushioning function against injury. Although the subcutis layer is not part of the skin,
it contains skin structures such as the sweat glands and sensory receptors.
5.1.2. Stems cells of the skin
Throughout the entire life of a mammal, the epidermis is maintained by constant replenishment
from stem cells, which possess full self-renewal/ proliferative capacity and produce progeny
that undergo terminal differentiation along the lineages of the interfollicular epidermis (IFE),
hair follicles (HF) and the sebaceous glands (SG) (Watt et al., 2006). Several stem cells
populations exist in the HF, but the best characterized is the bulge stem cells which resides in a
permanent portion of the HF. In addition to the bulge cells, there are also stem cells in the IFE,
the SG, and a separate stem cell population for the hair lineages in the hair matrix (Figure
5.1 A). However, it is also possible that the SG is maintained by the bulge stem cells. Although
these populations are interconvertible, they respond to constituents of the microenvironment
such as the ECM, growth factors and availability of nutrients, which determine the
differentiation pathways selected by stem cell progeny (Niemann and Watt, 2002).
Another property of stem cells is that they divide very infrequently. For sufficient keratinocytes
to maintain epidermal homeostasis, the stem cell progeny may first divide a finite number of
times before they become terminally differentiated. These cells are known as transit-amplifying
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(TA) cells. Terminal differentiation of the 1FE and SG lineages gives rise to one final fate,
which are the cornified cells and terminally differentiated sebocytes (which degrade into
sebum) respectively. However, the HF is more complex, comprising 8 different differentiated
lineages.
(i) The hair follicle
Under normal conditions, an anagen hair follicle (HF) consists of several parts, including the
bulge, dermal papillae (DP), the hair matrix, which give rise to the hair shaft lineages, and the
sebaceous gland (SG) (Figure 5.1 A and 5.3).
The bulge is a thickened region of the outer root sheath (ORS) that lies close to the attachment
site of the arrector pili muscle. It contains a reservoir of quiescent multipotent stem cells that
are capable of maintaining the epidermis and regenerate new hair growth.
At the proximal tip of the HF lies the dermal papillae (DP), which is a specialized population of
mesenchymal cells that provides growth stimulus during morphogenesis and at the start of each
hair cycle via signaling through epithelial-mesenchymal interactions. In addition, the size of the
DP is directly proportional to the size of the resulting follicle (Porter, 2003).
At anagen, the DP becomes encapsulated by the hair matrix (HM), which consists of HF
progenitors that rapidly proliferate, and subsequently differentiate into 7 specialized lineages of
keratinocytes, forming the hair shaft (HS) and the inner root sheath (IRS). The HS consists of 3
lineages, including the medulla, cortex and the hair cuticle. The IRS is also made of 3 lineages,
including the outmost Henle's layer (consists of a thin layer of flattened cells), the middle
Huxley's layer (consists of several layers of cuboidal cells) and the innermost cuticle layer
(made of tiny cuboidal cells). Like epidermal differentiation, HF differentiation results in
different lineages of keratinocytes, each of which has differential expression of molecular
markers (Figure 5.1B). Therefore, the type of keratin each layer expresses defines its unique
lineage and allows most layers to be identified.
At the onset of anagen, the matrix progenitors gradually become terminally differentiated and
more cornified as the whole structure moves distally. The cuticle layers of the HS and IRS then
separate from each other as the HS starts emerging from the skin. The IRS thus forms a channel
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of the HS as it moves. There is then a structural transition in the HF, during which all the cell
layers become highly compressed.
The matrix expresses numerous regulatory factors and signaling molecules during anagen,
some of which are expressed uniformly throughout the matrix (e.g. Ptcl), whereas others have
restricted expression pattern (e.g. Shh and Lefl). The prevalent hypothesis is that the matrix
contains equivalent multipotent cells which acquire their terminal differentiated state as they
leave the matrix according to their position (Niemann and Watt, 2002; Porter, 2003). This is
supported by previous studies in which markers specific to IRS and HS lineage determination
(e.g. GATA3) were detected in different layers immediately above the hair bulb (Kobielak et
al., 2003). On the contrary, other studies suggest that the HS and IRS lineages each have
specific progenitors, for example, ectopic expression of the Bmp inhibitor, Noggin, in the
matrix results in a defect in HS differentiation in Msx2-Noggin transgenic mice (Kulessa et al.,
2000).
Recently, it was shown by Legue and Nicolas, that the matrix is divided into several sectors,
which give rise to individual HF compartments (Legue and Nicolas, 2005). The study
employed clonal analysis of HF morphogenesis based on temporal induction of (3-galactosidase
labeling by OHT in the CMV Cre ER' x Rosa26 reporter mice to trace matrix progenitor cells.
It was found that the matrix cells are highly organized within the structure, and is divided into
SC, progenitor and post-mitotic layers in the radial dimension; and in the proximodistal
dimension, it is divided into 3 sectors of precursors for the IRS, the HS cuticle and medulla,
which corresponds to the order of the concentric cell layers in the HF, from the most peripheral
IRS, to the innermost medulla core. These precursors are capable of self-renewal and producing
transient progenitors, but the proliferative activity of distinct cell lineages is different.
On the other hand, the outer root sheath is a continuation of the 1FE, and is of a different
lineage from the HS and IRS. In contrast with the HS and IRS progenitors which occupy
specific niche, the ORS is produced by progenitors dispersed throughout the ORS that display
local division and apoptosis (Legue and Nicolas, 2005). The companion layer is a single layer
of small flattened cells internal to the ORS that is thought to be derived from the IRS lineage
(Niemann and Watt, 2002), although it has been a constant subject of debate (Gu and
Coulombe, 2007).
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The sebaceous glands (SG) lie above the bulge. Terminally differentiated sebocytes secrete and
supplement the HF with lipid-rich sebum and nutrients from the SG duct into the hair canal that
empties out to the skin surface.
(ii) Epidermal differentiation
The epidermis is composed of layers of keratinocytes that are in different differentiated states.
To maintain homeostasis, the basal keratinocytes continually undergo terminal differentiation
while old cells are shed from the skin surface. The basal layer consists of 3 cell subtypes: stem
cell (SC), transit-amplifying (TA) cells and post-mitotic differentiating (PMD) cells (Jensen et
al., 1999). The epidermal SCs have complete self-renewal capacity and high proliferative
potential. At the induction of IFE differentiation, selected progeny of SC become TA cells,
which go through finite number of cell divisions before committing to terminal differentiation.
PMD cells are the committed cells in the basal layer that are eventually detached from the BM
and migrate upwards through the suprabasal layers which consists the spinous, the granular and
the cornified layers, in the order of their differentiated state (Figure 5.2).
According to the above model, IFE homeostasis is maintained by 2 progenitor populations: SCs
and TA cells. Recently, this model is being challenged by a new finding that epidermal SCs
alone are able to maintain normal epidermis. Using inducible genetic labeling, it was shown
that under normal circumstances, individually labeled SCs were able to undergo both
symmetric (horizontal) and asymmetric (vertical) divisions at a rate that ensure IFE
homeostasis (Clayton et al., 2007).
Epidermal differentiation requires dermal-epidermal interaction via growth factors such as the
epidermal growth factors (EGFs), transforming growth factors (TGFs), and ECM proteins. And
so the programme of epidermal differentiation is a highly ordered and controlled process.
Keratinocytes at different differentiated state express specific growth factors and structural
proteins in a temporal and cell-specific manner. For example, as the PMD cells exit the cell
cycle and begin to detach from the basal layer, they switch from the expression ofK14 and K5
to K1 and K10. The spinous cells are the most proximal suprabasal layer that express K1 and
K10, this reflect their cytoskeleton of K1/K10 filament bundles connected to the adhesion
junctions (called desosomes) that hold the basal and suprabasal layers together as well as their
neighboring keratinocytes (Edmondson et al., 2003). Flowever, under wound healing or other
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hyperproiiferative situations, K6, K16 and K17 are also expressed in the suprabasal layers
(Fuchs, 2007).
(iii) Sebocyte differentiation
SGs are holocrine glands that are composed of round-shaped termination (acini) attached to a
common excretory duct connected to the hair canal. Sebocyte differentiation starts at the
periphery of the gland. The basal cells lining the SGs contain stem cells and highly proliferative
sebocytes that eventually differentiates and mature, as they migrate toward the central excretory
duct. As sebocytes disintegrate, they release the lipid-rich sebum made of triglycerides, wax
esters, squalene and the decomposed sebocytes into the hair canal for lubrication, waterproofing
and protection against bacterial infections (Fuchs, 2007).
SGs are also found in non-hair region such as the lips, eyelids, mammalian anal glands,
perputial glands. The structure consisting of the hair shaft, hair follicle and SG is often known
as a pilosebaceous unit.
5.1.3. The normal hair cycle
Throughout the entire life ofmost mammals, hair follicles go through cycles of rapid growth
phase (anagen), apoptotic-driven regression (catagen), and relative quiescence (telogen) during
which the hair follicles are constantly being renewed and regenerated (Figure 5.3). Each of the
hair stage in mouse is well-characterized and documented; anagen has been subdivided
morphologically into 6 and catagen into 8 different stages (Muller-Rover et al., 2001). The
major events of a hair cycle are summarized below:
At the start of a hair cycle, progeny of bulge stem cells (transit-amplifying cells) migrate
downwards to the mesenchymal compartment and rapidly proliferate to generate a new hair
matrix of IRS and HS progenitors. In response to mesenchymal cues from the connective tissue
sheath and the DP, the TA matrix cells change migration direction and terminally differentiate
into IRS or HS in a upward distal direction (Paus and Cotsarelis, 1999).
In mid-anagen, while the 7 lineages of HS, IRS and the companion layer keratinocyte are being
generated as an upward growth, the ORS grows downwards into the connective tissue of the
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dermis. The counter-current movement of these migrating cell layers is facilitated by the
slippage plane formed by the companion layer, which only form desomosome adhesion
junction with the IRS keratinocytes (Porter, 2003).
At catagen, the follicles undergo an apoptotic-driven regression when the lower part of the
follicle stops proliferating and enter apoptosis. The matrix cells are called TA cells because
they only survive through the anagen phase of a hair cycle. The hair bulb then shrinks in size,
pulling away from the mesenchymal cluster of DP cells which it previously enveloped. The
whole follicle then shortens and retracts upwards, drawing the DP closer to the bulge. The
proximity of the DP and the bulge is thought to be important for epithelial-mesenchymal
signaling in subsequent hair cycles. However, in mouse whiskers, the DP never reaches the
bulge before a new anagen (Oshima et al., 2001), supporting the notion that bulge SCs migrate
to the hair bulb where they become activated to proliferate.
While the hair shaft may be shed and part of the hair follicle structure degenerates, throughout
each hair cycle, the HF maintains several permanent non-cycling parts including the bulge SCs,
the SG, the connection with the arrector pili muscle and the DP which is in close association
with the HF. The hair shaft, including the 7 lineages of keratinocytes and the matrix progenitors
are the cycling portion of the hair follicle.
At telogen, the hair follicles are in a quiescent state, during which the club hair may be shed.
After a period of mitotic quiescence, signal from the DP initiates proliferation of bulge stem
cells for a new hair growth. In mouse, the first telogen usually lasts for 1 or 2 days, whereas the
second anagen may last more than 2 weeks (Muller-Rover et al., 2001).
5.1.4. Hair-related abnormalities
Of all the mouse mutants (spontaneous, targeted or randomly induced) with abnormal hair
phenotypes, the major characterisations may be divided into 6 categories (Nakamura et al.,
2001; Porter, 2003): (1) reduction in number of hair follicles, (2) abnormalities in HF
morphogenesis, (3) abnormalities of hair follicle cycling, (4) hair follicle or hair shaft structure
defects, (5) immunological disorders and (6) abnormal SG development. (Nakamura et al,
2001).
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This categorisation also reflects human hair growth disorders. For example, androgenetic
alopecia is partially due to the progressive shortening of successive anagen cycles, coupled with
a reversion of the androgenic-sensitive terminal hairs (thick, pigmented hair that penetrates into
the subcutis) of the scalp to vellus hairs (thin, unpigmented hair). Alopecia areata results when
anagen terminates prematurely.
In contrast, hirsutism occurs when abnormally enlarged vellus HFs become terminal HFs
inappropriately, a process that usually occurs in puberty when several regions of hair follicles
in the body, e.g. male facial region, convert from vellus to terminal hair follicles in response to
androgen.
In most of the conditions in both mice and human, the FIFs are not actually lost. So by
understanding the mechanism of the conditions, it may be possible to reverse the effects of
these disorders as we gain better understanding of the regulation of hair cycle and hair growth.
5.2. Background knowledge on dep
Depilated {dep) is an autosomal recessive mutation that is characterised by the loss of hair
shortly after birth. It arose spontaneously on a brachyury (T) tf background at the Jackson
Laboratories in 1966 (Green, 1970). Homozygotes are viable and fertile. Mutant mice can be
identified by an unusually thin and short hair coat as early as 1 week of age when hairs first
emerge from follicles. By 3 weeks some mice are nearly hairless, whereas others retain a rather
substantial coat. Adult hairs are greasy, matted and slightly depigmented in comparison to wild-
type.
The dep mutant is currently available as "B6C3Fe eJa-depH" at the Jackson Laboratory. It was
reported that many hair follicles are misshapen and disorientated with 20% of the hairs showing
an irregular arrangement of septa in the hair shaft. In addition, clumps of pigment are also
observed and are thought to be remains of degenerating follicles. However, the skin stage of
when this observation is taken was not specified.
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A similar description ofdep has also been entered in Skinbase18, the mutant mouse skin and
hair pathology database, including histological sections that illustrates the reported pigment
clumping phenotype ofdep.
The site of action of the dep locus was analyzed by the technique of dermal-epidermal
recombination grafting (Mayer et al., 1976). In this study, dennal-epidermal recombination was
made between embryonic skin of dep and normal mice transplanted onto histocompatible mice.
It was found that the grafts that contained mutant epidermis as one of the components (i.e. 'dep
epidermis-wild type dermis' and 'dep epidermis-r/ep dermis') produced hairs with a
morphology similar to hairs found in dep mice; whereas grafts of the combination 'normal
epidermis-dep dermis' produced hairs that are comparable to wild-type. This indicates that the
dep phenotype is of an epidermal origin.
Skinbase website: http://www.pathbase.net/~skinbase/mutant_images.php?mutant=De/?ilated_((%9_Chr4_38.8cM
European mutant mouse pathology database (Pathbasc), University ofCambridge, World Wide Web (http://www.pathbase.net)
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Figure 5.1. Schematic representation of the hair follicle
[A] Stem cell locations in mammalian epidermis (Watt et al, 2006). Apart from the bulge region (blue),
epidermal stem cells are also thought to be present in the basal layer of the IFE (green) and the SG (red).
The cells highlighted in yellow present transit-amplifying cells. Terminally differentiated cells are not
shown. [B] The hair bulb show ing 8 distinct lineages of keratinocytes of the hair follicle. The diagram
also includes the specific pattern of expression of several markers that allow individual lineages to be
distinguished.
Abbreviations: DP, dermal papilla; HF, hair follicle; IFE, interfollicular epidermis; SG, sebaceous
gland; ORS, outer root sheath; Cp, companion cell layer; IRS, inner root sheath; He, Henle's layer; Hu,
Huxley's layer; Ci, cuticle of IRS; Ch, cuticle of hair shaft; Co,cortex of hair shaft and Me, medulla.
[A]
□ Basal cell
□ IFE stem cell
■ Bulge stem cell




Figure 5.2 Differentiation of epidermal keratinocytes
(Diagram from Edmondson et al, 2003).
The basal cell layer consists of three types of cells namely IFE stem cells (SC), transit amplifying (TA)
cells and post- mitotic differentiating (PMD) cells. Epidermal differentiation begins when selected
daughters of SC becomes TA cells, which go through finite number of cell divisions and finally become
PMD cells that are committed to the process of terminal differentiation. The PMD cells detach from the
BM and move to the suprabasal layer where they continue to differentiate as they migrate upward
through successive layers ofbasal layer, spinous layer, granular layer, and finally becomes the cornified
layer of anucleated cells, which is eventually shed (Edmondson et al, 2003).
BM, basement membrane; Circular green arrow, represents self-renewal ability; green arrow, progression







Figure 5.3: The hair growth cycle
(Diagram from Fuchs etui, 2001)
At anagen, a mature hair follicle consists of the bulge, which lies under the sebaceous gland. At the base
of the follicle, is the hair bulb which consists of the dermal papillae, surrounded by the matrix, which
proliferates and differentiate into the 7 lineages of keratinocytes, that form the hair shaft (HS) and the
inner root sheath (IRS). The outer root sheath (ORS) is of a different lineage, and is a continuation of the
interfollicular epidermis (1FE).
Throughout the entire life ofmost mammals, hair follicles go through periods of anagen, catagen, and
telogen during which hairs are constantly being renewed and regenerated. At anagen, the matrix cells at
the hair bulb goes through rapid proliferation to generate an upward growth of a hair fibre. At catagen,
the follicles undergo an apoptotic-driven regression when the lower part of the follicle stops grow ing and
is reabsorbed, drawing the DP closer to the bulge which maybe for the purpose of epithelial-
mesenchymal signaling, and maybe essential in converting stem cells into matrix cells. And at telogen
















5.3.1. Characterization of dep phenotype.
(i) Visible phenotype of dep
Our observations were consistent with some of the documented descriptions of dep. In general,
dep seems to lose their hair shortly after birth, when hairs first emerge from hair follicles, but
others lose hair later (Figure 5.4A). The hair loss phenotype is heterogenous and is variable in
terms of the onset of phenotype, degree and region of hair loss.
Adult hairs of dep are greasy, matted and sparse throughout the body in comparison to wild-
type (Figure 5.4C). The hairs of adult mice are typically depigmented especially on the ventral
side of the body. The orange-brown colour indicates a lack of eumelanin, and this phenotype
becomes more prominent as the mutants become older (Figure 5.4D). The lack of eumelanin
can be observed by eye as early as P5 (Figure 5.5A), just after the eruption of hairs from the
follicles, at which stage, the hair distribution is sparse and disorderly (Figure 5.5B). The
development of skin tumors or lesions has never been observed in dep. Heterozygotes have no
phenotype, indicating it is likely that dep is a loss of function or partial loss of function
mutation.
Apart from the hair loss phenotype, it is often observed that dep mutants are smaller in body
size during the first few weeks of birth (Figure 5.4B). However, this difference becomes
insignificant and gradually disappears as the mice get older.
(ii) Histological analysis of dep
Crosses between dep heterozygotes were set up and skin samples were collected at weekly
interval of up to 12 weeks. Earclips from all mice were collected for genotyping on weaning so
that a set ofwild-type, heterozygote and homozygote was collected for each timepoint.
Comparison between dep and a control littermate is necessary due to the complicated breeding
background of dep and the possible discrepancy in morphology as a result of strain difference.
This also ensures that the animals are age-matched at every stage.
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Some sections were sent to Dr. Rebecca Porter (Department of Dermatology, University of
Cardiff) who analysed the samples by comparing H&E sections between wild-type and dep,
and by measuring the length of 8week dep mutant (without littermate control). In summary, she
concluded that dep has enlarged sebaceous glands, dilated infundibulum at telogen and a
delayed 2nd catagen. It was also observed that the dep HFs have unusually long epithelial
strands and possibly disintegrating HFs.
Subsequent analysis by myself verifies all findings except that, instead of a delayed 2nd catagen,
dep follicles seem to enter the 3rd anagen at 7-weeks, after it had gone through the 2nd catagen at
week 5/6 (Figure 5.6B), same as wild-type. The findings are detailed below. In general, the dep
anagen HFs also appear smaller in size. Despite the discrepancy, there is definitely a mismatch
in hair cycling events between wild-type and dep. In addition to the hyperplastic sebaceous
glands, the epidermis and outer root sheath of dep are also shown to be hyperproliferative using
specific markers. The thickness of the skin layer generally varies throughout the hair cycle, but
in some cases there are discrepancies between wild-type and dep.
Dilated infundibulum
The first catagen occurs at the same time in wild-type and dep, but when regression is
completed at week 3, the telogen follicles of dep have a dilated infundibulum [Figure 5.6A(iv)],
which is the upper segment of the HFs between the epidermis and the entry of the SGs.
Abnormal histological morphology
Despite the abnormal appearance of the telogen follicles, the mutant follicles start cycling again
at week 4 and enter anagen, as do wild-type. In wild-type, the hair bulbs, melanin, matrix cells
can be clearly observed at this stage, indicating that the matrix progenitors are actively
proliferating and differentiating [Figure 5.6A(ii)]. However, even though dep is also in anagen,
the morphology of the HFs at this stage is generally abnormal and malformed [Figure 5.6A(v)].
The follicles appear stunted and under-developed, which resemble the appearance of embryonic
hair follicles. Furthermore, the mutant follicles are not as deeply invaginated into the
subcutaneous layer.
Sebaceous hyperplasia of dep follicles
The morphogenesis of dep follicles appears normal in general, however, the sebaceous glands
are enlarged especially at anagen [Figure 5.6A(v)] whereas in wild-type, the SGs are not as
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often seen because they are relatively small. The IFE of dep also appears thicker comparing to
wild-type [Figure 5.6A(v)].
Mismatch in hair cycle events
The dep follicles go through the first hair cycle normally, and enter the second hair cycle at
about 3.5week. Both wild-type and dep follicles start to regress at about 6 week of age (Figure
5.6B). However, while wild-type HFs are still in telogen at 7week [Figure 5.6A(iii)], dep
follicles are already in the (3ld) anagen [Figure 5.6A(vi)] with apparent hyperplastic phenotype.
This persists until 9-wk, at which point the regression appears to have occurred with shortened
follicles. At 10 and 12 weeks, both wild-type and dep follicles are in telogen. The hair cycling
events ofwild-type and dep follicles are summarized in Table 5.1.
Apart from the above observations, however, dep generally has a complete morphology with
intact HF components.
Table 5.1: Epidermal Stages at weekly time points observed in histological sections.
WEEK C57BL/6 Dep
l Morphogenesis Almost Normal morphogenesis
2 Morphogenesis -> Catagen Morphogenesis
3 Telogen Telogen
4 Anagen Anagen
5 Late Anagen Early Catagen (anagen)
6 Catagen/ Telogen Catagen/ telogen
7 Telogen Anagen
8 Telogen Anagen
Note: Anagen (growth phase), catagen (destruction), telogen (rest stage).
The onset of dep phenotype
Consistent with the visible differences that can be readily identified by eye (Figure 5.5),
histological sections show the onset of dep phenotype is between P4 and P5. The hair follicles
between P4 wild-type and dep are similar (Figure 5.7), indicating that HF development is
normal at this stage. However, dep follicles at P5 shows an obvious thickening of the
epidermis; the sebaceous hyperplasia phenotype becomes noticeable by P7.
Discrepancy from previous findings
It was previously reported in 'Skinbase' that dep exhibits various degree of follicular dystrophy
based on histological sections, including melanosome clumping within the HFs. A similar
observation was made by Rebecca Porter when looking at a sample of dep skin (from dep x dep
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(ii) Expression of custom-made Zdhhc21 antibody.
The above conclusion was based on a comparison between patterns of RNA in-situ and protein
immunohistochemistry in separate experiments. To confirm the exact location of Zdhhc2l
expression, it requires counter staining with a marker of known pattern of expression.
Therefore, an antibody targeting Zdhhc2l was designed and made to allow better localization
and more relevant comparison with other markers.
Two peptides targeting the N- and C- terminals were designed from the 265 a.a. Zdhhc2l
peptide by Eurogentec (Double X purified program) based on hydrophilicity, surface
probability, antigenic index and the alpha helix predictions of the targeted peptide.
73- 87: GRLPENPKIPHAERE +C
219-232: CEEISRPRKPWQQT
MGLRIHFWD PHGWCCMGLI VFVWLYNIVI IPKIVLFPHY EEGHIPGILI IIFYGISIFC 60
LVALVRASLT DPGRLPENPK IPHAERELWE LCNKCNLMRP KRSHHCSRCG HCVRRMDHHC 120
PWINNCVGED NHWLFLQLCF YTELLTCYAL MFSFCHYYYF LPLKKRNLDL FWRHELAIM 180
RLAAFMGITM LVGITGLFYT QLIGIITDTT SIEKMSNCCE EISRPRKPWQ QTFSEVFGTR 240
WKILWFIPFR QRQPLRVPYH FANHV 265
A first bleed of the immunisation against the antigen was tested on western blot against lysate
of cells transfected with wild-type Hk-Zdhhc21 construct, two bands of size not expected of
Zdhhc21 (~3 lkDa) were seen with the bleed immunised against the N terminal peptide, no
bands were observed with the C-terminal peptide.
The purified antibody (against N + C terminal peptides) was tested against the same cell lysate
transfected with HA-Zdhhc21on western blot, but has not yet been successful.
Immunofluorescence of these cells transfected with \\A-Zdhbc21 construct shows that the N-
terminal antibody (N-dhhc21 hereafter) co-localises w ith the cis-Golgi marker Gm 130 in a very
small proportion of cells (data not shown). Ideally, the N-dhhc21 antibody may be tested
against cells transfected with HA -dep to show a mislocalisation of the protein.
Using the purified antibody, immunohistology was performed on skin sections. The IHC
pattern of N-dhhc21 localises to a specific region in the HFs of both wild-type and dep.
Although N-dhhc21 does not co-localise with GATA-3 (Figure 5.10), it is in a similar region as
observed with RNA probes. This emphasizes the needs of designing a Zdhhc21 antibody which
allows counter-staining and a more accurate localization of the protein.
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The N-terminal antibody localises to the Henle's layer of IRS
To determine the exact location ofN-dhhc21 expression, several markers have been used (see
Figure 5.IB for reference). N-dhhc21 co-localises partially with AE15 in 4-wk wild-type
follicles (Figure 5.11 A), but does not overlap with GATA3 staining (Figure 5.10). AE15 stains
all 3 layers of the IRS, whereas GATA3 only stains the inner 2 layers of the IRS: Huxley's
layer and the cuticle layer. This indicates that N-dhhc21 colocalises with the Henle's layer. If
the raised antibody is specific, it means that Zdhhc21 is expressed in the outermost layer of the
IRS, which is the Henle's layer. It was also observed that, at 4wk, N-Dhhc21 expression
overlaps almost completely with AE15 in dep follicles, suggesting that the inner two layers of
the IRS, and/ or the medulla may be absent in dep at that stage (Figure 5.11B). We show that
GATA3 is expressed in dep skin (Figure 5.9), suggesting that only the medulla (but not any part
of IRS) is absent in dep.
At 5-wk, however, the other regions of AE15 staining appear again in dep, and is identical to
wild-type (Figure 5.11C and D).
Specificity of the N-Dhhc21 custom-made antibody
The expression pattern observed with the N-antibody maybe due to other antibodies in the
source other than the one specifically targets the Zdhhc21 antigen. To test whether the
expression pattern is specific, saturating amount (lmg/ml) of the immunogen peptides was
added together with the purified N-terminal antibody to compete binding with the antigen on
the skin sections. Under normal conditions, the N-dhhc21 antibody stains about half of the
follicles in 5-wk wild-type skin, especially in the dermis. When theN-Dhhc21 specific
immunogen peptide is applied in addition to the antibody, none of the follicles were positive,
indicating that the immunogen completely blocks N-Dhhc21 binding specifically (Figure
5.12a). Therefore, the staining pattern is likely to be due to antigen-specific antibody, but not
any non-specific antibodies that might have accidentally developed through immunization.
In addition, staining with pre-immune serum and secondary antibody alone (Alexa 594 anti-
rabbit IgG), show that the specific pattern observed with the N-Zdhhc21 antibody was not
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caused by non-specific protein interactions with cellular proteins/ lipids/ carbohydrates, or non-
specificity of the secondary antibody respectively (Figure 5.12b").
5.3.3. Matrix proliferation and HF morphogenesis are normal in dep
Endogenous alkaline phosphatase (AP) staining can be used as a marker for the dermal papillae
(DP) and the dermal sheath, which is the outmost layer of the follicle. AP activity is observed
in the DP and dermal sheath, indicating that the HF morphogenesis in dep is likely to be normal
(Figure 5.13).
The hyperplasia phenotype observed in dep may be due to an increase in cell proliferation in
response to an upregulation of certain signaling events. To determine whether the underlying
cause of the basal layer hyperplasia is due to an increase in cell proliferation, we used Ki67, a
standard proliferation marker that stains cells in all phases except GO (Figure 5.14), and
Phosphohistone 3 (Ph3), a proliferative marker specific to M-phase (Figure 5.15). Neither
marker shows a significant difference in the number of positive cells. This indicates that the
matrix proliferation in dep is likely to be normal, and that the hyperplasia phenotype is not due
to an increase in proliferation.
The extent of cell death was also looked at using Caspase3a, a specific cell death marker, and
was also normal, indicating that the observed phenotype is not due to apoptosis (data not
shown).
5.3.4. Aberrant differentiation in dep epidermis
Epidermal progenitor compartment is expanded
Immunohistochemistry using keratin 5 (K5), marker of the ORS, bulge and the basal layer,
highlights the much thicker IFE and basal layer in dep (Figure 5.16). Although the SGs are not
usually visible using the K5 marker, I<5 staining reveals the appearance of SGs due to the
significant expansion of the organ.
Keratin5 is a marker of the epidermal progenitor compartment which marks basal keratinocytes
at an early differentiation state, the expansion of K5 signal directly indicates the expansion of
19 Control experiments from Figure 5.12b images provided by Margaret Keighren and Pleasantine Mill.
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the compartment. This indicates that the hyperplasia phenotype in dep is due to an actual
expansion of the progenitor compartment as a result of a disturbed programme of epidermal
differentiation, rather than an increase in proliferation.
Increased number of undifferentiated cells in dep basal layer
Nuclear staining of the epidermis using DAPI shows an increased number of nucleated cells in
dep epidermis that have not undergone terminal differentiation (Figure 5.17). In wild-type, the
cells flatten as they differentiate up the suprabasal layer, whereas in dep, the suprabasal cells
are often vertically elongated.
Usually, an epidermal proliferative unit (EPU) consists of a stack of cells including the basal
post-mitotic cell and their suprabasal differentiating progeny, and finally the cornified cells
(Allen and Potten, 1974; Kaur, 2006). In wild-type IFE, individual EPUs intersperse throughout
the basal layer. Whereas in dep, individual EPUs can not always be distinguished due to an
increased number of cells.
Expansion of the suprabasal layer of dep epidermis
The expansion of K.5 staining in dep (Figure 5.16) suggests an expansion of the basal layer (i.e.
epidermal progenitor compartment). To further address this finding, a basal/ progenitor marker
P63 was used to determine whether the K5+ compartment contains an increase in proliferative
cells.
P63 (also known as p51 or KET), was originally identified as a member of the p53 tumor
suppressor family. It is highly expressed in the basal or progenitor layers ofmany epithelial
tissues and is involved in initiating epithelial stratification during development and maintaining
proliferative potential of basal keratinocytes in mature epidermis (Blanpain and Fuchs, 2007;
Koster et al., 2004). When P63 expression is knockdown in the epidermis, the mice fail to
develop stratified epithelia as well as epithelial appendages and limbs (Koster et al., 2007).
Although P63 expression is required in the highly proliferative basal cell layers, its
downregulation is required in the differentiating layers to ensure correct terminal
differentiation.
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In dep, there is an increase in P63+ cells in the basal layer which may be a result of an overall
increase of nucleated cells in the epidermis. Normally, proliferative keratinocytes are only
found in the basal layer, so P63 is expected to express in proliferating transit-amplifying (TA)
cells, which count for the majority of the basal cell layer. However, double staining ofK5 and
P63 reveals that the progenitor cell layer is expanded beyond its normal one-cell layer thickness
in dep (Figure 5.18).
The P63 signal in layers beyond the first basal layer typically appears weaker than those in the
first basal layer. This suggests that, even though K5 expression is sustained, the progenitor cells
gradually lose their P63 status and perhaps their proliferative ability as they migrate away from
the basal layer and become more terminally differentiated (Figure 5.18, white arrows).
The increased frequency of P63+ cells in the basal layer suggest that dep epidermis has an
increase in cell proliferation and that epidermal stratification may be delayed. This aspect of
phenotype resembles closely to the Ptcl"""""es (mesenchymal dysplasia) mutant that has
epidermal hyperplasia and an expansion of the epidermal stem cell compartment (Nieuwenhuis
et al„ 2007).
Since K5 staining in dep covers the entire thickness of the epidermis (excluding the comified
layer), it is necessary to use a suprabasal marker to determine the region of expansion.
Normally, keratinocytes switch off K.5/K.14 expression as they detach from the BM into the
suprabasal layer where they express K10 instead. However, double labeling with K10 and P63
shows that the expression pattern of K10 overlaps with that of K5, and that the suprabasal layer
is thickened in dep (Figure 5.19). In dep epidermis, K10 is absent from the basal layer (first
epidermal layer), but express suprabasally in up to 5 or 6 cell layers. Some of these suprabasal
layers contained large and round keratinocytes with prominent nuclei (Figure 5.19, green
arrow), instead of the flattened shape usually seen in terminally differentiated cells. Although
P63+ cells are seen in the K.10+ suprabasal layer of dep skin, they are also found in wild-type
epidermis, but at a lower frequency. The expression pattern ofK5, K.10 and P63 in wild-type
and dep epidermis is represented in Figure 5.20.
The sustained K5 expression is not coupled with sustained progenitor properties, as evident by
the observation that P63+ cells never get beyond the second/ third cell layers. But instead, the
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sustained K5 expression seems to be associated with a delay in terminal differentiation. It is not
clear whether the downregulation of K5 is required for correct terminal differentiation, or
whether these are 2 independent consequences as a result of a disruption in epidermal
homeostasis.
Taken together, the elevated P63+ cells and the expansion of the suprabasal layer indicate an
aberrant differentiation. The causes or consequences of the sustained K5 expression is
unknown, however, it seems to couple with mislocalisation of undifferentiated dep
keratinocytes. Although the number of P63+ cells is significantly increased in dep epidermis,
Ki67 and Ph3 staining (Figure 5.15) suggest that it is unlikely to be due to an increase in
proliferation rate.
Analysis of differentiation markers of each layer including involucrin (granular and upper
spinous layer), profilaggrin (differentiating granular layer), filaggrin (keratinocytes in transition
from nucleated granular to anucleated cornified layer), and loricrin (cornified envelope) may be
necessary to determine whether a specific layer of the suprabasal compartment of the epidermis
is expanded.
Another observation is that, even though P63+ cells lining the SGs are clearly visible in dep but
not in wild-type due to their small size, the P63+ cells are more sparsely distributed in SG-
lining basal cells of dep when compared to the epidermis. It seems that there is not an increase
in the number of sebocyte progenitors. The sebocytes within the SG cavity are not positive for
P63, so they are likely to be differentiated lipid-secreting sebocytes as expected.
Immunostaining using markers of the SGs such as the adipogenic transcription factor PPARy
(an early differentiation marker which govern genes involved in lipid synthesis), and ORO (a
terminally differentiation marker) may be used to determine the status of these sebocytes.
5.3.5.The hyperplasia phenotype is not due to upregulation of Shh signaling.
At anagen, Shh signaling is required to maintain a balance between cell proliferation and
differentiation in the epidermis. It promotes proliferation of hair progenitor cells in the distal
matrix cells. It controls spatially and temporally expansion and differentiation of HF progenitor
cells to prevent ectopic proliferation of the matrix.
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During epidermal morphogenesis, a series of epithelial-mesenchymal signals are turned on to
instruct the undifferentiated epithelium and mesoderm to placodes and dermal condensate
(Fuchs and Raghavan, 2002). Loss of Shh expression in knockout skin grafts results in absence
of hair shaft due to aberrant differentiation (St-Jacques et ah, 1998). Whereas Shh
overexpression leads to formation of basal cell carcinomas in transgenic mice (Oro et ah, 1997).
During development, Shh is expressed in the placode, while the Shh targets, Ptcl and Glil are
expressed in the dermal condensate. In postnatal skin, Shh is normally restricted to a small
group of cells in the anterior or posterior hair matrix. Ptcl is expressed in the epithelial portion
of the hair bulb and the DP of postnatal skin. The expression of Glil partially overlap with Ptcl
in the hair bulb.
The expression level and pattern of Shh, and its responsive genes, Ptcl and Glil are compared
in wild-type and dep hair follicles by RNA in-situ on postnatal skin (Figure 5.21), but no
significant difference were found. Therefore, we conclude that the dep mutation does not result
in direct or indirect upregulation of Shh target genes in the skin.
5.3.6. Sebaceous hyperplasia
Tail epidermal in-situ assay
In comparison with the epidermis of the dorsal skin, tail epidermis contains fewer numbers of
follicles and the follicles are arranged as triplets. The tail follicles have more complex tertiary
structure with a pigmented scale pattern. Although the tail follicles do not cycle in synchrony
with the backskin, the follicle triplets do coordinate with each other even though the central
follicles typically remain in anagen for longer than the flanking two.
The recent development of whole-mount labeling techniques in mouse epidermis has facilitated
examination of follicles in large areas of the epidermis without the need to prepare conventional
histological sections (Braun et al., 2003). So far, two-dimensional images from skin sections
reveal cross-sections of the HFs, allowing us to study expression pattern against various
antibodies in different compartments. However, it is often difficult to assess co-localisation of
two markers, and the access to the overall structure is restricted. In contrast, whole-mount
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labeling and confocal microscopy allow us to analyze the 3D topography of the follicles. Tail
epidermis is commonly used because compared to the dorsal skin sample, it has easier access,
and the epidermis can be spilt from the dermis more readily.
Tails from wild-type and dep mice were collected. After incubation in 5mM EDTA at 37°c for
4 hrs, the epidermis was separated from the dermis to expose the follicles underneath the
epidermal layer. An initial in-situ assay was then carried out by Ian Smyth as a collaboration.
Normally, wild-type tail follicles are arranged as triplets, with a pair of well-defined SGs per
follicle. When examined for K.14 and K.15 expression in dep, the SGs show various
abnormalities including an evident hyperplasia, malformed and extra glands (Figure 5.22).
Despite the differences observed with confocal microscope, the tail of the mutant does not
show any visible phenotype in any mice collected and the tail does not exhibit hair loss.
Sebum staining using the lipophilic dye Oil Red O (ORO) also shows the sebaceous
hyperplasia appearance and also an accumulation of lipid in the infundibulum (Figure 5.23),
which may explain the greasiness of the dep hair coat. The limitation of using this type of lipid
staining is that it is an assay of sebum production (i.e. not in-situ), therefore the region that is
positive for ORO does not necessary represent the site of production/ secretion. Therefore, the
samples must be handled gently to prevent any artifacts created by physical movement.
Comparison with glands with SG-like morphology
Although dep exhibits a prominent SG hyperplasia phenotype, rather than being a cause of the
hair loss phenotype, it may be a consequence of an imbalance of various cell types in skin
homeostasis secondary to the hair loss phenotype.
To get some idea of a causal link of the SG phenotype, glands that have SG-like morphology
were collected from adult mice to see if they are also affected in dep. They included the
meibomian gland, preputial gland (male), anal gland and ceruminous gland.
Histological sections were compared for the preputial glands (Figure 5.24), and no difference
were found in terms of gland size, number of sebocytes and sebocyte size. The other glands
were sent to Rebecca Porter and she reported no difference (data not shown). This shows that
the dep mutation is unlikely to affect sebocyte proliferation in other tissues, and that the SG
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phenotype is specific to hair follicles. So, the SG hyperplasia phenotype is likely to be a
consequence secondary of a skin/hair phenotype.
5.3.7. HS differentiation is delayed in dep
Apart from the phenotypes already described, H&E sections reveal an abnormality in hair shaft
development in dep mice. In wild-type mice, at anagen, strands of hairs can be seen in the
epidermis and emerging from the HFs through to the skin layer. However, these hair shafts are
not seen in dep HFs. Occasionally, differentiating hair shafts may be observed in dep at that
stage, but are different from that of wild-type (Figure 5.6ii and v). It may be that the dep HFs
lack correct hair shaft differentiation, rather than losing hair by an active shedding.
Immunohistochemistry on skin sections using hair shaft-specific markers shows that this is the
case. The staining pattern ofAE13, marker of the acidic hair keratin filaments in the cortex and
cuticle of the hair shaft, appears to be different between wild-type and dep (Figure 5.25). The
AE13 staining in wild-type appears as a oval-shaped hoop, within which lies the medulla, the
innermost core of the hair shaft. However, this non-staining space is missing in dep HFs; the
AE13-staining structure on the 2 sides seem to 'collapse' onto each other, indicating that the
medulla may be absent in dep in early anagen.
AE15 is an antibody against trichohyalin granules, which are normally present in all 3 layers of
the IRS and the medulla. At early anagen (4 weeks), AE15 signal can be clearly seen in the IRS
and medulla in wild-type HFs as two clearly separated compartments. However, in dep, the
AE15 signal only appears as one region (Figure 5.26A, also Figure 5.11A and B), indicating
that the medulla is absent. Combining with the AE13 staining data (Figure 5.25), it suggests
that the AE15 region represents the IRS and that the medulla is absent, indicating a lack of hair
keratin-specific protein of the medulla being made at this stage of anagen.
At late anagen (5 weeks), however, the expression pattern ofAE15 in dep becomes normal
again (Figure 5.26B, also Figure 5.11C and D). It is possible the dep HFs require longer time to
reach a threshold for hair-specific keratin production, during which the full extent of hair
growth is attained for a functional hair to be made.
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[D] 10-week
dep _ het _ WT
Figure 5.4. Gross phenotype of dep
[A] Hair loss phenotype of dep. An example of an early hair loss phenotype showing dep being almost
completely bald at week 4. At this stage, dep has a normal body size comparable to wild-type. [B]
Reduced body size. The mutant mice are often observed to have a reduced body size during the first few
weeks after birth, but the difference becomes insignificant as they grow older. [C] Greasy hair coat
appearance. Comparison between wild-type and dep reveals the typical greasy phenotype and disorderly
pattern of the dorsal hair coat of dep. It also appears to be sparse and matted which is typical of the
phenotype. [D] Depigmentation of dep hair. At later stage, the hair of dep mutants are typically
depigmented, especially on the ventral side. Patches of hair loss region can also be observed at this stage.
The described phenotypes appear at various different stages and do not correlate to the age shown.
[A] 4"Wee\A/T Wdep _ WT _
3-week
WT




Figure 5.5. Mutants can be identified at P5
[A] Lack of pigment in dep. Dorsal skin samples collected from P5 mice showing a lack of pigment in
dep in comparison to wild-type and heterozygote. [B] Sparse and disorderly pattern. The same samples
under the microscope (xlO) reveals the sparse and disorderly pattern of dep. Scale bar, lOOni.
[A]
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Figure 5.6. H&E staining reveals the major histological phenotypes of dep
[A] At 3-wk, both wild-type [i] and dep [iv] have undergone catagen, and are now in telogen, when the
follicles are at rest, but the infundibulum of dep is dilated [iv]. But after a week, dep HFs start to cycle
again and are in anagen [v], when the melanosomes can be observed in the hair bulb ofwild-type HFs
[ii]. Even though dep is also in anagen, the HFs resemble embryonic follicles in size and appearance,
indicating that the HFs are malformed at this stage. Furthermore, the dep HFs are not as deeply
invaginated into the subcutaneous layer. There is also a hyperplasia of sebaceous gland (SG) and the
interfollicular epidermis (IFE). The dep HFs go through the first hair cycle normally, and then into the
second anagen again at about 3.5-wk. But at 7-wk, the WT follicles [iii] are at the end of its second hair
cycle in telogen and have regressed into the upper dermis but the mutant follicles [vi] are in anagen,
indicating a cycling difference between WT and dep HFs. The magnification of each picture is indicated,
highlighting the variability in thickness throughout a hair cycle. The follicles pictured are from similar
mid-dorsal regions, (a) epidermis (b) dermis (c) subcutaneous layer.
[B] At 6-wk, both WT and dep undergo telogen. indicating that the anagen observed at 7wk is a











Figure 5.7. The onset of histological phenotype appears as early as P5
At P4, the thickness of the epidermis and the size of sebaceous glands are similar between wild-type and
dep. At P5, an obvious thickening of the epidermis can be observed. At P6 and P7, the difference




Figure 5.8. The degree of pigmentation in medulla varies in dep
Sample of plucked hairs from a 9-wk dep dorsal region. The medullary septae are pigmented to various
degree within a sample of dep hair. Nevertheless, the septal patterns are normal, in contrast with
















Figure 5.9. Transcript of Zdhhc21 is present in the inner root sheath
RNA in-situ hybridisation on El 7.5 embryo shows thatZdhhc21 is expressed in hair follicles. Skin
sections in anagen shows that both wild-type and dep transcripts are localised to a very specific region in
the hair bulb. The signal is evident when the follicles are in anagen. Using a marker of the IRS, GATA-3,
it shows that the site of expression seems to be at the inner root sheath. The GATA3 signal and the BM
purple stain of the Zdhhc21 transcript seem colocalised. The dep follicles are clearly smaller comparing
to wild-type at the same magnification, and the GATA3 signal is biased towards the differentiating end
of the follicles, whereas in wild-type, the signal is all around the hair bulb.
Scale bar, 100pm.
Zdhhc21 (Region ofZdhhc21 transcript expression)











Figure 5.10. The N-Dhhc21 antibody does not co-localise with GATA3
The N-dhhc21 Ab does not colocalise with GATA3, which targets the sheath cuticle and Huxley's layer
of the IRS, in either wild-type and dep follicles at 5week, or any other stage of anagen (data not shown).
The N-dhhc21 Ab appears to target the layer that lies immediately outside of the GATA3-staining region.
Scale bar, lOOpm.
a-GATA3 (sheath cuticle and Huxley's layer of IRS)
<x-N-Dhhc21
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Figure 5.11. The N-Dhhc21 antibody targets the outermost layer of the inner root sheath
At early anagen, the N-Dhhc21 Ab colocalises partially with AE15 [A], which normally stains all 3
layers of the IRS and the medulla. However, in dep the N-Dhhc2l pattern overlaps almost completely
with AE15 [B], suggesting that the inner two layers of the IRS, and/ or the medulla may be absent in dep
at this stage. At 5wk, the AE15 and N-Dhhc21 costaining pattern becomes normal in dep [D], in
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Figure 5.12. Specificity of N-Dhhc21 antibody.
[A] Antigen blocking of the N-Dhhc21 antibody with specific immunogen peptide. a-N-Dhhc21 Scale
bar, 100pm. [B] Staining with pre-immune serum (pre-bleed) and secondary antibodies as negative
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Figure 5.13. Morphogenesis of dep follicles is normal
AP staining on 2-wk dorsal HFs shows that dep has a normal pattern of alkaline phosphatase activity in
the DP and dermal sheath, despite the reduction in follicle size. This indicates that the HF morphogenesis
is normal. The black pigment of the melanosomes can be observed from these pictures. Scale bar.
I00_m.
AP (dermal papillae, dermal sheath)
Figure 5.15. The number of mitotic cells in dep follicles at anagen is normal
At early anagen, when the dep phenotype is most prominent, the number of Ph3+ cell between wild-type
and dep appear similar. Scale bar, 100 m.





Figure 5.14. The number of proliferating cells remain normal in dep follicles
[A] The distribution of Ki67+ cells highlights the malformed follicles at the hair bulb of dep at early
anagen. The Ki67+ cells appear to be all around the hair bulb. [ B] At 5-wk, the distribution of Ki67+
cells becomes normal. [C] The number of K.i67+ cells at the infundibulum between wild-type and dep is
similar, even though the dep sebaceous glands are enlarged. Scale bar, I00_m.











Figure 5.16. Expansion of the epidermal progenitor compartment of dep
lmmunohistochemistry on 4-wk dorsal skin sections using _-K5 highlights the significantly thicker
epidermis, the outer root sheath, and the basal layer. The SG hyperplasia appearance is also marked. The
expansion of the K.5 signal indicates the expansion of the epidermal progenitor compartment of dep.
Scale bar, lOOrn.
-K5 (Basal layer, Outer root sheath and Bulge)
Figure 5.17. Epidermal proliferative units (EPU) in dep epidermis are indefinable
[A] DAPI staining, and [B], counterstained with -cat, show an overall increase in cells in the dep
epidermis, as well as in the mesenchymal compartment. [C] Individual EPUs can be easily identified in
wild-type; whereas in dep, there is an increase number of sparsely distributed cells of ambiguous status
based on the shape of cells.
Red: cells that belongs to an identifiable EPU; yellow: basal cells; green: cells that can be not identified
as basal cell or part of an EPU. Scale Bar, 20_m.
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Figure 5.18. The staining of K5 is expanded with an elevated number of P63+ cells
K5 and P63 double staining in 4-week dorsal skin (A and B), and tail epidermis (C). [AjUsually, K.5 is
expressed in the basal layer of the epidermis, which consists of one single layer of cells consisting of
epidermal stem cells, transit amplifying cells, and post-mitotic basal cells, which migrate out of the basal
as they differentiate. The P63+ cells represent the later two populations. In dep, however, K5 is
expressed further up the skin layer, possibly in the suprabasal layer including the spinous and granular
layer. The expression of P63 also persists beyond the first cell layer. There is an increase in the overall
number and density of cells in the epidermis. [C] Tail epidermis ofWT and dep highlighting the increase
in cell density and the vertically elongated shape of basal cells. Scale Bar for [A], 100_m; [B] and [C], 10
m.
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Figure 5.19. The suprabasal compartment of dep is expanded
klO and P63 double staining in 4-week dorsal skin, showing that the suprabasal layer is thickened in dep.
cn, cornified layer; gr, granular layer; sp, spinous layer; be!, basal cell layer. Scale Bar = 10 m.
Figure 5.20. Schematic representation of K5 and K10 expression in dep epidermis
A simple representation of K.5 and k 10 staining of the basal and suprabasal layers in wild-type and dep
epidermis. Although K5 staining is expanded in dep, klO staining shows that the expanded region is
likely to represent the suprabasal layer. There is an increase in the overall number of keratinocytes,
which is reflected by the increased number of P63 cells, which persists through to the suprabasal layer.
I lowever, P63-positive cells are rarely seen in the third layer from the basement membrane. In wild-type,
cells become more flattened and gradually become anucleated as they migrate upwards and become more
differentiated. In dep. however, circular nucleated cells are often seen in the suprabasal layer, suggesting
that terminal differentiation may be delayed.
SS basal layer (K5 staining)
8S suprabasal layer (KlO staining)





Figure 5.21. Expression of Shh, GUI and Ptc1 in 7-wk wild-type and dep skin
The expression pattern ofShh and the Shh-responsive genes, Picl and GUI is similar between wild-type
and dep, suggesting that the hyperplastic phenotype is unlikely be due to Shh upregulation. Scale bar,
100 m.
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Figure 5.22. Tail epidermal in-situ analysis of dep (Ian Smyth)
Wild-type tail epidermis consists of triplets of HFs, each of which has a pair of SGs. Whereas the SGs of
dep follicles are often hyperplastic and malformed. At some places there are also extra glands and some
follicles are bent. An unusually large number of melanocytes were also reported.
-K. 14 (basal layer of epidermis), -K15 (bulge).
WT










Figure 5.23. Lipid accumulation in dep infundibulum (Ian Smyth)
Staining of sebum using Oil Red O (ORO) reveals the sebaceous hyperplasia phenotype and an
accumulation of lipid in the infundibulum (arrow), which may explain the greasiness of dep hair coat.
ORO (sebum/ lipid staining)
Figure 5.24. Comparison of perputial glands between wild-type and dep
Despite the obvious sebaceous hyperplasia in the dep hair follicles, there is no difference in size and
number of sebocytes between wild-type and dep perputial glands. Boxed area in panels [A-C] are shown
at higher magnification in panels [D-F], Furthermore, no difference is observed in other glands that have
similar morphology to the SGs, including the anal glands, mebomian glands, ceruminous glands (data not
shown). Scale bar, 50pm.
Figure 5.25. Hair-keratin deficiency in dep at onset of anagenThe hair-specific keratin marker AE13
directs against the hard, acidic keratins in the hair shafts, including the cortex and cuticle layers. In wild-
type HFs, the AE13 signal appears as hoops within which is the medulla, whereas in dep, the signal only
appears at the tip of the hair follicles in 4-wk dorsal skin samples. At week5, most follicles restore
normal AE13 staining (data not shown). Scale bar, 50pm.
a-AE13 (cortex and cuticle layers of hair shaft) MK6
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Figure 5.26. Aberrant HF differentiation in dep at onset of anagen[A] The hair-specific keratin
marker AE15 is normally expressed in the IRS and the medulla of the hair shaft, as shown in 4-wk dorsal
HFs ofwild-type and heterozygote. Whereas in dep, AE15 is only positive in the IRS but not in the
medulla, indicating that there is a lack of hair shaft-specific protein being made at this stage of anagen.
[B] However, at 5-week, AEI5 staining pattern becomes normal again in dep. Scale bar, 50 m.
-AE15 (IRS + HS medulla)
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Figure 5.27. Conditional knockout of Smad4 exhibits phenotype similar to dep
(Picture from Qiao et al., 2006) At P10, almost no hair shafts are visible in Smad4 hair follicles. At
PI 7, SGs are hyperplastic which look similar to dep.
P10 P17
WT Smad4;* WT Smad4 7
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5.4. Discussion
5.4.1. Comparison of dep phenotype with existing mutants
The dep phenotype is mainly characterised by a progressive hair loss, SG hyperplasia,
epidermal and outer root sheath hyperplasia, and small follicles of the hair bulb. Although
previous literature has not reported a mutant or transgenic mouse that has similar phenotypes,
the histological appearance of the Smad4 conditional knockout mouse, in which Smad4 was
removed by activating the MMTV-Cre promotor expressed in the epidermis and hair follicles
(Qiao et al., 2006), exhibits a similar but more severe phenotype than dep (Figure 5.27).
The absence of Smad4 in the epidermis blocked HF differentiation and cycling, leading to a
progressive hair loss. The mutant follicles also have a reduced expression of Lefl, and
hyperproliferation of the outer root sheath, epidermis and basal keratinocytes. In particular, the
absence of pigmented septae in hair shafts resembles closely to that of dep.
Lefl is a transcription regulator for hair-specific keratin genes, that mediates the Wnt signalling
pathway by associating with its co-activator beta-catenin. Since there is a reduced level of Lefl
in the Smad4 epidermal knockout mouse, it may be possible the dep phenotype may involve the
Wnt signalling pathway, based on the fact that HS progenitors in the matrix require expression
of Lefl to become responsive to Wnt signalling. IfWnt is unable to signal, it affects the
differentiation of matrix cells along the HS lineage, which may result in a secondary phenotype
such as SG and epidermal hyperplasia.
5.4.2. Sebaceous gland (SG) hyperplasia is likely to be a secondary phenotype.
Initially, the increase greasiness observed in dep was considered to be a possible cause of hair
loss. Indeed, it is possible that excess sebum combined with dead cell flakes may clog hair
follicles and inhibit normal hair cycle. As a result, dry and brittle hair may result due to
clogging of the HFs which prevents sebum from traveling downwards to the hair canal for
nourishment and lubrication, and upwards for waterproofing and protection against antigens.
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However, our data shows that other glands with SG morphology do not exhibit hyperplasia as
observed in the hair follicles, indicating that the SG phenotype is unlikely to be primary for the
dep phenotype, but rather, it is more likely to be a consequence due to a disturbed
differentiation programme secondary to the hair loss phenotype, given the observation of
hyperplasia in the ORS and the epidermis as well as the SGs.
Excessive sebum production is commonly associated with acne and inflammation. However,
this is not observed in the dep mutants. It may be possible that the dilated infundibulum allows
sebum to be released to the skin surface, or that the lack of penetrating hair shafts prevents
blocking of the infundibulum.
5.4.3. The complex hair cycling events
The most complicated aspect of the dep phenotype, is perhaps its mismatch in cycling with
wild-type. On one hand, even though dep displays a striking phenotype at the start of anagen,
the hair shaft structure and Wnt signaling response (Figure 6.2E and 6.3B, Chapter 6) resumes
by 4.5-wk to 5-wk, and the HFs start to regress at 6-wk, same at wild-type. This perhaps
demonstrates a potential ability of the epidermis to restore normal function at the absence of
correct temporal signaling, possibly by accumulating signal until it reaches a certain threshold.
In this sense, normal HS differentiation is delayed, which is consistent with the epidermal
situation, where we see P63+ cells beyond the basal epidermal layer, suggesting a delay in
epidermal differentiation.
On the other hand, even though the normal HS differentiation is resumed, the various peripheral
compartments remain hyperplastic. In addition, while the wild-type follicles are normally in
telogen for more than 2 weeks before the third anagen, dep enters the third anagen prematurely
at 7-wk despite the delay in HS differentiation. Since the hair cycles in mice are only
synchronized for the first 2 weeks, we are unable to trace the pace of subsequent cycles.
However, give the above observation, we wonder if dep HFs generally cycle more frequently
than wild-type do. This hypothesis is consistent with the finding that the guard and awl hairs in
dep are slightly shorter - possibly due to a reduced in anagen length.
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Although the required threshold is reached for correct HS differentiation, its delay might have
caused a mismatch in other cycling events, which may result in an overall imbalance in
epidermal homeostasis. Therefore, it is possible that the loss of the signal required, is partially
redundant for cycling progression, but not for maintaining epidermal homeostasis. This
demonstrates the importance of precise temporal and spatial coordination to allow precise
timing of events in successive hair cycles.
Mice that are completely bald are only observed within the first 2 hair cycles (i.e. up to 12
weeks), whereas adult mice usually have some hairs although a sparse hair phenotype. This
may be explained by the fact that cycling events of individual HFs are only synchronized
within the first 2 cycles, after which they cycle independently of each other. A murine hair
cycle usually takes about 3 months; so it is unlikely that the hairs are lost all at once.
It may be possible that the infundibulum is required to dilate briefly for the emergence of hair
shaft during anagen. In dep, the dilation of the infundibulum continues to telogen as well as in
anagen HFs. The dilated infundibulum due to a mismatch in cycling events, and as a result
promotes a premature anagen.
One of the fundamental questions in studying hair cycle, is why does hair cycle? It has been
suggested that hair cycling is evolved as a mechanism for physical adaptation to change in
environments, and transformation of HF keratinocytes. Most importantly, hair cycle confers
protection against malignant degeneration by ridding the organism of uncontrolled growth in
the rapidly dividing skin tissue (Stenn and Paus, 2001).
Many signaling molecules involved in the hair cycle are also involved in tumor progression.
One of the interesting questions about dep is, even though dep exhibits hyperplasia in various
epidermal compartments, tumors have not been observed in the mutant, at least not under
unchallenged lab conditions.
136
Chapter 6 - Potential involvement of Wnt signaling in dep
6.1. Introduction
Throughout the entire life ofmost mammals, the cycling portion of the HF is constantly
regenerated at the start of each hair cycle (anagen). This growth requires the multi-potential
stem cells (SC) that reside at the lowest non-cycling permanent portion of the HFs. This region
is named the 'bulge' because of new growth that adds extra layers to the SCs, and because of its
appearance possibly as a result of the new hair shaft pushing the old one to the side. Bulge SCs
divide less frequently than other keratinocytes, but are activated to generate new HF at the
onset of each anagen. However, only a small number of bulge SCs is activated at anagen, and
most SCs remain quiescent for a long time.
The relationship between the bulge and the hair matrix is a frequent topic for debate. More
commonly known is the 'bulge activation hypothesis' (Fuchs et al., 2001; Niemann and Watt,
2002), which states that there is only one population of HF stem cells, which is the bulge, and
that the bulge SCs are activated to divide at the end of HF regression when it comes to close
proximity with the dermal papillae. The progenitors then migrate along the ORS to the base of
the HF to form the matrix.
An alternative to this hypothesis, is that SCs themselves might exit the bulge and migrate to the
base of developing HF. This hypothesis is based on the observations that vibrissal bulge never
comes to close proximity with the DP during HF regression, but yet the hair bulb region
contains clonogenic keratinocytes that respond to morphogenetic signals (Oshima et ah, 2001).
This hypothesis maintains that the bulge is the only population of HF stem cells.
A contradictory model has been proposed by Panteleyev and colleagues (Panteleyev et al.,
2001), which states that there are two location of HF stem cells, namely the bulge and the
matrix. While the HS and IRS lineages are derived from the matrix progenitors, only the ORS
is derived from the bulge. This model proposes that SCs from the bulge migrate to matrix
during anagen, and survive through the apoptosis-driven catagen. The matrix SCs then respond
directly to the DP to replenish the HS and IRS at the onset of the next cycle. On the other hand,
the matrix cells may replenish the bulge under certain circumstances. This model differs from
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the one-HF stem cell model, in the location of epithelial-mesenchymal signalling (DP->bulge
vs DP->matrix), and the origin of the cycling portion of the HF.
In support of this model, a lineage marking study has shown that, on average, the matrix
contains up to 4 active long-lived progenitors which are capable of differentiating into multiple
follicular lineages in the hair matrix (Kopan et ah, 2002; Niemann and Watt, 2002).
The epidermal lineage network also contains stem cell populations in the IFE and SG and it is
proposed that these populations of SCs are interconvertible. At any one time, this network is
maintained at a precise homeostasis; any disruption to any of the pathways may result in an
overall imbalance, which is likely to affect other compartments as well as the resulting lineages
of the pathway in question. Many signalling pathways are involved in maintaining the
epidermal homeostasis, some of which are discussed below.
Under normal conditions, SCs in the bulge are in a quiescent and undifferentiated state.
However, when placed in culture or in response to tissue damage, they are capable of long-term
cell-renewal (Watt et ah, 2006). It is important that SCs maintain their quiescence and only
divide when required to prevent premature exhaustion of the SC pool under epidermal stress.
On the other hand, SCs must be capable of cycling to supply and replenish the functions of
terminally differentiated cells in tissues.
6.1.1. Maintenance of SC quiescence
The quiescent status of the SCs is largely maintained by factors that are expressed within the
SCs. The first protein that was associated with this function was the Bl-integrin that was
reported to express in human epidermal stem cells at a higher level than that in the TA cells.
Reduced Bl-integrin expression in SCs triggers exit from the SC compartment (Jones and Watt,
1993), demonstrating that Bl-integrin is required for maintaining SC quiescence in the
epidermis.
Using a K.15 promoter to target mouse bulge SCs (Liu et al., 2003), a lineage tracing and
microarray profiling approach was carried out for identification of factors that maintain SC
quiescence. The factors identified by this approach include the Wnt-inhibitory protein Dkk3
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(Dickkopfl) and other signaling proteins that are upregulated in the HFs such as the BMP and
TGFB pathways. The SC identity of the isolated cells was verified by their ability to
reconstitute all HF lineage and maintain an intact HF (Morris et ah, 2004).
More recently, a new strategy was used in the Watt group that allows the generation of cDNA
libraries from individual SC and TA cells isolated by FACS (fluorescent activated cell sorting)
(Jensen and Watt, 2006). Using this approach, Lrigl (Ligl/leucine-rich repeats and Ig-like
domains), a negative regulator ofEGFR receptors, was demonstrated to be a major determinant
of SC quiescence in human IFE SCs.
Although the LEF1/TCF family proteins can act as functional bipartite transcriptional activator
upon association with B-catenin (directing cells along the hair lineage), T cell-specific
transcription factor (Tcf3) was among the proteins identified in SCs by the global gene
profiling approach with previous knowledge that Tcf forms a complex with P-catenin which is
important in activating Wnt-responsive genes in progenitor proliferation. Tcf3 alone represses
transcriptional regulators of IFE, SG and HF differentiation, and when Tcf3 is sustained
transgenically, terminal differentiation of all 3 lineages are repressed (Nguyen et ah, 2006),
demonstrating the role of Tcf3 in maintaining the progenitor, non-differentiated state of
epidermal cells. On the other hand, a reduction of Tcf3 expression and upregulation of Lefl, in
combination with Wnt activity are required for placode formation (Fuchs, 2007).
6.1.2. Genes that regulate exit from the stem cell compartment.
Apart from the factors that regulate stem cell quiescence, the bulge SCs also express a range of
factors that regulate exit from the SC compartment to allow the epidermis to be repaired and
replenished.
One of the factors that promotes exit from the SC niche is the proto-oncogene c-Myc, which
stimulates epidermal SC differentiation in cultured human keratinocytes when transiently
activated in c-MycER mice, and causes depletion of the SC compartment (Arnold and Watt,
2001; Bull et ah, 2005). The activation of c-Myc drives SCs to the TA compartment and
stimulates differentiation into IFE and SG at the expense of HF lineages (Arnold and Watt,
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2001; Takeda et al., 2006). On the other hand, conditional ablation of c-myc results in alopecia
as a result of long-term failure to sustain HF SCs (Arnold and Watt, 2001; Fuchs, 2007).
The Rho GTPase, Racl, regulates the exit of the SC compartment by negatively regulating Myc
(Benitah et ah, 2005) through PAK2 phosphorylation. When Racl is deleted in the
KMCreER/floxed Racl adult mice, SCs are stimulated and undergo terminal differentiation
prematurely, leading to failure in maintaining IFE, HF and SGs. It is therefore concluded that
Racl and Myc represent a global SC regulatory axis (Benitah et ah, 2005).
In addition, Myc acts by negatively regulating genes that mediate keratinocyte adhesion, such
as integrins and actin cytoskeleton components (Frye et ah, 2003). Whereas Racl enhances
integrin levels (Benitah et ah, 2005), confirming their critical regulatory role in cell adhesion
and cytoskeleton in controling exit from the SC niche.
Another factor that was identified by the global gene expression profiling approach was the
Lim-homeodomain transcriptional factor Lhx2, in the absence ofwhich mutant animals display
defects in patterning and cell fate determination during brain development (Rhee et ah, 2006).
It was demonstrated that LHX2-deficient bulge SCs are unable to retain Brdu label and use SCs
more rapidly. The involvement of Lhx2 is positioned downstream of signals necessary to
specify HF SCs (e.g. Wnt and Shh), but upstream from signals required to drive activated SCs
to terminally differentiate (e.g. Bmp) (Rhee et ah, 2006), showing its role in maintaining the
growth and undifferentated properties of HF progenitors.
Other factors that control the exit from SC compartments include Cdc42 (cell division cycle
42), which controls progenitor differentiation through P-catenin stabilisaton (Wu et ah, 2006),
and Bmp signaling (Kobielak et ah, 2007). When Bmprla was conditionally ablated by K14-
Cre in epidermis, HF stem cells are activated to proliferate to form tumor-like branches that
express high level of Lefl and P-catenin. Whereas sustained expression of Bmprla in SCs of
transgenic mice results in premature HF differentiation.
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6.1.3. Signals required in HF maturation and lineage differentiation.
Involvement of canonical Wnt signaling in HF development and hair cycling
Wnts encode secreted glycoproteins that stimulate receptor-mediated pathways and initiate
numerous cellular and transcriptional responses. Wnt signaling has diverse functions; Wnt is an
important mediator of key cell-cell signaling events in virtually every aspect of embryogenesis,
and is required for the control of homeostatic self-renewal in a number of adult tissues.
Perturbations in Wnt signaling is implicated in several hereditary diseases, developmental
disorders, degenerative diseases, and cancer in human (Clevers, 2006; Logan and Nusse, 2004).
The canonical Wnt pathway involves stabilization of the cytoplasmic pool of the key mediator
P-catenin. Wnt proteins act by binding to receptors of the Frizzled (FRZ) and LRP families on
the cell surface, which relay signals to p-catenin through the inhibition of the degradation
machinery by members of the Dishevelled (Dvl) family. P-catenin is then translocated to the
nucleus and interacts with the T cell-specific transcription factor (TCF) and lymphoid
enhancer-binding factor (LEF) families of high-mobility-group (FlMG)-box transcription
factors to promote and regulate expression of targeted genes.
Without Wnt signaling stimulation, the scaffolding protein Axin assembles a protein complex
that contains glycogen synthase kinase 3b (GSK3b) and the adenomatous polyposis coli protein
(APC), forming the "P-catenin destruction complex", which targets p-catenin to be degraded by
the proteosome pathway. Wnt signaling can also initiate an independent 'non-canonical'
signaling pathway involved in planar cell polarity (PCP), that may lead to protein kinase C
(PK.C) and Jun kinase (JNK) activation, resulting in calcium release, which induces cytoskeletal
rearrangement and convergent extension movements during embryo development (Dasgupta et
al, 2005).
Canonical Wnt signaling is essential for the induction of HF formation, HF maturation and
lineage differentiation. Multiple Wnt genes are expressed in the epithelium prior to the 'first
dermal signal' from mesenchyme to epithelium that causes induction of the hair follicle placode
(Andl et al., 2002; Reddy et al., 2001). Once the placode is formed and the dermal cells are
condensed to form the DP precursors, these regions express nuclear P-catenin in response to
Wnt (DasGupta and Fuchs, 1999; Merrill et al., 2001). Furthermore, the embryonic placode and
DP exhibit Wnt reporter activity, which demonstrates Wnt involvement in HF initiation. On the
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other hand, ectopic expression of the Wnt inhibitor Dickkopf-1 (Dkkl) results in impaired HF
formation (Huelsken et ah, 2001). In addition, the formation of de novo HFs after wounding is
controlled by Wnts (Ito et ah, 2007).
In postnatal skin, hair shaft differentiation of the matrix is largely dependent on Wnt/ p-catenin
signaling, which targets hair shaft-specific keratin genes (Ha/Hb) through the Lefl/p-catenin
complex (Merrill et ah, 2001). Ablation of P-catenin with K14-Cre causes failure in placode
formation at embryogenesis, blocks HF differentiation and cells adopt an epidermal fate instead
(Huelsken et ah, 2001). Postnatal transgenic mice expressing a stabilized p-catenin controlled
by K14 undergo de novo hair morphogenesis and develop tumors composed of the hair lineages
(Gat et ah, 1998). Furthermore, activity ofWnt reporter genes were detected in hair shaft
precursor cells during anagen, and in the bulge at anagen onset (DasGupta and Fuchs, 1999).
To investigate how different levels of p-catenin activation affect stem cell differentiation, Watt
and colleagues (Silva-Vargas et ah, 2005) developed the K14ANp-cateninER transgenic mice,
that can be stimulated with the oestrogen analogue 4-hydroxytamoxifen (40HT) at desired
levels. It was found that high-level activation triggers ectopic HF differentiation from cells in
the 1FE, whereas low level of P-catenin activation results in conversion of HFs into cysts of IFE
(Watt et ah, 2006), indicating that a precise level of P-catenin activation is required for specific
niche.
Furthermore, Wnt3 and its putative effector Dishevelled 2 (Dvl2) are normally expressed in HS
progenitors; overexpression ofWnt3 or Dvl2 in transgenic mice result in a similar short-hair
phenotype due to altered differentiation of HS progenitors, and cycling hair loss resulting from
HS structural defects and associated with an abnormal profile of protein expression in the HS.
This indicates that Wnt3 has a function in hair growth (Millar et ah, 1999).
Involvement of other regulatory proteins in HF development and hair cycling
Other regulatory proteins that control the transcription of hair shaft keratin genes include
Hoxcl3 (Peterson et ah, 2005) and Foxnl (Mecklenburg et ah, 2001). Mice overexpressing
Hoxcl3 in the epidermis develop severe hair growth defects and alopecias (Peterson et ah,
2005). Recently, Foxql was proposed to be a downstream target ofHoxcl3 (Potter et ah, 2006)
and together they control medulla differentiation through a common regulatory pathway.
142
The progenitors of the HS and IRS have a common origin in the HF matrix (Niemann and Watt,
2002). GATA3 and Lefl/Wnts are essential for matrix stem cell determination between HS and
IRS lineages. In particular, GATA3 is expressed at the onset of IRS differentiation and
epidermal stratification and acts by recruiting HDACs to repress target gene expression,
without which IRS progenitors do not differentiate (Kaufman et al., 2003). And although the
HS cortex progenitors differentiate, the overall hair structure is aberrant, giving rise to a HS
phenotype secondary to the loss of IRS.
Notch signalling is essential for the regulation of multiple stages ofHF differentiation and
homeostasis (Okuyama et ah, 2007) and its precise expression is required for correct
differentiation. Activated Notch is normally cleaved by y-secretase to generate a nuclear
intracellular cofactor (NICD) for the transcription repressor RBP-J. Sustained expression of
active Notch 1 in the IRS progenitors delays differentiation, leading to abnormal hair formation
and anagen-associated alopecia in transgenic mice. Whereas conditional knockout of y-
secretase using Msx2-Cre results in a failure of IRS cells to maintain their fates, and result in a
complete conversion of HFs to epidermal cysts (Pan et ah, 2004).
While the Wnt signal is essential for placode formation, the inhibition ofBMP (bone
morphogenetic protein) signal is required at the epidermis/ hair placode switch. In particular,
different modes of BMP inhibition are specific to the formation of different types of follicles
(Fuchs, 2007). On the other hand, BMP receptor signalling is required for correct IRS and HS
differentiation in postnatal HFs. In the absence of BMP receptor 1A (BmprlA) activation,
GATA3 is down-regulated and Lefl is up-regulated. However, despite the accumulation of
Lefl, the Bmprl A-null follicles are unable to activate Lefl/B-catenin-regulated keratin genes,
due to a lack of stabilized B-catenin (Kobielak et ah, 2003).
Transgenic mice that express the BMP inhibitor Noggin under the Msx promotor, which drives
expression in proliferating matrix cells and differentiating HS precursors, have impaired HS
differentiation and reduced expression of the HS keratin-associated transcription factors
including Foxnl and Hoxcl3 (Kulessa et ah, 2000). Recently it was reported that the
transcriptional interactions between ectodysplasin receptor (Edar) and BMP signalling are
central to generation of the primary HF pattern (Mou et ah, 2006).
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The proxisome-proliferator-activated-receptor- y (PPAR-y) is expressed in differentiated
sebocytes and is required for sebocyte differentiation (Di-Poi et al., 2004). Overexpression of c-
myc in suprabasal in epidermis and HF of transgenic mice results in SG hyperplasia, suggesting
that it has a role in SG homeostasis (Bull et ah, 2005). And recently, a population of cells have
been identified by their expression of the transcriptional repressor Blimp 1, which regulates SG
homeostasis and plays a role in governing bulge SC activity. The loss ofBlimpl (using K14-
Cre) results in elevated c-myc expression and SG hyperplasia (Horsley et ah, 2006).
6.2. Hypothesis of the dep hair loss phenotype
The phenotype of dep described in Chapter 5 leads us to think that the hair loss phenotype of
dep may be due to a lack of correct hair shaft differentiation. Based on the strikingly similar
phenotype between dep and the Smad4 conditional knockout in the epidermis (Qiao et al.,
2006), we speculate that dep may have an effect on the concentrated level ofWnt signals in
growing HFs.
Wnt signalling is known to have an important role in the differentiation of matrix cells along
the hair shaft lineage (Merrill et al., 2001). It is possible that the hair shaft differentiation
pathway is affected in dep due to a disruption in the Wnt signaling pathway (Figure 6.1 A).
Blocking of the Wnt signaling pathway does not only affect terminal differentiation of hair
shaft progenitors, but is likely to perturb epidermal homeostasis and affect other compartments
other than the resulting lineages in question. This disruption may push proliferation and
differentiation towards other lineages such as the sebocytes, the IFE, and keratinocytes of the
ORS, as reflected by the hyperplasia phenotype.
(i) Wnt pathway as target for Zdhhc21
Based on the hypothesis, we might consider the possibility ofWnts themselves being the
substrate target of Zdhhc2l. Since both wild-type and dep proteins are expressed in the Henle's
layer of the IRS, which consists of 3 distinct cell lineages surrounding the matrix cells, it is
likely that the substrate ofZdhhc21 that is affected also reside in the same keratinocytes in the
IRS. Out of the Wnt family, 4 members are expressed in the IRS, some of which are specific to
the IRS, others are expressed in other compartment, such as Wnt5a, which is expressed in the
matrix as well as the IRS (Reddy et ah, 2001).
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Following this notion, the palmitoylation ofWnt3a is reported to be required for bioactivity and
for obtaining the threshold concentration for initiating a signal (Willert et al., 2003). Therefore,
it is conceivable that that dep may have an effect on one of these Wnt proteins due to its
inactivity as a PAT.
However, such possibility is less likely based on the topological prediction of Dhhc21 and the
cellular location of its known targets (discussed in Section 6.4.4.2). Nevertheless, the mutation
may have an indirect effect on Wnt signalling via a Wnt-related substrate in the IRS that may
cause a loss of canonical Wnt signalling in the nearby matrix cells. As a result, there will be a
lack of TCF/Lefl differentiation ofmatrix cells that bind to and drive the promoter of hair-
specific keratins to form a functional hair shaft that can break through the skin to form a nice
even coat, leading to a hair loss phenotype.
(ii) Depigmentation in dep may be a result of a lack of HS progenitor cells
The lack of differentiating hair shaft keratinocytes may subsequently lead to an abnormal or
uneven transfer ofmelanin in the HFs because the melanosomes are not adequately transported
or incorporated into the keratinocytes, causing the depigmented hair coat observed in dep.
(iii) Hyperplasia phenotype may be caused by ongoing signaling of Shh and Ihh
The hyperplasia phenotype of the IFE, HF and SG may be caused by an ongoing Shh/ Ihh
signaling which is likely to be normal (as judged by the comparable Shh, Glil and Ptcl
expression between wild-type and dep) but may cause progenitor cells to enter the other
lineages when Wnt signaling is compromised.
The response to Wnt signalling in dep epidermis may be tested by looking at the expression of
Wnt downstream effectors, such as (S-catenin and Lefl, since a reduced or ectopic expression of
these proteins may be indicative of a defect in the Wnt producing or responding pathways.
6.3. Results
6.3.1. Wnt response is reduced in dep hair follicles
To test whether the dep mutation has an effect on Wnt signaling, we looked at the expression
pattern of the transcriptional response to Wnt in the epidermis.
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Immunostaining of Lefl shows a specific pattern in the wild-type matrix, where HS progenitors
reside, as well as the cortex of the HS. However, in dep, although Lefl appears positive in the
matrix, the stained cells do not exhibit an apparent nuclear signal, and there are no Lefl + cells
further up the hair shaft (Figure 6.2). It may first appear that the morphological difference
between wild-type and dep follicles may account for the difference in the Lefl-staining pattern,
i.e. lack of Lefl-expressing cells rather than a lack of signal. However, the structural difference
is likely to be a consequence of a disruption in Wnt signaling in the HF progenitors of the dep
matrix, which is reflected by the aberrant Lefl expression pattern.
The P-catenin antibody (clone 15B8) shows a robust Wnt response in wild-type HFs, as judged
by the presence of nuclear P-catenin in the matrix and the HS cortex, the outcome ofWnt
signal. However in dep, even though there is apparent p-catenin signal, it appears more diffused
and possibly cytoplasmic in the matrix (Figure 6.3), indicating that there may be an absence of
Wnt signaling at this stage that prevents translocation of P-catenin into the nucleus to interact
with transcription factors and regulate transcription of HS specific keratin genes. Without the
presence ofWnt signals, excess P-catenin that is not utilized or stabilized may accumulate at
cell-cell adherens junctions, as seen in Figure 6.3.
While most of the hair follicles display clear nuclear P-catenin signal in wild-type HS cortex,
we also observe that only some of the follicles have p-catenin positive cells in the dermal
papillae, whereas the intensity of signal in the HS cortex varies between follicles. This
observation may reflect the coordinated reciprocal signaling between the DP and the epidermis
(DasGupta and Fuchs, 1999; Maretto et al., 2003).
To conclude, nuclear staining of p-catenin and Lefl is only observed in wild-type but not in
dep. The expression pattern in wild-type is consistent with previous findings which shows that
Wnt responsive cells reside in the HS precortex region and cuticle (DasGupta and Fuchs, 1999;
Millar et al., 1999).
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Figure 6.1. Lack of Wnt palmitoylation may cause dep phenotypes
[A] Diagram showing the lineage relationship within the epidermis. It is believed that there is a
population ofmultipotent stem cells which reside in the bulge, and the stem cells for the IFE, HF and SG
cells are interconvertible (double arrows). Many signalling pathways are involved in maintaining the
homeostasis of the network. Wnt signaling is important in the initiation of hair follicle formation in
embryos, and also the differentiation of matrix cells along the HS lineage. For this to happen, a very
concentrated level ofWnts is required to initiate the pathway. It is therefore speculated that the HS
differentiation pathway (yellow arrow) maybe affected due to an unpalmitoylated Wnt protein, as a result
pushes proliferation and differentiation towards other lineages, including the sebocytes, ORS and the
epidermis.
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[B] Both WT and dep Dhhc21 are expressed in the IRS,
which is consists of 3 distinct cell lineages surrounding
the matrix cells, the substrate that is affected must also
reside in the IRS. It is speculated that Wnts are involved
because 4 members of the Wnt family are known to
express in the IRS (Reddy et al., 2001). Moreover,
Wnt3a requires palmitoylation to be bioactive and to
obtain the concentration required for the signal. So it
maybe the case that dep affects palmitoylation of a Wnt
proteins, causing a loss of canonical Wnt signaling in the
nearby matrix cells, resulting in a lack of TCF/Lefl
differentiation of matrix cells which bind to and drive
the promoter of hair-specific keratins to form a
functional hair shaft which can break through the skin to
form a nice even coat. If there is no differentiating hair
shaft cells, melanin transfer w ill become abnormal and
uneven. The hyperplasia phenotype maybe caused bv
ongoing Shh/Ihh signaling which is norma! and cause
cells to enter the other lineages when Wnt signaling is
compromised.
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Figure 6.2. dep has reduced number of HF progenitors at onset of anagen
Lefl immunohistochemistry on wild type (A) and dep (B,C,D) dorsal hair follicles at 4-
week.lmmunostaining of Lefl shows a very specific pattern in the wild-type matrix, as well as the cortex
of the hair shaft (A). Whereas in dep, the expression pattern in the matrix is aberrant, and there is a lack
of signal further up the hair shaft (B.C,D). While the melanosomes are clearly visible in wild-type as
black granules, dep follicles lack such appearance possibly due to an absence of hair shaft progenitor
cells that import the melanosomes. (E) At 5 week, dep follicles resumes Lefl expression in the hair shaft
cortex, and the medulla is now visible with appearance of melanosomes in appropriate compartments.
However, the outer root sheath appears thickened (white bars) even though the HS development becomes
normal again. (F) Staining with the secondary antibody (biotin-conjugated anti-rabbit) alone does not
give any specific signal, indicating that the specific nuclear staining is not due to non-specificity of the
secondary antibody. Scale bars, 50jti.
-Lefl (matrix, pre-cortex, cortex, dermal papillae)
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Figure 6.3. Lack of Wnt response in dep follicles at early anagen
Representative images of (3-catenin immunostaining at 4-wk [A] and 5-wk [B] dorsal skin ofwild-type
and dep. Nuclear P-catenin is clearly observed in the hair shaft progenitors of wild-type matrix and hair
shaft cortex at 4-wk. Whereas P-catenin expression in dep matrix appears to be non-nuclear and possibly
cytoplasmic and at cell-cell junctions at this stage. [B] At 5-wk, nuclear expression of P-catenin can be
seen in hair cortex of dep, and is comparable to wild-type. The same pattern was observed in 4.5-wk skin
(data not shown). Scale bars, 50pm.
P-catenin (nuclear expression in Wnt responsive cells)
a-K5 (IFE, ORS, basal layer)
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6.4. Discussion
6.4.1. Testing Wnt response in vivo and in vitro
In addition to looking at the expression of Lefl and P-catenin, the Wnt response may be
assayed by using the |3-catenin-activated transgene driving expression of nuclear galactosidase
(BAT-gal) transgenic mice that expresses the lacZ gene under the control of P-catenin/ Tcell
factor responsive elements (Maretto et al., 2003).
The advantage of BAT-gal reporter mice over the existing P-catenin staining data is that the
former provides a more specific signal in the nuclei of Wnt-responding cells. Excess or non-
stablised p-catenin normally accumulates at cell-cell junctions, making it difficult to look for
nuclear signal against cytoplasmic expression because the background signal may obscure
interpretation of nuclear signal against noise.
Previous literatures have demonstrated that the BAT-gal transgenic mice are reliable reporter of
Wnt/ p-catenin activity (Barolo, 2006). Normally, BAT-gal activity can be detected during
anagen (P4) in the hair shaft precortex, dermal papillae and matrix cells, even though individual
hairs display differences in expression pattern (Maretto et al., 2003). Based on the expression
data of Lefl and p-catenin, we expect that the LacZ activity in dep may be reduced. Using the
BAT-gal transgenic reporter mouse, it may be possible to determine the effect of dep mutation
on canonical Wnt activity, and support the expression data of P-catenin and Lefl.
The Wnt response may also be reported in cell culture assay using the TOPFlashl FOPFlash-
luciferase reporters of Lefl/p-catenin signaling. TOP (Tcf-optimal promotor) is an artificial
promoter that contains multimerized Lefl/Tcf binding sites, whereas FOPFlash is a negative
control plasmid that contains mutant binding sites (DasGupta and Fuchs, 1999). The assay has
been used in conjunction with various reporter genes to identify Wnt-responsive cells (Kobielak
et al., 2007). Cultured wild-type and dep keratinocytes may be subjected to assays with the
TOPFlash reporter gene, which is active when p-catenin and Lefl are stabilized. It is predicted
that without nuclear p-catenin expression, there will be a reduced level of Lefl-dependent
transactivation of TOPFlash in the dep assay.
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6.4.2. Melanin Transfer in hair shaft progenitor cells of dep
As dep exhibits a remarkable depigmentation phenotype in early stage epidermis and in hair
coat, we hypothesize that there is inadequate differentiation of hair shaft keratinocytes for
normal transfer of melanin granules (melanosomes). Skin sections of early anagen have shown
a lack ofmelanosomes in dep HFs, however, it is unclear whether this is due to a hair shaft
defect or a disrupted programme in melanocyte differentiation.
To study the nature of the depigmentation phenotype, the Dct-lacZ reporter may be used to
trace differentiating cells of the melanoblast lineage. The Dct-lacZ transgenic mouse carries the
lacZ reporter under the control of the Dct promotor (Mackenzie et ah, 1997), and has been used
to show that the receptor tyrosine kinase, KIT, is involved in guiding melanoblast distribution
in developing hair follicles (Jordan and Jackson, 2000). The Dct-lacZ reporter mouse has also
enabled the identification of melanocyte stem cells in the bulge region of hair follicles
throughout the hair cycle (Nishimura et ah, 2002).
By crossing the Dct-lacZ transgenic mouse to the dep mutant and tracing the expression of the
lacZ reporter gene using a p-gal assay, we may trace migration of differentiating cells of the
melanoblast lineage before they produce visible melanin pigment. This will provide clues to
whether the abnormal transfer of melanosome in dep is due to a lack of differentiating HF
progenitor at the onset of anagen, as predicted by our hypothesis, or a misregulation in
melanoblast migration.
6.4.3. The rate of cell proliferation in dep epidermis
The hyperplasia phenotype in the SG, HF and ORS observed in dep maybe due to an increased
rate of proliferation, as judged by the elevated number of P63 cells that have proliferative
potential and an expansion of the K5+ compartment. To determine whether the rate of cell
proliferation is increased in dep skin, the BrdU pulse-chase labelling protocol may be applied in
which all newly synthesized DNA are in S-phase cells are labelled with Brdu. The cells that
divide infrequently, such as the bulge stem cells, and the stem cells of the IFE, SG and HF, will
retain the BrdU label into adulthood, and can then be visualized as DNA label-retaining cells
(LRC) (Braun et al., 2003). The development of whole-mount labeling techniques in human
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and mouse epidermis have greatly facilitated the evaluation of SC number and location (Braun
et ah, 2003).
While the LRC reservoirs are not significantly depleted by successive hair growth cycle, the
expression ofANLefl to block P-catenin signaling induces transdifferentiation of HFs into IFE
and sebocytes, and causes depletion of LRC primarily through proliferation (Braun et ah,
2003). It was concluded that LRCs are sensitive only to certain proliferative stimuli, and that
changes in lineage can occur with or without the recruitment of LRC into the cycle.
Assuming that the number of stem cells in wild type and dep were equal at the time of Brdu
injection (However, we must be cautious with the possibility that this may not be the case), an
increase of BrdU+ cells in the IFE, SG or HF after the chase period would indicate an increase
in proliferation rate in those compartments. This maybe coupled with a depletion of LRC by
successive hair growth cycle, which indicates an elevated rate of proliferation and/or
transdifferentation into the hyperplastic compartments.
6.4.4. The dep mutation may affect the Wnt signaling pathway
To date, 19 Wnt members have been identified in mouse, each of which contains at least one
site for N-glycosylation, and has up to 23 to 26 conserved cysteines (Coudreuse and
Korswagen, 2007). In the postnatal HF alone, 7 members of the Wnt family are reported to
express independently with overlapping but unique patterns in keratinocytes of different lineage
and differentiated state (Reddy et ah, 2001). This suggests that the Wnt family is involved in
maintaining a normal HF, and that individual Wnt members are likely to have a highly specific
role. Furthermore, different Wnt members are recruited at different stages of development. The
specificity of spatial and temporal expression of individual Wnt members allows the
establishment of local signaling centers in specific niches that are required for correct terminal
differentiation of keratinocytes of specific lineages.
The specificity in Wnt expression may partially explain why dep does not display a
macroscopic phenotype until a certain stage, why the mutation does not result in a more severe
phenotype and why the mutation predominantly affects the epidermis but not other tissues
despite the overall significance ofWnt signaling.
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The sparse HFs in dep in Fig 5.5B may be explained by a disruption ofWnt signaling in
placode formation, since a loss of function mutation of Lefl causes absence of vibrissae and
greatly reduces number of hair follicles throughout the body (van Genderen et ah, 1994).
However, histological sections do not show a difference in HF density between wild-type and
dep at the same stage. If dep has a normal HF density despite partial loss ofWnt function, it
may be the case that postnatal initiation of anagen requires long-range Wnt signaling events
between the Henle's layer and the matrix, i.e. between Wnt-secreting and Wnt-responsive cells.
Whereas during placode formation, the epithelial- mesenchymal distance would be relatively
short and so signaling events may act in a more paracrine manner.
Another possibility that is not mutually exclusive to the above notion, is that the Wnt members
may be redundant for other functions such as the progression of hair cycling (since the growth
of HS catches up in late anagen), but not for maintaining epidermal homeostasis, as judged by
the hyperplasia phenotype that persists into telogen.
On the other hand, the Dhhc family may also be redundant for palmitoylating certain substrates
of Dhhc21 including those required for hair follicle development and hair cycle progression
through a Dhhc21-independent mechanism. However, it is conceivable that in the hair follicle,
the PAT activity of Zdhhc21 is indispensable for maintaining certain aspects of epidermal
homeostasis as evident in the apparent disruption in the system.
In addition to differential expression ofWnt members, there may also be distinct difference in
the way HF and IFE cells respond to increasing (3-cat expression. The SC progeny migrating
from the bulge may change in chemistry as they migrate along and the response to Wnt may
change. This is demonstrated in (DasGupta et ah, 2002), which shows that stabilized p-cat acts
in epidermis to promote hair fates and in hair cells to promote epidermal fate.
6.4.4.1. Experiments for testing dep effect on Wnt palmitoylation
To test whether the dep mutation has an effect on Wnt palmitoylation, and whether Wnt is a
direct palmitoylated substrate of dep, the [3H] palmitate labeling protocol may be used as
described in Chapter 4. However, this protocol is notorious for requiring extensive exposure
time, often up to one month. Due to this limitation, alternative protocols have been developed,
for example, cells may be co-transfected with the PAT (Dhhc21 -dep) and candidate substrate
(Wnt) DNA constructs, and treated with lM hydroxylamine (pH7) for 20 hours, followed by an
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assay for a band shift. As hydroxylamine removes palmitate groups attached to cysteines via
thioester linkage, the loss of palmitate may be detected by a change in protein migration on
SDS-PAGE.
The efficiency of the bandshift method is dependent on the number of palmitate groups the
substrate incorporate. Using this method, a number ofDHHC clones have been shown to
increase palmitoylation ofCSP (Cysteine String Protein) in HEK culture, since CSP
palmitoylation adds up to 14 palmitates and thus the extent of it can be successfully detected by
a 8kDa bandshift on blots of transfected cells (Greaves and Chamberlain, 2006).
Members of the Wnt family are cysteine-rich with over 5% of the protein sequences being
cysteines (Coudreuse and Korswagen, 2007). Although the Wnt family is known to be
palmitoylated (Willert et ah, 2003), it is not known how many palmitate groups the Wnt
proteins incorporate. But despite the abundance in cysteine residues, only one cysteine (C77)
that locates at the N-terminal ofWnt3a has been reported to associate with a palmitate group.
Since the incorporation of one palmitate group is unlikely to be detected by a band shift, the
conventional [_,H] labeling protocol can be used, however, the exposure time may take up to
one month.
6.4.4.2. Loss ofPAT activity in dep is likely to have an indirect effect on Wnt signaling
The key but still largely unanswered question is how Zdhhc21 can affect the Wnt signaling
pathway. Despite previous findings that Wnt3a requires palmitoylation for bioactivity (Willert
et ah, 2003) and that Zdhhc21 is a PAT (Fernandez-Hernando et ah, 2006), members of the
Wnt family are unlikely to be direct substrates ofZdhhc21 for palmitoylation.
Based on the proposed topology of most DHHC proteins, the Dhhc putative catalytic motif is
predicted to be intracellular rather than in the lumen of the cis-Golgi (Fukata et ah, 2006; Keller
et ah, 2004). And if the Dhhc motif is cytosolic, Wnts are unlikely to be palmitoylated by
Dhhc21.
Dhhc21 localizes to the cis-Golgi, whereas Wnt palmitoylation is believed to take place in the
ER, possibly by porcupine (Coudreuse and Korswagen, 2007). As Wnts are secreted proteins
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that require active translocation via its signal peptide to cross the membrane and reach the
lumen, Wnt palmitoylation would require to occur prior to translocation into the lumen.
Proteins that are shown to be specific palmitoylation substrates of Zdhhc21 are intracellular
such as eNOS (Fernandez-Hernando et al., 2006) and Lck (Fukata, unpublished data). This
implies that the active site of Dhhc21 faces the cytosol, and so the substrates for DHHC PATs
are likely to be cytosolic, non-secreted proteins.
In a more recent study, however, it was proposed that the palmitoylation ofWnt3a may take
place in the Golgi (Komekado et ah, 2007). When cells are treated with Brefeldin A, an
inhibitor of vesicle transport from ER to Golgi, Wnt3a was not palmitoylated although
glycosylation is unaffected, indicating that palmitoylation ofWnt3a may take place in the
Golgi, where Zdhhc21 resides.
It may be possible that Wnts can undergo other lipid modification such as isoprenylation which
tethers Wnts to the cis-Golgi membrane, where they can access the catalytic motif of Dhhc21.
6.4.5. Potential palmitoylated substrates of Dhhc21
6.4.5.1. Candidate substrates for the skin and hair phenotype
Having shown that dep HFs displays a Wnt-related phenotype as judged by the lack of nuclear
staining of Lefl and p-catenin, the substrate ofDhhc2l is likely to be a player in the canonical
Wnt signaling pathway. Since the mutant protein is shown to have a loss of PAT activity in cell
culture, the substrate is likely to be a palmitoylated protein that is expressed in the Henle's
layer of the IRS. In addition, based on the predicted topology of the Dhhc motif and the
identification of intracellular substrates for Dhhc21, the substrates targeted in the hair loss
phenotype must also be an intracellular, cytosolic protein.
Given the loss of nuclear expression of P-catenin and Lefl in dep follicles at early anagen, we
can speculate that the loss of Dhhc2l PAT activity may affect translocation of P-catenin into
the nuclei ofWnt-responding cells. Alternatively, the unpalmitoylated substrate may affect
other mechanisms upstream of P-catenin translocation that may potentially reduce
responsiveness to Wnt signaling (e.g. Frizzled). On the other hand, based on the differential
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expression of different Wnt members in the hair follicles, there is a possibility that the problem
exists in the Wnt-secreting cells, possibly during the process of post-translational modification,
sorting or secretion.
Another category of proteins that partially fulfill the above criteria are the extracellular matrix
receptors of the integrin family. Integrins do not only play a role in adhesion and signal
transduction between cells, their roles in regulation of stratification and the initiation of
terminal differentiation are also well-documented (Watt, 2002). Normally, keratinocytes of the
basal layer and ORS express several integrins including a2pi-, a3pi-, a5pi-, a9pi-, avp5- and
a6p4-integrins (Watt, 2002). Ectopic expression of integrin pi in the suprabasl layer can lead to
perturbed keratinocyte differentiation (Carroll et ah, 1995).
It was also shown that the ligation or mutation of the pi integrin subunits can negatively
regulate the initiation of terminal differentiation in primary human keratinocyte culture (Levy et
ah, 2000), probably via its ability to directly bind and control the activity of focal adhesion
kinase (FAK), which negatively regulates cellular tension (Fuchs, 2007). Furthermore, the a3,
a6 and P4 subunits are known to be palmitoylated (Yang et ah, 2004), making this category of
proteins a possible candidate of Zdhhc21 PAT target.
On the other hand, in a recent study, targeted deletion of integrin-linked kinase (ILK) in
epidermal keratinocytes was shown to cause epidermal defects and hair loss phenotype (Lorenz
et ah, 2007) which is similar to dep in terms of the premature HF appearance and hyperplasia of
the suprabasal layer and ORS. Flowever, this phenotype was revealed to be caused by the
inability of keratinocytes to firmly stabilize lamellipodia (cytoskeleton actin projections),
leading to an impaired downward migration of ORS cells to replenish the matrix and an
accumulation of progenitor cells in the ORS. It is however, not a result of abnormal p-catenin
stability, matrix differentiation or stem cell maintenance (Lorenz et ah, 2007).
In addition, the deletion of integrin a3 in the epidermis (Conti et ah, 2003) also shows some
degree of similarities to dep such as defective differentiation of HF keratinocytes and stunt
follicles. These abnormalities are reported to result from a combination of factors including F-
actin disorganization and a defect in lamina densa integrity. To test the possibility that integrins
may be involved in the HF phenotype of dep, we may investigate the expression of individual
integrin subunits to look for any abnormal pattern which may lead to the observed phenotype.
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In addition to the HF phenotype, interactions between cells and the extracellular matrix is
known to regulate melanocyte behaviour (Li et al., 2004). So the loss of integrin function in
keratinocytes may potentially disturb melanocyte distribution (Lopez-Rovira et al., 2005),
which may potentially lead to pigmentation phenotype as seen in dep.
The insulin-like growth factor (IGF-I) also plays a role in epidermal homeostasis in which it
predominantly enhances cell proliferation, survival and migration. Disturbance in the IGF
signaling pathway has been implicated in the pathophysiology of several skin perturbations,
particularly those exhibiting epidermal hyperplasia (Edmondson et al., 2003).
6.4.5.2. Loss of PA T activity may affect substrates that cause other phenotypes
Given the widespread expression pattern of Zdhhc21 based on RT-PCR, there is the possibility
that dep may affect palmitoylation of substrates other than that involved in the hair loss
phenotype. The effects on the loss of Zdhhc21 PAT activity on other tissues are unclear.
However, both our RNA in-situ and immunohistochemistry data show a specific expression in
the hair follicle; and the effect of the dep mutation on hair-related phenotype was discussed in
Chapter 5.
Although the major phenotype of dep appears to be hair-related, it is apparent that dep also
exhibit other phenotype during development as well as in adulthood. During early development
(first few weeks postnatal), homozygotes often appear smaller in body size and body mass,
even though the difference becomes insignificant as the mutant enters adulthood. It may be
possible that the loss of PAT activity has an effect on certain growth-related factors that are
required for the early development stage. It is unclear of whether the molecular causes behind
this observation have any effects on the adult mutants.
In several occasions, the mouth region of dep appears to be expanded (personal observation).
Histological sections show a severe epidermal hyperplasia of the lips. In addition to the
epithelial phenotype, there also seems to be a subtle craniofacial/ maxillo-mandibular
difference between wild-type and dep, in that the jaw of dep seems to be broader comparing to
wild-type.
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6.4.5.3. Identification ofpalmitoylation targets of Zdhhc21
To identify genuine substrate that are underpalmitoylated in dep, the ABE chemistry protocol
could be applied. Primary cell culture can be set up from wild-type and dep epidermal
keratinocytes or embryonic fibroblasts. The culture may then be subjected to ABE chemistry in
which all the palmitoylated proteins are labeled with biotin. The biotinylated proteins are then
pulled down by streptavidin beads and visualized by 2D-PAGE. The protein spot pattern of
wild-type and dep can be compared and in theory, any loss of band in dep would represent a
protein that is under-palmitoylated. The corresponding spots in wild-type can then be extracted
and subjected to sequence analysis by mass spectrometry (MS). This approach provides the
potential to identify novel substrates that without the need of any assumption and knowledge of
the pathways.
Another approach that may be applicable is by using an MS-based technique called the stable
isotope labeling with amino acids in cell culture (SILAC) developed in the group of Matthias
Mann (Ong and Mann, 2006). SILAC is a simple and accurate approach that involves growing
2 populations of cells (e.g. wild-type and dep keratinocytes) in culture media that are identical
except that one media contains amino acids labeled with stable isotopes, and the other one with
unlabeled amino acids.
After adequate number of cell divisions, the 2 populations of cells can then be harvested and
mixed together to allow identical subsequent treatments. The palmitoylated proteins can then be
pulled down by the ABE chemistry, and subjected to MS analysis, which compares the
abundance of palmitoylated proteins between the wild-type and dep. This method allows subtle
difference in degree of palmitoylation to be detected in a standardized way.
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Chapter 7 - Concluding Remarks
The initial effort to identify novel genes following germ cell mutagenesis half a century ago has
allowed the spontaneous dep mutation to be mapped to the b-del interval on chromosome 4.
The advent of increasingly abundant genomic data and DNA-based molecular markers has
allowed the del-233F mutation to be readily identified in Zdhhc21.
In this project, the subsequent verification of characterization of the mutant allele has opened
up an unexpected area of focus, which is the PAT activity in vivo. The combination of BAC
transgenic rescue and cell culture assay has identified dep to be the first example that
demonstrates a role of PAT enzymatic activity in vivo.
Currently, large-scale production of targeted mutations in C57BL/6N ES cells in the
EUCOMM project is underway. Zdhhc21 was among the first set of constructs to be made in
the recombineering pipeline. Once the Zdhhc21 knockout (floxed) mutant ES cell line is made
into mice, the mutation may be activated by crossing with the desired Cre recombinase driver
strain, such as the K5-Cre, which targets the epidermal stem and transit-amplifying cells, or
other keratin promoters such as Kl, K6, K.14 and involucrin, to investigate the role ofZdhhc21
in specific epidermal compartment.
Using the ABE proteomic screen for Zdhhc21 substrates, we may identify the causative
component of dep that is affected by PAT-deficiency. Based on existing knowledge on Wnt
signaling pathway and its involvement in epidermal homeostasis, the proteomic approach may
potentially identify a novel member of the Wnt pathway.
Once the specific substrate is identified, it may also be conditionally targeted in hair follicles to
see if it produces any dep-related phenotype. If it is a protein-coding gene that has previously
been characterized, a knockout and conditional ES cell line may be available from the
EUCOMM ES cell mutagenesis archive. Furthermore, the mutation may be activated by
crossing with a specialized K14-Cre strain (Benitah et al., 2005; Silva-Vargas et ah, 2005), in
which the Cre recombinase can be induced by 4-hydroxy-tamoxifen (40HT) in a temporally
controlled manner. This will allow us to inactivate the target gene at specific stages of the hair
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cycle. According to our observations, the predominant dep phenotype occurs during early
anagen when matrix progenitors are differentiating. Using the tamoxifen-induced knockout
strain, we may verify this finding.
Currently, several members of the DHHC family have been associated with human conditions
such as mental retardation and schizophrenia. In addition, out of all the PATs in mouse, there is
increasing evidence that supports a role in palmitoyation (Section 4.1.3.). However, none of
these literatures has reported an identified substrate associated with a mammalian condition.
The conditional targeting approach, in combination with the proteomic screen, will prove the
link between the PAT-deficient Zdhhc21 and the dep phenotype. This will not only facilitate
our understanding on the role of palmitoylation, it will potentially add insight to our current
understanding of epidermal homeostasis and hair cycle regulation.
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Chapter 8 - Materials and Methods
8.1. Nuclei Acid Manipulation
8.1.1. Solutions used in molecular biology
The following solutions were prepared by HGU technical staff and autoclaved and stored at
room temperature: lM Tris (tris [hydroxymethyl] aminomethane) ph7.5 and ph8.0, TE buffer,
EDTA (ethyldiaminetetra-acetic acid di-sodium salt), 20xTBE (Tris-Borate-EDTA20), 20%SDS
(sodium dodecyl sulfate), 20x SSC (sodium chloride/ sodium citrate buffer21), 5M NaCl
(Sodium Chloride), 5M NaOH (Sodium Hydroxide). Adjustment to any pH is accomplished by
adding either HC1 or NaOH, and monitored using a pH meter (Fisherbrand Hydrus 400)
calibrated over a range of standard buffer.
8.1.2. Gel electrophoresis
The loading buffer used in most agarose gel electrophoresis was 6x bromophenol blue loading
buffer (30% glycerol and 0.025% bromophenol blue in dH20). To make an agarose gel for
electrophoresis, required amount of agarose powder (Hi-Pure, Biogene) was dissolved in
lxTBE by heat. Different concentrations of agarose gel (w/v) were used to resolve DNA
fragments of different size. Molten agarose was cooled before the addition of Ethidium
Bromide, which stains nucleic acid, to a final concentration of 0.5pg/100ml. The DNA marker
used were lOObp marker (Promega) and lkb marker (Invitrogen) depending on the expected
size of fragments and strength of gel. The gel was then placed in a gel tank with lxTBE, which
acts as a buffer and provide ions for conductivity, and a current is applied. After adequate
migration as indicated by the loading buffer, the gel is placed on a ElV-transilluminator.
8.1.3. Determining concentrations of nucleic acids
The intensity of DNA maybe visualized and estimated against DNA of a known concentration
on agarose gel by electrophoresis, or by measuring the absorbance (optical density, OD) in a
spectrophotometer (GeneQuant) at a wavelength of 260nm (A26o). A 260/280 ratio of 1.8-2.0
indicates DNA purity.
8.1.4. Digestion by restriction enzymes
Most restriction enzymes (restriction endonuclease) used were from Roche. To cut double-
stranded DNA, enzyme was added to a concentration of 5-10u/pg DNA in lx Roche buffer. For
fragments that were subjected to further DNA manipulation, DNA was digested for 3-4 hours.
20 20xTBE: [216.0g Tris Base + 110.Og Boric acid + 80ml 0.5M EDTA (pH8.0)] in 1 litre H20.
21 20xSCC: (175.3g Sodium Chloride + 88.2g Sodium Citrate) in 1 litre H20.
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DNA digested for genotyping purpose was typically digested overnight. The digested fragments
were then visualized by electrophoresis. For DNA manipulation, desired fragment of expected
size was excised from the gel and purified by the QIAquick® Gel Extraction Kit.
8.1.5. Ligations
The vector and insert to be ligated were purified with QIAquick® Gel Extraction Kit or
QIAquick® PCR purification kit. Alternatively, the DNA may be precipitated by EtOH in 10%
v/v 3M NaOAc (Sodium Acetate) and 3 volumes of chilled 100%EtOH, incubated at -70°c for
20mins. The tubes were spun at 13k rpm for lOmins to pellet DNA, and washed with 70%
EtOH before resuspending in TE buffer. The fragments used for ligation were often treated
with SAP (shrimp alkaline phosphatase) at 37°c for 1 hour to remove phosphate group so that
the ends do not re-anneal.
To join the 5'phosphate and 3'hydroxyl groups of double stranded DNA, the following reaction
was typically used: lpl 10xT4 ligase buffer, 6:1 molar ratio of insert to vector22 and 0.5pl T4
ligase (Roche) up to lOpl ddH20. Larger ligation mixes were often used especially when the
concentration of insert is low, and the volume needs to be compromised. A control reaction
with no insert is included. The reactions were incubated at 16°c overnight, before bacterial
transformation.
8.1.6. Polymerase Chain Reaction (PCR)
The Invitrogen DNA polymerase was used for most PCR reactions. For PCR that requires high
fidelity, Pfu23 (Stratagene) was added to the PCR reaction. For difficult GC-rich and repetitive
sequences, Bio-x-act24 (Bioline) was used according to manufacturer's specifications.
Working stocks of dNTPs (deoxyribonucleotide triphosphate) were made into lOmM from
dATPs, dCTPs, dGTPs, dTTP, and a final concentration of 0.2mM is used for each reaction.
Primers were designed using the Primer325 software and purchased as lyophilized desalted
compounds (from Sigma Genosys, Invitrogen or Eurogentec). On arrival, stocks were
resuspended in ddfLO into lmg/ml and stored at -20°c. Working stocks of 50ng/pl were made
and about 2.5ng/pl ofeach primer was used in each PCR reaction.
22
6:1 molar ratio of insert to vector: Insert mass (ng) = 6x [insert length (bp)/ vector length (bp)] x vector mass (ng)
23
Pfu: isolated from the hyperthermophilic marine archaebacterium, Pyrococcus furiosus, possess both 5'-to 3'-DNA
polymerase as well as 3'- to 5'- exonuclease activities which prevent mis-incorporation of nucleotides.
4
Bio-X-act is a formulation of several enzymes which delivers high specificity for long or difficult reactions. It also
posses the proofreading 3'- to 5'- activity as does Pfu.
Primer3: https://sourceforge.net/projects/primer3
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Routine PCRs were carried out in Abgene thin-walled thermo tubes on the Hybaid Omnigene















ddH20 up to 15pl.
The cycling conditions are as follows unless otherwise stated:
5'@94°c
[30"@94°c => 30"@Tann26 => l'@72°c] x 30cycles
10'@72°c
10'@4°c
END (may store at -20°c)
8.1.7. Reverse Transcription (RT)-PCR
(a) RNA extraction
BALB/c mice were sacrificed and tissues were collected and immediately placed into blue
RNAse-free mortar tubes that are used with the hand-held electric homogeniser on dry ice.
Total RNA for the selected tissues were extracted with TRI Reagent® (Sigma) according to the
manufacturer's specifications. Briefly, tissues were disrupted in the phenol-based reagent which
contains denaturants and RNase inhibitors. Chloroform was then mixed with the lysate and
centrifuged to separate mixture into 3 phases. RNA was then precipitated from the aqueous
phase with propan-2-ol.
(b) RT-PCR expression profile
Gene-specific RT primers were designed to amplify across the last 2 or 3 exons of the gene to
ensure clear distinction of cDNA from any genomic contaminants. Sequences of RT primers
26 Tann': the annealing temperature, which is about 5°C below the Tm, where Tm=[4x(G+C)+2x(A+T)]°C.
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are available on request. RT-PCR reactions were carried out using the Promega Access RT-
PCR system according to the company instructions except that quarter reactions were used.
8.1.8. DNA sequencing
In many cases, PCR primers used for amplifying a region of interest were used for sequencing.
But in some cases, additional sequencing primers internal to the region of interest were used.
Sequencing primers were diluted to a concentration of 50pg/pl or 20pM and submitted to the
HGU Technical service together with the PCR products or purified plasmids.
The dye terminators used was BigDye (Perkin-Elmer), which consists ofDNA polymerase,
dNTPs, and ddNTPs-Dye terminators. Successive rounds of amplification results in
incorporation of one of the 4 ddNTPs, each tagged with a different fluorescent dye in each
extension product.
The sequencing reaction was as follows:
Sequencing primer 5 pmol
DNA template lOng
The sequencing program was as follows: [30"at 96°c => 15"@55°c => 4'@60°c] x 25cycles
Sequencing products were EtOH precipitated and separated with an ABI3100 by the HGU
Technical service to discriminate ssDNA fragments of different length. Sequencing traces were
analyzed using Sequencher software.
8.2. Microbiology
DNA plasmids (usually carry an antibiotic-resistance gene e.g. Ampr) may be transformed into
Subcloning Efficiency® Dh5a Chemically Competent cells (Invitrogen) according to
manufacturer's specifications. Briefly, plasmids were transformed into bacterial cells by heat
shock at 37°c for 20secs, during which the uptake of plasmid DNA take place. The plasmid-
containing cells were then selected by streaking the transformant onto an L-agar plate27
containing the antibiotics (e.g. ampicillin at a concentration of lOpg/ml).
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Individual colonies maybe tested by PCRs for identity, before being inoculated into appropriate
volume of L-Broth28 containing the antibiotics, and grown at 37°c overnight at 250rpm for large
scale cultures. The plasmid DNA were then isolated and purified from the culture using
QiaPREP® Spin miniprep kit or EndoFree® Plasmid Maxi kit according to manufacturer's
specifications.
Briefly, cell pellets were suspended with an alkaline solution with detergent (NaOH/SDS) and
RNaseA. The alkaline conditions denature DNA and proteins; and the detergent lyses cells and
denature proteins. The mixture was then neutralized and adjusted to a high salt condition which
is necessary for binding ofDNA onto column. The plasmid DNA remains in solution whereas
the cell debris and protein precipitates and are removed. The plasmid was further purified using
a column containing silica gel that binds DNA at high salt conditions, and elutes DNA in low
salt conditions.
[L-Broth and L-agar were prepared by EIGU technical staff and autoclaved and stored at 4°c
until use.]
8.3. Cell culture and Protein assay
8.3.1. Protein manipulation
Maintenance of cells
The cell lines used in this thesis includes: NIH3T3 (mouse embryonic fibroblast cell line),
HEK293 (human embryonic kidney cell line) and COS7 (African green monkey kidney cell
line). Cells were maintained in conical flasks in Dulbecco's Modified Eagle's Medium (DMEM,
Gibco Life Technologies) supplemented with 10% foetal calf serum (FCS, Sigma), 2% L-
glutamine (30mg/ml), Penicillin and Streptomycin at 37°c in a well-ventilated and sterile tissue
culture incubator with 5% C02. lx Phosphate Buffered Saline (Dulbecco's PBS, Life
Technologies), an isotonic saline solution was used for washing cells.
26 L-Broth: (10.0g Tryptone + 5.0g Yeast extract + 10.0 NaCI + 1.0g Glucose) in 1 litre H20.
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Passaging cells
The cell density was monitored daily and passaged when the culture reached -80% confluence.
To passage cells, the growth medium was removed by aspiration and the cells were washed
briefly with 1 xPBS. The cells were then trypsinized for no longer than 4 mins in 5ml trypsin29 -
versene30 solution at 37°c, followed by inactivation of trypsin was then inactivated by diluting
in growth media. (For COS7 cells, cells were rinsed with versene prior to trypsinization.) The
cell suspension was then diluted into desired amount in tissue culture flasks.
Preparation of frozen stock
To prepare frozen stock for long-term storage, cells were trypsinized and counted under a
coverslip on a conventional hemacytometer viewed under the microscope. Cells were washed
in lxPBS, and resuspended to lxlO6 cells per ml of freezing medium31. Appropriate amount of
cell suspension were then dispensed into 2ml cryovials and stored at -80°c overnight, before
transferring to liquid nitrogen for long-term storage.
Protein extraction from tissue culture cells
200pl lxPLB (passive lysis buffer) from Promega was added to 6-well plates, incubated at RT
with shaking and scraping. The cell suspension was then centrifuged at 13000 rpm, for lOmins
at 4°c. The supernatant was used for protein assay or stored at -80°c.
Transfectlon of DNA plasmids into cells
DNA plasmids were transfected into cells using Lipofectamine 2000 (Invitrogen) as per
manufacturer's specifications. For a 6-well plate, 2pg ofDNA plasmids (in no more than 4pl)
was mixed with lOOpl OPTIMEM (Gibco Life Technologies), and 6pl Lipofectamine was
diluted in lOOpl OPTIMEM and incubated at RT for 5mins. The 100pl DNA mixture and lOOpl
Lipofectamine were then mixed and incubated at RT for 20mins. At the end of the incubation,
800pl OPTIMEM was added to the mixture, before dispensing into the well containing cells of
80-95% confluence. The cells were incubated in the mixture for 4-5hrs before replacing with
fresh growth medium.
29 Trypsin (pH7.8): (1:250 Trypsin + 5.0ml Phenol Red + 0.06g Penicillin + 0.13g Streptomycin) in 1 litre PBS.
30 Versene: (10 Dulbeccos tablets + 0.4g sodium EDTA + 0.2% Phenol Red) in 1 litre H20.
31 Freezing medium: 10% dimethyl sulfoxide (DMSO) in FCS.
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For immunofluorescence, a coverslip was added in each 6-cell well prior to cell plating. The
coverslips may be treated with 0.1% polylysine for lhour to improve adhesion of cells to the
coverslip.
Protein concentration measured using the Bio-Rad Bradford total protein assay
The bovine serum albumin (BSA) standard curve was set up at concentrations: 0, 5, 10, 20, 30,
40 and 50pg per ml of 20% Biorad assay solution. 5pl of protein extract was added to 1ml
assay solution. The assay was run on GeneQuant, which uses the standard curve to determine




Protein extracts were diluted into 2pg/pl and lOpl of which was mixed with 10pl 2xSDS-PAGE
(sodium dodecyl sulfate- polyacrylamide gel electrophoresis) loading buffer32 that disrupts the
disulfide bonds. The SDS disrupts the 2°, 3° and 4° structures and coats protein with negative
charge. Sometimes, the protein was further denatured at 95°c for 2mins, and loaded onto the
protein gel, alongside with lOpl Precision Plus protein Kaleidoscope size standard (Bio-rad) to
determine the molecular weight of the protein in question.
Preparation for SDS-PAGE (sodium dodecyl sulfate- polyacrylamide gel
electrophoresis)
The apparatus to hold gel was set up ready for the gel to be poured. The separating gel and
stacking gel were prepared as follows. In both cases, Temed (TetraMethylenediamine) was only
added immediately before pouring the gel because it activates the acrylamide monomers,
causing them to begin the polymer chain reaction and crosslink randomly with the elongating
polymer. This polymerisation takes place as soon as Temed is added. The protein is first sieved
through the larger-pore stacking gel which tightening the protein band, followed by the
separating gel which resolves negatively charged proteins by size.
32 2xSDS loading buffer: 1ml 1.5MTris (pH6.8) +600pl 20%SDS +3ml glycerol +1.5ml p-mercaptoethanol +0.2%
bromophenol blue + up to 10ml H20. Stock and working solutions stored at -20°c and 4°c respectively.
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50pl 10%APS (Ammonium Persulfate)
5pi Temed
Once the gel was set, it was placed in the tank in lx Tris-glycine running buffer35 (25mM Tris,
250mM Glycine, 0.1% SDS). After the samples and size standard were loaded on gel, it was
run at 200V for about 40mins until the loading buffer is near the bottom of the gel.
Transfer and detection of protein
The resolved proteins were then transferred onto a polyvinylidene difluoride membrane
(Hybond-P, Amersham Pharmacia Biotech) in a semi-dry blotter with minimal amount of
cathode buffer (0.025M Tris pH9.4, 20% MeOH, 0.04M glycine)36 for transferring protein.
Non-specific binding sites were blocked by incubating in 5% non-fat dry milk in lxTBST
[20mMTris-pH7.6, 150mM NaCl and 0.1% Tween20 (v/v)] for 30mins before probing with
appropriate primary antibody in diluted in 5% non-fat dry milk in TBST for lhr. After stringent
wash in lxTBST, the filter was incubated with the secondary antibody conjugated to
horseradish peroxidase (HRP, Amersham) and detected using enhanced chemiluminescence
substrate (ECL plus) Western blot detection system (Amersham Pharmacia Biotech). See Table
8.2. for primary and secondary antibody details.
Total proteins may also be visualised by staining with non-permanent Ponceau S solution
(Sigma).
8.4. Animal Husbandry
All mice were maintained in the MRC Transgenic Unit in a specific pathogen free (SPF)
environment and experiments were carried out under Home Office license. The dep mutants
were maintained by either (het x het) or (horn x horn) cross. The morning of vaginal plug
detection counted as embryonic day 0.5 (E0.5).
33 4x Separating buffer (1.5M Tris/HCI pH8.8): (18.2g Tris Base + 4ml 10% SDS) in 100ml H20 adjusted to pH8.8.
34 4x Stacking buffer (0.5M Tris/HCI pH6.8): (6.1 g Tris Base + 4ml 10% SDS) in 100ml H20 adjusted to pH6.8.
35 5xTris-qlvcine buffer: (15.1g Tris Base +94g Glycine +50ml 10%SDS) up to 1 litre deionised H20.
36 Cathode buffer: (6.25ml IMTris pH9.4 + 50ml MeOH + 0.75g glycine) up to 250ml H20.
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Crosses between dep heterozygotes were set up and skin samples were collected at weekly
interval of up to 12 weeks. Earclips from all mice were collected for genotyping on weaning so
that a set ofwild-type, heterozygote and homozygote was collected for each timepoint.
Comparison between dep and a control littermate is necessary due to the complicated breeding
background of dep and the possible discrepancy in morphology as a result of strain difference.
This also ensures that the animals are age-matched at every stage. For timepoints prior to 3
weeks of age, the whole litters were sacrificed to comply with the Home Office regulations
regarding to live tissue collection.
8.5. Generation of Transgenic BAC Rescue line
8.5.1. Preparation of BAC transgenic constructs
(i) BAC clone
The BAC clone used in this study was supplied by BAC PAC Resources Center (BPRC) at the
Children's Hospital Oakland Research Institute, CA. The clone is from the RP23 mouse BAC
library, with clone number RP23-76J17, and is hosted by the E.coli DH10B strain. The plasmid
contains a chloramphenicol resistant (CmR) gene, which can be selected for by growing cells in
medium containing Cm. RP23-76J17 contains genomic region ofmouse chr.4 of approximately
228kb. The candidate gene, Zdhhc21, and both ends of the BAC were sequenced to confirm the
physical position of the clone. The clone includes an intact copy of Zdhhc21, and Cerl, which
lies ~40kb upstream to Zdhhc21.
(ii) Generation of ACerl BAC construct
In the first step, the targeted region of Cerl in RP23-76J17 was replaced with the zeocin
resistant (zeoR) gene. In the second step, the zeoR gene was removed by treatment with FLP
recombinase, leaving only 85bp of foreign DNA in the modified BAC (Figure 8.1.).
Bacterial strain: EL250 has an integrated X prophage inserted in the bacterial genome. The
prophage encodes the heat inducible recombination enzymes control of the A,cl857 heat
inducible promoter. The prophage also encodes FLP recombinase on the arabinose inducible
pBAD promoter. Throughout the experiment, EL250 was maintained at 30°c because the
prophage encodes toxic sequences that can be induced by heat in 40'. In EL250 the FLP is in
the part of the prophage occupied by Tetracycline resistant (TetR) in DY380. This means there
is no antibiotic selection for strain EL250.
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Amplification primers for targeting CerF. The FRT-ZeoR-FRTcassette used for targeting Cerl
was amplified from plasmid pBSKGFPFRTzeoFRT with the following primers (698bp):
5' -cgactgtagccgtgCAGAGGGAGCCTCTCTTTTAGGCCCGTCCATCTGTGATCTTATCATGTCTGGATCAGATCC- 3 '
5' -GCATCACCATCTTGACCACGGGGGTTGGGCTGGTGCAGTTCAGCATCAAGTGCCCAGCGCCCTCTGATCA- 3 ' .
These primers contain the 5' regions (the 50bp in gray) homologous to the flanking regions of
the targeted Cerl sequence, and the 3' regions (20-25bp in blue) homologous to sequences in
pBSKGFPFRTzeoFRT flanking the FRT-ZeoR-FRT cassette.
The PCR conditions used were as followed: 1 .OmM Mg2+, 0.4pM dNTPs, 0.2mM each primer,
150ng DNA in a 25(0.1 reaction. Touchdown PCR was optimized to start from 64°c to 60°c for
15 cycles to minimize PCR-induced errors.
pBSKSGFPFRTzeoFRT was linearized with Apal and Sad, and cleaned up on Qiagen prior the
PCR. The PCR products were further digested with Notl, Sail and Dpnl to remove trace of
intact plasmid. This step ensures that all zeoR colonies are the EL250 cells that contain BAC,
but not the host bacteria ofpBSKGFPFRTzeoFRT. Digested and amplified products were then
purified using Qiaquick, and finally drop dialysed before being transfected into the EL250
cells.
Induction of X recombination: Overnight EL250 culture containing the target BAC was grown
from a single colony, diluted 40-fold in LB with Cm, and grown to an ODsoo = 0.4 at 32"c (3-
4hrs). The culture was then transferred into a 42°c shaking water bath at 200rpm (by hand) for
15'. This temperature induced production of the RED enzymes for recombination. After the 15-
min induction, the culture was immediately placed on ice slurry to cool down.
Preparation ofelectroporation-competent cells: The culture was centrifuged at 3500rpm in
Sorvall RT6000 (4°c for 15'); the cell pellet was then resuspended in ice-cold sterile water. This
process was repeated twice before transferring into a 1.5ml Eppendorf tube and further
centrifuged at 13k rpm for 2'. This preparation applies to (1) unmodified BAC transformation
into EL250 cells [electro-competent EL250 cells provided by Peter Budd]. (2) PCR product of
donor DNA containing FRT-zeoR-FRTcassette into BAC-containing EL250 cells.
Cell transfonnation: About lOOng in lpl purified linear donor DNA (drop dialysed) is
transferred into 5()pl competent cells in a precooled electroporation cuvette using a Bio-Rad
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gene pulser set at 2.5kV, 25|iFD with a pulse controller set at 200 Ohms. The electroporated
cells are immediately diluted with 1ml of LB medium and incubated at 32°c for 30' with
shaking. The transformation is then plated on low salt LB with zeocin and chloramphenicol
respectively. Six colonies from the Zeo plate are then transferred to 200ml low-salt LB
(Zeo/Cm) from which maxipreps are made and subsequently amplified with primers flanking
the targeted region to be deleted, or digested with several restriction enzymes and compare
pattern with parent DNA to ensure that the right clones are selected and that rearrangement had
not occurred.
The PCR primers flanking the target Cerl region were:
5' -tatgtgatgccccgactgta-3' (Cerl_KO_20mer-F)
5' -CGTCTTCACCATGCACTGAC-3' (Cerl_KO_2Omer-R)
Arabinose Induction of FLP recombinase: Overnight EL250 culture containing the intermediate
modified BAC [Figure 8.1 (iv)] is grown from a fresh colony, diluted 50-fold with a
concentration of 1% Arabinose and grown in LB (Cm) for 3 hrs with shaking. The culture is
then spread in different dilutions on plate with Cm and grown overnight at 30°c. Ten colonies
are selected and grid on both Chloramphenicol and low salt Zeocin plates. This method should
identify colonies which have lost the zeoR gene, following induction of the FLP by arabinose
(i.e. the colony should grow on Cm but not Zeo). The validated colony is then re-spread to
single colony and maxiprep is prepared for further validation by sequencing.
8.5.2. Injection into mouse fertilised eggs37
The BAC was then linearised to minimise the amount of foreign DNA38. After linearization, the
modified BAC transgene was microinjected individually into hundreds of male pronuclei in
fertilised eggs. To detect BAC transgene integration, Southern blot analysis using a FRT probe
or PCR using BAC-specific primers and primers flanking the dep deletion may be performed.
Female mice were superovulated with 2 gonadotrophins: PMS (Pregnant Mare's Serum) and
hCG (human chorionic gonadotropin) and mated to males. Zygotes were then dissected out of
the oviduct a day after intravaginal plug is observed (i.e. 1 -eel 1 stage), at which point fertilised
eggs are visible as a bulge in the oviduct. The cumulus was digested with hylauronidase and
37 Microinjection/ transfer of embryos: all procedures performed by Margaret Keighren, HGU, MRC.
36
Linearising BAC before microinjection: Abe and colleagues (Abe et at, 2004)reported a 3-fold reduction of transgene
integration rate and fewer intact transgene integration when circular BAC DNA was injected.
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removed. After dissection, the zygotes were recovered in the KSOM culture medium with C02
supply at 37°c for 30mins. Embryos were then concentrated in droplets of injection medium
FHM in oil, for ease of handling.
The microinjection apparatus were set up. Embryos were held by Vacutips (Eppendorf) with
minimal suction and about 3pl of 2ng/pl constructs were injected into each pronucleus with the
Femotips needles (Eppendorf). The injected embryos were cultured in KSOM medium to 2-cell
stage and transferred to oviducts of pseudopregnant recipients.
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Figure 8.1: Strategy for deleting Cer1 in a BAC using prophage/ recombination
Stepl - The FRT-zeoR-FRTcassette (ii) is generated by PCR from plasmid pBSKGFPFRTzeoFRT (i)
using recombination oligonucleotides which contains 50bp homology with the target BAC (iii).
Step2 - The target BAC clones are transfected into EL250 cells which are then induced for X
recombinase function at42°c. These cells are made electroporation-competent and transfected with the
amplified FRT-zeoR-FRT cassette (ii) by electorporation. Recombination occurs between the linear
cassette and the target BAC, resulting an intermediate modified BAC (iv).
Step3 - The FLP recombinase is induced by arabinose to remove part of the FRT-ZeoR-FRT cassette,
leaving about 85bp of foreign DNA (replacing the 2-kb Cerl sequence) in the final modified BAC (v).
(i) pBSKGFPFRTzeoFRT








(iv) Intermediate Modified BAC
H
4 Recombination in EL250 E.colicells
Em7.ZeocinR
(v) Final Modified BAC
Induce FLP recombinase to remove one
of FRTs and the ZeocinR
125 bp 34 bp 20 bp f
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8.6. Screening ENU-DNA archive for Zdhhc21 mutations.
8.6.1. Screening for Zdhhc21 alleles in the Harwell archive:
DNA source
DNA samples analysed in this screen include the original GSK-Harwell archive, which consists
of twenty-four 96-well plates, and the "ethio logics" archive ofbetter DNA quality that consists
of 32 plates. In total, approximately 5300 Fi ENU DNA samples were screened for possible
substitution within Zdhhc21 Exon3 and 4. DNA from Fl mice ofC3H/HeH x BALB/c hybrids
with the BALB/c male parent treated with ENU. All samples were obtained from Harwell
MRC.
Primer design and exon choice
The 7 exons in Zdhhc21 were sequenced in BALBc/C3H DNA to check for polymorphism.
Exon 3 and exon 4 were selected on the basis of their size and predicted functional importance
which may be more likely to impact the integrity and function of the protein (Figure 3.1C).
Exon 3 contains the Znf_dhhc domain which is highly conserved across species; the domain
extends to exon 4 which encodes for the third transmembrane domain.
PCR products for exon 3 and 4 are 257bp and 312bp in length; in which 112bp and 139bp are
coding sequences respectively. In total, approximately 1.33 Mb of coding sequence was





Conformation Sensitive Capillary Electrophoresis (CSCE)
According to a protocol previously optimized by Joanne Morgan (HGU, MRC). Mutation
detection was performed on an ABI 3100 automated capillary DNA Sequencer that utilizes
conformation sensitive capillary Electrophoresis (CSCE). DNA samples from 4 individuals
were pooled (2.5pl of 5ng/pl DNA) giving a total of 50ng in the PCR reaction. Conditions for
PCR were as followed: 200pM dNTPs, 1.5 mM MgC12, 0.2pM forward and reverse primer, lx
Invitrogen buffer and 0.5 unit Taq (Invitrogen). PCR was carried out using the following
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cycling conditions: 94°c for 15', 40cycles of [94°c for 30", annealing temperature at 55°c for
45", 72°c for 1']. The final extension at 72°c for 10'.
Heteroduplex formation
Following amplification, heteroduplexes were formed using the conditions: 96°c for 10', 72
cycles of [96°c for 20", decreasing temperature by 0.5°c per cycle], followed by 60°c for 30'.
FAM used on ABI310 with Tamra350 size standard.
Re-derivation ofmutant allele
Frozen sperm stocks were obtained from Harwell, and the mutation was re-derived by Brendan
Doe (MRC Transgenic Unit, Edinburgh). The mutation was successfully rederived by
intracytoplasmic sperm injection (1CSI), which involves direct injection of a single sperm into
an oocyte to increase the chance of fertilization.
8.6.2. Optimizing PCR conditions for screening the RIKEN archive
The RIKEN archive consists for 10 000 DNA samples from Fl-ENU mutagenised mice from a
cross between C57BL/6 and DBA/2. Any polymorphism between the 2 strains was checked by
sequencing, and avoided by re-designing PCR primers where possible.
The PCRs were optimized as lOpl reaction with Takara EX Taq® as follows:
lOx buffer, l.Opl; 50mM Mg2+, 0.0pl[1.5mM], 0.1pl[2.0mM], 0.2pl[2.5mM], 0.3pl[3.0mM];
2.5mM dNTPs, 0.8pl; 5pM F primer, 0.4pl; 5pM R primer, 0.4pl; O.Olpg/pl DNA, l.Opl;
Takara EX Taq, 0.05pl; and H20 up to 10pl.
The PCR cycling conditions for each exon have been optimized as below; the annealing
temperature for each primer pair is indicated in the below table.
5'@94°c => [30"@94°c, 30"@Tann, 1 '@72°c] x 30cycles => 10'@72°c => 10'@4°c => END
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1 TTCTCCCCAGGATTGTCTTG 2.5-3.0 50-55 154 239 Checked and
avoided.CTTCACAGAAGGTAATAATAC
2 CCTGATAGATGTTGACTAAAATGC 2.0-2.5 55 99 335 Checked
GAGTGCTTGCAACTGAAAACGG
3 GTCTGAGCATCCCTCGCT 1.5-2.5 55-58 112 257 Checked
GCTGACAGGTTCTCACTGTCTT
4 TGATCCTGATGTGAGCATCTT 1.5-2.5 55-58 139 312 Checked
CCCGTAAAGCTCACTGGTGT
5 N/a N/a 117 N/a 1 coding SNP
6 N/a N/a 44 N/a Too many
7 AGCTGACTGAAGGGCACC 1.5-2.0 55-58 134 249 Checked
AAAACCTGTAACGCATTTCCA
8.7. Zdhhc21 knockdown experiment using siRNA technology
Preparation of pDECAP-Zdhhc21expression vector
The vector was designed and constructed by Ian Smyth and Peter Budd in summer 2004, when
the experiment was carried out for the first time. Single colonies were grown from frozen
glycerol stock in SURE cells and purified using Quiagen DNA maxiprep DNA.
Generation of transgenic mice
The 2-kb fragment of pDECAP-Zdhhc21 was released from the background sequences by
digesting the vector with BglU and BamW\ and cleaned up on Quiagen Quiaquick gel
purification columns, re-run on LMP and concentrated on a PCR purification column. The
fragment was further purified on Microcon and SpinX and microinjected into fertilised mouse
oocytes and transferred into oviduct at one-cell stage.
Genotyping
The embryos or mice at appropriate stage were then typed by PCR amplified to detect the
expression of both the forward and the reverse sequence as dsRNA, assuming that a hairpin





If an embryo is positive for both fragments, dsRNA may have successfully expressed.
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8.8. Genotyping Embryos and Mice
8.8.1. DNA extraction
Tail tip or ear clip samples were digested in 1.5 microfuge tubes at 55°c overnight in 500pl
lysis buffer (50mM Tris, lOOmM EDTA, 0.5%SDS)39 with 0.2mg/ml proteinaseK (sigma). The
following day, tubes were vortexed and centrifuged at full speed for lOmins, genomic DNA
was then precipitated with 500pl isopropanol, washed with 70% EtOH and resuspended in
appropriate amount ofTE buffer.
8.8.2. Genotyping dep mutation
Breeding animals were genotyped by PCR amplification of Exon7 fragments from genomic
DNA extracted from tail biopsies or ear clips. The exon7 of Zdhhc21 is amplified by standard
PCR (Tann 58°c, 1,5mM Mg2+) using the following primers, one of which is labeled with a
fluorescent tag: 5'FAM-AGCTGACTGAAGGGCACC3' (Exon7F) and
5'AAAACCTGTAACGCATTTCCA 3' (Exon7R), which yields a 249bp fragment.
The 3-bp deletion in dep was then detected on the ABI 310 genetic analyzer. The PCR
fragments were first denatured in 70% formamide solution40 at 95°c for 5mins to separate
dsDNA into single strands, and were cooled immediate to 4°c to prevent re-annealing of
unwound DNA. The samples were then run on the ABI 310 genetic analyzer which reads out
the size difference of denatured fragment robustly.
8.8.3. Genotyping the Harwell L91F mutation
Standard PCR was performed using the following primer pair: 5'GTCTGAGCATCCCTCGCT-
3' (Zdhhc2 l-ex3F), 5'-GCTGACAGGTTCTCACTGTCTT-3' (Zdhhc21-ex3R) which yields a
fragment of 257bp. The 479C->T mutation disrupts a Sac\ restriction site, which nonnally cut
once at GAGCTAC and divide the 257bp PCR fragment into about 174bp and 83bp with 3'
overhang. The mutant PCR fragment contains a mutation at the Sad site and therefore remains
uncut. This method allows rapid genotyping between wild-type, heterozygote and homozygote
mice for the Harwell allele. 15pl of PCR product was cut in 2pi buffer with lOU(l pi) Sad
restriction endonuclease (Roche) in a 20pl reaction at 37°c, and visualized by electrophoresis.
39
Tissue lysis buffer: (5ml IMTris.HCI pH8 + 20ml 0.5MEDTA + 5M 10%SDS) up to 100ml ddH20.
40
70% formamide solution: 13.5pl deionised formamide (Sigma), 0.5pl Size standard (GeneScan-350 TAMRA); 4.0pl
ddH20; 1 (jl diluted PCR product.
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8.8.4. Genotyping of BAC transgenic litters
(i) Distinguishing between homozygotes and heterozygotes
In the case where the BAC construct was microinjected into heterozygous embryos between
dep and F1 (C57/CBA), the homozygotes and heterozygotes of the resulting progeny were
genotyped by the proximal and distal sputnik markers immediately flanking the BAC region.
Sputnik markers from genomic DNA were developed using the Sputnik program41 to spot
tandem repeat motifs.
The proximal sputnik marker (274bp) was amplified by:
5'CTGCTTCTCAAAAGCCAAGG-3' (proxl3 8F)
5'CCTGGAAAGCAGTAGCCATC-3' (proxl38R)
The distal sputnik marker (389bp) was amplified by:
5'GGCTTGAACTGGTGGAGAAA-3' (disl45F)
5'GCCCAGCTTTAGGCTGTAGA-3' (disl45R)
(ii) Genotyping the BAC transgene
The presence of the BAC transgene in the genome was genotyped by 3 markers, including the
CmR marker which is specific to the plasmid, and two markers at both ends of the BAC region,
amplifying the borders between the BAC carrier plasmid and the BAC genomic region.
The primers used for amplifying the CmR gene from the BAC-containing plasmid were:
5'TCCATGAGCAAACTGAAACG-3' (CmR-F)
5'CATGATGAACCTGAATCGCC-3' (CmR-R)
The primers used for amplifying the proximal end of the BAC clone was:
5'TAATACGACTCACTATAGGG-3' (T7-L3 4 8)
5'GAGCTTCATGTATGTCCTT-3' (76J17-3'Rii)
The primers used for amplifying the distal end of the BAC clone was:
5'TATTTAGGTGACACTATAG-3' (SP6)
5'GCAACTTGTAACTTGGGTAT-3' (76J17-5'Ri)
Out of the 3 markers, the BAC end markers were more reliable at typing incorporation of the




8.9. Detailed phenotypic analysis of dep
8.9.1. Preparation of samples
(a) Processing and Sectioning
After dissection, skin samples were fixed in 4% PFA for several hours depending on the age of
sample. Samples for cryostat sectioning were fixed for a minimal of 1 hour and cryo-protected
in 30% sucrose overnight before embedded in optimal cutting temperature (OCT, Raymond A
Lamb) compound on dry ice. Samples for paraffin embedding were fixed for longer and
dehydrated through a graded EtOH series of 30%( 1 hr), 50%( 1 hr), 70%(1 hr), 95%(2hr x3) and
100%EtOH (lhr x2).
The samples were placed in a cassette and flanked by biopsy pads then processed as follows:
50%EtOH +50%Xylene (15')
Xylene (40' x2)
50%xylene +50%Wax (30', @60°c)
Wax (45' x2, 120' xl, @60°c).
After processing, the skin samples were embedded in wax at stored at 4°c until sectioning.
Sections of 5-6pm were cut on a microtome and collected on SuperFrost® Plus silanized slides.
For cryosections, frozen samples were stored at -80°c until sectioning on a cryostat microtome.
The cryosections were allowed to come to RT and post-fixed in -20°c acetone for 10' before
subsequent experiments.
(b) Tail epidermis preparation
Whole tail was cut off from the mouse, and the skin is subsequently peeled off from the bone
and connective tissue. The skin was then put in 5mM EDTA in lxPBS and incubated at 37°c
for 4 hours, after which the epidermis can be easily separated from dermis using watchman
forceps to expose the follicles underneath the epidermal layer. The epidermis/ follicles were
then fixed in 4% PFA for a few hours, dehydrated through EtOH series, and stored at 4°c until
required.
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(c) Preparation of whole-mount hair slide
Hairs were plucked from the upper back of the mouse, and use glycerol as a mounting medium
with a refractive index similar to that of glass will be used so as to maximize the microscopic
lighting.
8.9.2. Hematoxylin and Eosin (H & E) staining
Sections of 6pm were stained with haematoxylin and eosin (H&E) stain for initial analysis.
Hematocylin stains cytoplasm and acidophilic structure red. Eosin stains nuclei and other
basophilic structure blue.
Paraffin sections were dewaxed with xylene (2x5'), then washed in 100%EtOH (2x5') and
hydrated in decreasing EtOH series of 90%, 70%, 50% and 30% (2' each), followed by a final
wash in dH20.
Slides were stained in haematoxylin for 4-5mins, and differentiated in acid/ alcohol (1%HC1 in
70%MeOH) for a few seconds. The sections were then blued up in saturated Lithium Carbonate
(LiC03) for a few seconds. For eosin staining, sections were incubated in eosin stain42 for 1-
5mins depending on the thickness of sections. Each step described is followed by thorough
wash under tap water.
After stringent wash in water, the sections were then washed in 100%EtOH (2x2'), and
hydrated through an increasing series of EtOH (2'each). Slides were then cleared in xylene
(3x5') and mounted in DePex mounting medium (BDH).
8.9.3. Immunohistochemistry (IHC) and Immunocytochemistry (ICC)
All steps were performed at room temperature (RT) unless otherwise stated.
Paraffin sections were dewaxed in xylene twice for 30' and 15', and subsequently hydrated
through EtOH series: 100% x2, 90%, 70%, 50% and 30%, followed by washes in 1 X TBST43
(15'x3).
42 Eosin stain: (3parts 1% aqueous Eosin + 1 part 1% EtOH). Acetic acid added to a final concentration of 0.05%.
43 IxTBST (0.01% Triton-X) - 1ml 10% Triton-X and 100ml 10xTBS into 900ml Ultrapure water.
10xTBS - 385ml 1M Tris.HCI, 13.9g Tris Base (Trizma), 87.66g NaCI into 1L in ultrapure H20, adjusted to pH7.6-7.8,
autoclaved. 10% Triton-X - 5g Triton in 50ml Ultrapure H20. Heat at 65°c to dissolve if necessary. Sterilize by filtering
through 0.22pm filter using a 60ml syringe.
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For sections that will be labelled with Horseradish Peroxidase (HRP), endogenous peroxidase
was quenched to avoid background staining: sections were incubated in a hydrogen peroxide
solution (3% H202/ 10% MeOH/ lxTBST) for 30mins, followed by washes in lxTBST (15'x3).
For successful immunostaining, antigen retrieval was carried out to denature any protein
folding or other cellular component around the antigen. This technique was especially
applicable for paraffin-embedded sections. Cryostat sections were exempted from this step
because of their fragility that makes them easily destroyed by heat. Sections were heated in
ImM EDTA solution adjusted to ph7.5-8.044, or in citrate buffer (1.8mM citrate acid and
8.2mM sodium citrate solution)45 for about 30mins depending on the antigen, during which the
power was monitored and adjusted intermittently to avoid sections being boiled off from the
slides. The slides were then cooled for at least 30mins before washing in lx TBST for 15mins
(x3).
Slides were then blocked in 10% donkey serum46 (Sigma) (or against host of secondary
antibody) in 1 x TBST for 1 hour, followed by washes in lxTBST (5'x3). Primary antibodies
(1° Ab) diluted in 5% donkey serum were then added onto slides and incubated overnight at 4°c
in humidified chamber.
After washes in lxTBST (15'x3), secondary antibodies (2° Ab) diluted in 5% donkey serum
was added and incubated for 1 hour, followed by stringent washes in lxTBST (3x15').
[Biotinylated 2° Ab was used for colormetric reaction.]
[Following 2°Ab incubation, ABC substrate [HRP-streptavidin, Vectorstain Elite avidin-
biotinylated protein complex (ABC) kit] was added to slides and incubated for 30min in
humidified chamber. After brief washes (2x5'), appropriate color substrate was added (Nova-
red, Vector Lab, which produces a red precipitate). The reaction was closely monitored under
light microscope and stopped in water when the signal to noise ratio is optimal.]
For fluorescent labeled staining, samples were co-stained with DAPI (4'6-Diamidino-2-phenyl-
indole) which counterstains DNA in the nuclei. For colourmetric reactions, 0.01% light green
was used for counterstain.
44
1mM EDTA solution (1ml 0.5M EDTA in 500ml ddH20).
45 Citrate Buffer (9ml 0.1M citric acid solution + 41ml 0.1M sodium citrate solution + 450ml ddH20, adjusted to pH6)
46
Donkey serum (from Sigma) - heat inactivated at 65°c for 30mins before use.
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After briefwashes, fluorescent slides were mounted in Vectashield (H-l 000) mounting
medium, and the edges were sealed with clear nail polish. [The colormetrically sections were
then dehydrated through EtOH series and then into Xylene, which allows slides to be mounted
in the xylene-soluble, non-aqueous DePex mounting medium (BDH), and have a longer-lasting
conserving effect on the stain.]
The advantage of using the ABC kit is that it enhances response to signal, and that it allows
sections to be permanent mounted in a non-aqueous mounting media. Furthermore, it enables
control over the intensity of signal by close observation. The drawback is that double labeling
(counter-staining) with another antibody may be difficult and that it limits the possibility of
improving image presentation using graphics editor.
8.9.4. Antibodies used for analysis
Table 8.2. List of antibodies used for dep analysis
Antigen Clone Name Host Species Dilution
AE13 T.T.Sun lab Mouse IHC 1:10 (serum)
AE15 T.T.Sun lab Mouse Ig IHC 1:2 (serum)
Brdu BUI/75 (Abeam) Rat IHC 1:100
Brdu B44 (BD) Mouse IgGl IHC 1:50
Brdu BU-33 (Sigma) Mouse IgGl IHC 1:400 (not work)
p-catenin 15B8 (Sigma) Mouse IgGl IHC 1:500
P-catenin (Sigma C2206) Rabbit IHC 1:2000
P-galactosidase IHC
Cleaved Caspase3 (Aspl75) (Cell Signaling) Rabbit IgG IHC
c-myc 9E10 (Sigma) Mouse IHC 1:200 (not work)
GATA3 HG3-31 Mouse IHC 1:75
Gml30 35 (BD) Mouse IgG 1 ICC 1:200
Grp78 (Stressgen) Rabbit IHC 1:500
HA (Upstate) Mouse IgG3 WB 1:400 IF 1:200
HA (Sigma) Rabbit IF 1:25
K5 (Covance) Rabbit IHC 1:1000
Mouse keratin 6 (MK6) (Covance) Rabbit 1:500
Mouse keratin 10(MK10) (Covance) Rabbit IHC
Ki67 TEC-3 (DakoCyto) Rat IHC 1:50
Lefl4' Grosschedl lab Rabbit IHC 1:500
P63 BC4A4 Mouse IHC 1:50
Phosphohistone H3 (SerlO) P04H3 Rabbit IHC 1:50
Lck 3A5 (Chemicon) Mouse IgG2bk WB 1:600
N-dhhc21- custom made by GRLPENPK.1PHAE Rabbit WB 1:500, ICC,
Eurogentec RE IHC48 1:100
47
Lef1 antibody was provided by Prof. Rudolf Grosschedl, Max-Planck Institute of Immunobiology.
48IHC using the purified N-Dhhc21 antibody requires citrate buffer treatment for antigen retrieval.
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The 2° Abs used for Western blotting were:
ECL a-Mouse IgG, Horseradish Peroxidase-conjugated (sheep), 1:10000 (GE Healthcare UK Limited).
ECL a-Rabbit IgG, Horseradish Peroxidase-conjugated (sheep), 1:10000 (GE Healthcare UK Limited).
The 2° Abs used for IHC and ICC were:
Rhodamine (TRITC)-conjugated (donkey) a-Rabbit IgG (Jackson Immunoresearch Lab)
FITC-conjugated (donkey) a-Mouse IgG 1:250 (Jackson Immunoresearch Lab)
Alexa 488 (donkey) a-Mouse IgG 1:500 (Invitrogen - Molecular Probes)
Alexa 594 (donkey) a-Rabbit IgG 1:2000 (Invitrogen - Molecular Probes)
Alexa 488 (donkey) a-Rat IgG 1:500 (Invitrogen - Molecular Probes)
Biotin-conjugated (donkey) a-Rabbit IgG 1:400 (Jackson Immunoresearch Lab)
8.9.5. Alkaline Phosphatase (AP) Staining
Vector® Red Alkaline Phosphatase substrate kit (Vector Labs) was used according to
manufacturer's instructions. Two drops of Reagent 1 was added to 5ml AP substrate buffer
(lOOmM Tris.HCl pH8.2-8.5) and mixed well. Two drops of Reagent 2 and 3 were
subsequently added to the buffer respectively and mixed in between. The sections were
incubated with AP substrate solution at RT and monitored under a light microscope. The
substrate also produce a highly fluorescent, bright red precipitate when viewed with rhodamine
excitation and emission filter system. When suitable staining develops, the reaction was
stopped by washing sections in buffer for 5mins, followed by brief wash in water. The sections
were then dehydrated with increasing series ofEtOH concentrations, cleared in xylene and
mounted in DePex mounting media (BDH).
8.9.6. RNA in-situ hybridisation
*A11 solutions used for hybridization or prior to hybridisation were treated with (or made from solutions
treated with) diethyl pyrocarbonate (DEPC49, Sigma), which is a strong inhibitor ofRNases.
*RNaseZap® (Ambion) was also used to remove RNase contamination on work surface and equipment.
Making Zdhhc21 RNA probes for in-situ hybridisation
The Zdhhc21 cDNA transcript was generated by RT-PCR from El2.5 RNA using the Promega
Access RT-PCR kit. The cDNA product (747-bp) was then cloned into pGEM-T and grown on
L-Amp plate. A single colony was grown into an overnight culture of 200ml LB + Amp at 37°c
and purified by the Qiagen® maxiprep kit. The RT-PCR primers used are as follows: 5' -
CATGGGCTTGATTGTCTTTGT-3 ' (F) and 5 ' —ACGTGATTGGCAAAGTGGTAG-3 ' (R) . The insert is
orientated by direct sequencing using T7 and Sp6 primers.
49
Depc treatment: depc was added to solutions (0.1% depc), left in fume hood overnight and autoclaved by heat.
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Preparing RNA probes from existing plasmids
RNA probes were made from the following plasmids. The restriction endonuclease used for





pBSKS(+)-Zd21 Zdhhc21 (a-S) Spe I T7
pBSKS(+)-Zd21 Zdhhc21 (sense) HindiII T3
PBluescriptll KS M shh 16.1 Shh (a-S) HindiII T3
pBluescriptll KS.Glil.#58 Glil (a-S) Notl T3
pBluescriptll KS ptchl Ptcl (a-S) BamH\ T3
'HK15' HK15 (a-S) Spe I T7
pBS-HK17-3'UTR HK17 (a-S) £coRI T3
Plasmids for the following probes: Shh, GUI, Ptcl, HK15, and HK17 were provided by Dr.
Pleasantine Mill (Mill et al., 2003).
The following labeling reactions were set up to label riboprobes with digoxygenin (DIG) and
incubated at 37°c for 2hrs:
2pl 1 Ox transcription buffer
2pl lOx Dig RNA labeling mix (Roche)
1 pi RNase inhibitor (Promega)
2pl RNA polymerase (T7 or T3)
1 (0.1 linearized template DNA (lpg/pl)
10.5(0.1 ddH20 (depc-treated)
2|ol RNase-free DNasel was added and incubated at 37°c for 2hrs to remove template DNA.
The reaction was stopped by added 2pl 0.2M EDTA (pH8).
RNA was precipitated with 2.5pl 4MLiCl and 75|ol -20°c chilled 100%EtOH, incubated at -
80°c for at least 30mins. It was then centrifuged at full speed for 15' at 4°c, and washed with
70%EtOH. The pellet was resuspended in 110|ol depc-treated H20 and stored in aliquots at -
80°c.
Preparation of slides for RNA in-situ hybridisation
Prior to hybridization, the sections were deparaffined in xylene, rehydrated in decreasing series
of EtOH concentrations, treated for 30mins with 20|og/ml proteinaseK prewarmed to 37°c,
acetylated for lOmins in 0.1 M triethanolamine (TEA)/ 0.25% acetic anhydride solution50,
dehydrated in increasing series of EtOH concentration and air dried.
50 0.1M TEA/0.25% acetic anhydride: (1ml 5M NaOH +10ml 100%TEA +1,5ml acetic anhydride) up to 500ml ddH20.
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RNA in-situ hybridisation
About 5-8fu.l labeled probes in 200pl hybridization buffer51 were denatured at 85°c for lOmins,
and applied to each slide and incubated in humidified chamber52 at 55°c overnight.
Post-hybridisation
The slides were washed at 60°c in decreasing concentrations of SSC buffer (5x, 2x, 0.2x, each
for 15' x2). Slides were then blocked in lxblocking reagent (Roche) in lxTBST for lhour, and
the hybridised probes were detected with sheep a-digoxigenin antibody (Roche), conjugated to
AP (lhour). Unreacted conjugate was removed by washing in 2mM Levamisole in lxTBST
(2x15') with agitation. Sections were equilibrated in APB buffer53 for 15' before addition of the
BM Purple colour substrate (Boehringer Mannheim), which contains BCIP that is oxidized by
AP to indigo, and NBT that is reduced, as a result forms a dark blue precipitate.
Stop colour reaction and mounting
The slides were closely monitored under light microscope and the color development was
stopped in ddH20 when sufficient signal has developed (i.e. optimal ratio of signal :noise). The
slides were then dehydrated with increasing concentration of EtOH, cleared in xylene and
mounted with Depex mounting media (BDH).
8.10. Palmitoylation Assay
8.10.1. [3H] palmitate labelling
Metabolic labeling with [3H] palmitate was carried out by Masaki Fukata as a collaboration;
and the protocol was described in Methods (Fukata et ah, 2006). Very briefly, N1H3T3 cells
were labeled with [3H] palmitate by a 4hr-incubation with 0.25-0.5mCi [3H] palmitate diluted in
DMEM supplemented with BSA. Total proteins were then extracted and resolved by SDS-
PAGE. The gel was fixed in isopropanol: H20: acetic acid (25:65:10) and subjected to
fluorography for at least 24hr.
51 Hybridisation buffer: 50% distilled formamide, 5xSSCpH4.5, 1%SDS, 50pg/ml yeast tRNA and 100pg/ml heparin.
52 Chamber buffer (5xSSC pH4.5/ 50% formamide).
53 APB buffer: (20ml MgCI2 +20ml 2MTris pH9.5 +8ml 5MNaCI +4ml 10%Tween20 +600pl 2M levamisole) up to 400ml
with ddH20.
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8.10.2. Acyl-Biotinyl Exchange (ABE) chemistry
(i) Preparation of expression plasmids
The mammalian expression plasmid pcDNA3-Lck was provided by Masaki Fukata (originated
from Dr. Arthur Weiss, UCSF), based on GenBank Accession no. Ml2056.
The mammalian expression vector ofwild-type Zdhhc21, pEFBos-HA-Zdhhc-21 (with EF1-
alpha promoter), was provided by Masaki Fukata. It was then modified by using the
QuikChange® Site-Directed Mutagenesis Kit (Stratagene), to introduce single nucleotide
changes for the following Zdhhc21 alleles: L91F, C95S and C106S. The dep mutation, del-
233F, was modified from pEFBos-FlA-Zdhhc-21 by subcloning dep cDNA (by RT-PCR) into
the BamHX sites flanking the insert (by Peter Budd).




All buffers were added with the serine protease inhibitor, phenylmethylsulphonyl fluoride
(PMSF) to a final concentration of 50pg/pl.
Harvesting proteins and NEM treatment
NIH3T3 cells were co-transfected with 2pg of PAT (Dhhc21) and substrate (Lck) expression
vectors as described in Section 8.3.1. Transfected cells were washed twice in lxPBS/ lOmM
NEM, briefly resuspended in lOOpl 1% SDS/ lOmM NEM/ LB54 (RT, 5'), and solubilized with
addition of 900pl 2% Triton/ lOmM NEM/ LB. The mixture was then rotated for at 4°c for lhr,
and centrifuged at 13000rpm (4°c, 10'). Protein was precipitated from the supernatant by the
chloroform-methanol (CM) method55 (Wessel and Flugge, 1984). Precipitated protein was
resolubilized and denatured with 200pl of lOmM NEM/ SB56 (37°c, 10'), and diluted with
800pl 0.2% Triton/ ImM NEM/ LB. The supernatant was transferred into 1.5ml tube and
rotated at 4°c overnight.
54 LB (lysis buffer): 50mM Tris/HCI pH7.5, 5mM EDTA, 50mM NaCI.
55 CM precipitation: samples were transferred into 15ml Corning centrifuge tubes before each precipitation. All other
steps were performed in 1.5ml centrifuge tubes.
56 SB (solubilization buffer): 4%SDS, 50mM Tris/HCI pH7.5, 5mM EDTA.
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Hydroxylamine treatment and biotin labeling
The next day, NEM was removed by three sequential CM precipitations, after each
precipitation the protein was resolubilized in 200pl (37°C, 10'), and divided into 2 portions to
be treated with or without hydroxylamine with rotation (RT, lhr):
800pl of 1M Hydroxylamine pH7.4/150mM NaCl/ 0.2% Triton/ ImM Biotin-HPDP (Pierce).
800pl of 1M Tris pH7.4/ 150mM NaCl/ 0.2% Triton/ ImM Biotin-HPDP.
Both samples were then CM precipitated, dissolved in lOOpl TB57, diluted in 900pl 0.2%
Triton/ 0.2% SDS/ LB, and rotated at 4°c for 30mins. Following full-speed centrifugation (4°c,
3') to remove particulates, samples were incubated 30pl streptavidin-agarose (Pierce) with
rotation (4°c, overnight).
Unbound proteins were removed from the beads by 3 washes with 1ml 0.1% SDS/ 0.2% Triton/
LB; and the bound proteins were eluted through cleavage of the cysteine-biotin disulfide
linkage with 200pl of lxSDS/ lOmM DTT (37°c, 15mins).
57
IB: 2% SDS, 50mM Tris/HCI pH7.5, 5mM EDTA.
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Appendix IB: Primer sequences of markers used for rrtapped the b-del chromosomes.











D4Nds9 (Bell) (Bell et al, 1995)
151D13-SP6 TGCCACCCTGCTTAGTGTTC ICATTTCCCCTCTCGCCTTTC
D4mit25(bell) (Bell et al, 1995)
D4mit7 N/A
s65.16(T/C) ATTGGTCCAGGGGCTTAGAT TTTAGCATGGTGAGCCTGA
D4mit178 (Bell) GCCCTGAAGGTAAATCAGTAACT GCTCAGGAGGTACATTGCCT
435B11-SP6 TCAATGTGCCCATACATCAAG TGTCTATGGCATTGTTAGTAGC
C2a TGAGCCACTGTTTTTACTCTGG TGAAGTAGATGGTAAGGGTGGC




D4mit132 (Bell) ACAATATTGACAGGTTCAATCAATT TCCACCTCCATATGTGTCACA
TTCCTGACACTTGTATTTGTCTGA AGACCCAGGGTTTAGTCTTTAATG
140B18-T7 CAATTCCCAGTGGTTGACTG GATAGGAAAGACAGCCCAAAG
D4mit85 (Bell) CAGGGAAGGTGTTTGCAAAT TCTCCCCTCCTGGTAGGG
222P16-T7 GAGCAATACCAAGCCAGAAAC TCCAGTGGAGTTCAGCACAC










D4Mlt86 (Bell) (Bell et al, 1995)
D4Rck122 (Bell) TGATCTGACATTTGACTG TGATAGAATATCTTTACC
471C18-T7 CATGTTTGAGACCGAGCATC ACATATGCTGTGTTGTCATTCC





D4mit84 G I IGGGICI I I I I IGI I IGI Al IG TTCATCTGACAAAATTAATGCCC
245P22-T7 TCATGTCAGCTCAGGCTTTG TGGCTCTCACCTGTATGAGTG
r76.5 GCTACTGGATATGTGAGCGAAT TTGTCAGCCAGCTCCAATTA


























S79T51 _____ TGCTCTGAGTTCTGCTTCCA AGGTAAGGGCGGAAACTCTC
S7!T53 AACAAATGAGCCCCACACAT GTGTTTGAGGGAAGCCACAT
S79.54 ATGCGATTGGTGCATACAGA CCATCTGCAGGAAATTGTGA
Mpdz -ex47-3' ATGCAGAGCAATTTGCATTC TCTCCGACCAACACAGCATA


















(Bell et al, 1995)
































Novell GI ICCAG I I I I ICCI CCA I IGIC AGACATATCCCTGCACACATTG
s82.38(t/c) GGGCAGTCTCTGTGGAAAAG TCTACAGCTTGGGTCCATCC
Novel2 (Bnc2) TTTGGTCAACAGTTTTACGATGC TGCACCAGGAACAGTTTATTTG
D4Jkn1(bell) GGACCGGGCTACATAGAGAAG CTATATCTCTTACTAATTTCTTAAGTG
bo247M5-SP6 GTGGAATCCTTGCCTGAG CCACAGTGTTTGGGGAAAAC
N/A' - published markers, or markers that are described on www.informatics.jax.org
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Chromosome deletions in the mouse have proven invaluable in the
dissection of gene function. The brown deletion complex com¬
prises >28 independent genome rearrangements, which have
been used to identify several functional loci on chromosome 4
required for normal embryonic and postnatal development. We
have constructed a 172-bacterial artificial chromosome contig that
spans this 22-megabase (Mb) interval and have produced a con¬
tiguous, finished, and manually annotated sequence from these
clones. The deletion complex is strikingly gene-poor, containing
only 52 protein-coding genes (of which only 39 are supported by
human homologues) and has several further notable genomic
features, including several segments of >1 Mb, apparently devoid
of a coding sequence. We have used sequence polymorphisms to
finely map the deletion breakpoints and identify strong candidate
genes for the known phenotypes that map to this region, including
three lethal loci (l4Rn1, l4Rn2. and l4Rn3) and the fitness mutant
brown-associated fitness (baf). We have also characterized misex-
pression of the basonuclin homologue, Bnc2, associated with the
inversion-mediated coat color mutant white-based brown (B").
This study provides a molecular insight into the basis of several
characterized mouse mutants, which will allow further dissection
of this region by targeted or chemical mutagenesis.
brown locus | chromosome deletion | mouse genome sequence
The mouse brown (b) mutation is one of the oldest known lociand wa one of the first to he cloned. The mutatio is i the
tyrosinase-relatedprotein 1 Tyrpl) gene, encoding a melanocyte
enzyme required for the production of dark eumelanin (I).
I Iomozygous loss of Tyrpl results in a brown coat; because it was
a simply scored phcnotype, brown was used as part the mouse-
specific locus test carried out at the Oak Ridge National Lab¬
oratories and elsewhere (reviewed in ret. 2). Wild-type mice
were exposed to chemical or radiological mutagens and crossed
with a tester stock homozygous for seven recessive visible
mutations. The efficacy of the mutagenic treatments is assessed
in the resulting Fi progeny. These experiments generated many
chromosomal deletions that inactivated l'yrpl, particularly in the
progeny of animals exposed to radiation or clastogenic chemical
mutagens such as chlorambucil or melphalan.
Deletions around the seven specific loci have provided a
unique opportunity to study gene function within these intervals.
Individual deletions are hemizygous viable but when homozy¬
gous or in combination with others give lethal or visible phe¬
notypes, which indicate the presence of essential genes neigh¬
boring the specific loci. Intercrossing deletions of different
extents provided an avenue to map the resulting phenotypes. The
3704-3709 | PNA5 | March 7,2006 | vol. 103 | no. 10
deletions also provided the means to produce physical maps of
genetic markers. Studies of this kind have been published for
several loci, including albino (Tyr), piebald (Ednrb), pink-eyed
dilution (p), and the brown deletion complex (2-6).
Studies of the brown deletions established genetic and physical
maps of the interval by using a panel of 25 deletions spanning
=8.5 cM of chromosome 4 (6-8). Complementation analyses
defined phenotypic loci in the region, including three lethals and
a phenotype, termed brown-associated fitness (baf), which results
in postnatal runting and increased preweaning mortality. Pre¬
vious studies have also described a chromosomal inversion,
white-based brown (H"), that was hypothesized to cause inap¬
propriate expression of an unknown gene, resulting in melano¬
cyte death and loss of hair pigmentation (9).
We have generated a finished and manually annotated se¬
quence from a bacterial artificial chromosome (BAC) contig
spanning the brown deletion complex. The region is very gene-
poor and includes several large segments devoid of any protein-
coding genes. We identified single-nueleotide polymorphisms
that permit refinement of the deletion breakpoints that delineate
known phenotypes. The sparse gene content means that we have
identified one or a few candidate genes for each of the five
phenotypes.
Results and Discussion
Sequence and Annotation of the Tyrpl Deletion Complex. The fin¬
ished sequence of each of 172 BACs from a clone contig
encompassing the 'Tyrpl deletion complex was individually an¬
notated to identify genes, transcripts, and pseudogenes (Fig. 1;
for a complete version of this figure, see Fig. 5, which is published
as supporting information on the I'NAS web site). The annota¬
tions can be viewed in the Vertebrate Genome Annotation
(VEGA) browser (http://vega.sanger.ac.uk/index.html). The
extent of the deletion complex was determined by locating the
midpoints of those deletions extending furthest proximally
(Tyrpl"R3m) and distally (Tyrpl8Puh). These deletions define an
unusually gene-poor genomic segment of =21 megabases (Mb)
from a point just distal to Ugs3 as far as, and including, llnc2. This
Conflict of interest statement: No conflicts declared.
Abbreviations: BAC, bacterial artificial chromosome; Mb, megabase.
Data deposition: The sequences reported in this paper have been deposited in the EMBL/
GenBank database. For a complete list of accession nos., see Table 4, which is published as
supporting information on the PNAS web site.
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Fig. 1. Schematic representation of the annotation of the Tyrpl deletion region. The deletion interval extends as far as, but not including, Rgs3 at the proximal
end and includes Bnc2 at the distal end. Yellow blocks represent finished sequences, marked with accession numbers (available at http://vega.sanger.ac.uk/
index.html), of individual BAC clones forming the tiling path across the region. A black block on the end of the clone represents an overlapping, redundant
sequence. The five gray-black tracks show the distribution of different types of repeats, as defined by repeatmasker. The red line indicates a fraction of G and C
nucleotides. Arrows show the position and orientation of annotated genes and pseudogenes, with the color of the arrows indicating the type as shown in the
key. Thefive colored boxes are the extents of the critical regions for the deletion phenotypes as indicated. The wider box is the minimal critical region, the narrow
box is the maximum, and the boxes are delineated by the deletions and markers listed in Tables 2 and 3. The ends of the boxes are the positions of the markers.
The arrows in the boxes reflect the intact chromosomal ends, pointing into the deletion.
segment contains only 53 protein-coding genes (see Table I,
which is published as supporting information on the PNAS web
site). We can be confident that 39 of these genes are true genes
because they have orthologous protein-coding transcripts in
other species. The remaining 14 genes are all identified by the
existence of mouse cDNAs, which contain ORFs distributed
across multiple exons and are predicted to encode peptides
containing between 110- and 354-aa residues. One of them is
Smyth et al.
derived from the 3' end of the adjacent Frmd3 gene. None of the
remaining thirteen, however, shows significant homology to
transcripts from any other species nor do their predicted protein
products have any recognizable motifs. Ten of these predicted
genes arise from a 10-fold local amplification of a 15-kb genomic
segment. Although Ihere are EST matches to these amplified
arrays, none of them are perfect, and it is not clear which of the
repeated segments are transcribed. Furthermore, the human
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Fig. 2. Distribution of genes and evolutionary-conserved regions (ECRs). (A)
The number of protein-coding genes (black bars) and noncoding RNAs (white
bars) in each 1Mb interval across the region, beginning at the 3' end of Rgs3.
Where a gene or transcript spans more than one interval, it is placed in the one
containing the 5' end of the 5' most transcript. (6) The percentage of ECR
content in each 1Mb interval, as in A. The fraction is calculated as the total
length of sequence, after masking repeats and exons, that reaches the thresh¬
old. Black bars are mouse-human ECRs at 80% identity over >200 bp, and
white bars are mouse-chicken ECRs at 70% identity over >100 bp.
genome sequence contains a recognizable homologue neither to
the transcript nor to the 15-kb amplified segment from which it
derives. The rat genome does contain a single orthologous
genomic segment, but this segment is located on rat chromosome
15 not on the rat homologue of mouse chromosome 4, which is
chromosome 5.
The deletion complex also gives rise to 28 spliced transcripts,
identified by mouse cDNAs, which are derived from between
two and five exons but contain neither any significant ORF nor
show homology to transcripts from other species. In addition,
there arc 74 recognizable pseudogenes, almost all of them
processed.
The overall gene density across this region is just >2 genes per
Mb compared with the genome average of =10 genes per Mb.
Furthermore, the genes are not evenly spaced (Fig. 2/1). More
than half are located in the megabases at each end oflhe complex
and in a 2-Mb region in the center, leaving only 20 genes spaced
across the remaining 18 Mb. There are seven stretches of >1 Mb,
including one of 2.5 Mb, that are totally devoid of any protein-
coding transcript. Another large segment of 1.9 Mb is solely
occupied by 10 exons encoding isoforms of the 5' UTR of the
I'lprd gene. Furthermore, the 29 spliced noncoding transcripts
are also not evenly distributed across the region; rather, they
appear to be clustered in those regions that are enriched for
genes (Fig. 2/1).
The function, if any, of these noncoding RNA is unknown.
Their localization near to established genes may indicate thai the
transcripts are hitherto unidentified parts of transcripts of the
known protein-coding genes, or their expression may be a
nonfunctional by-product of local transcriptional activity. Alter¬
natively, it is possible that their transcription has a function in
opening up the chromatin, or maintaining it in an open state, to
facilitate expression of protein-coding genes.
Repeat content is correlated with gene density in the mam¬
malian genome (10). Fig. 1 illustrates this correlation across the
deletion region. Gene-poor segments are rich in LINE elements,
whereas SINEs are more abundant in the gene-rich areas. The
Fig. 3. Schematic representation of a region of striking evolutionary rear¬
rangement. The orthologous regions of human chromosome 9 (Hs9), mouse
chromosome 4 (Mm4), and rat chromosome 5 (Rn5) are shown. The orienta¬
tions of the genes are indicated by the following colored arrows: Tle1 in
orange, Rasef in blue, and Frmd3 in red. Lines connect the 3' and 5' ends of
each. The second, short red arrow in mouse and rat genome represents the
RP23-292J1.4 transcript, which apparently derives from a 3' end duplication
and inversion of Frmd3. The 10 green arrowheads in the mouse line represent
the 9-fold amplification encoding the transcripts related to RP23-289L21.1,
which are absent from the rat and human lines. Open green arrowheads are
the two pseudogenes of the same gene.
gene and transcript "deserts," however, still contain substantial
numbers of nontranscribed conserved sequences. Fig. 2B shows
the distribution of nontrancribed segments that are conserved
between the mouse sequence and the orthologous human and
chicken sequences. Surprisingly, the locations of the conserved
segments do not appear to correlate with transcript locations.
The gene-rich first megabase of the region has a lower concen¬
tration of noncoding conserved segments, and the central part,
which is also relatively enriched for genes, has a low level of
noncoding conservation.
The function ofmost of the conserved segments in the genome
is unknown, and they may indeed have a diversity of roles. The
conserved sequences located close to genes are candidates for
regulatory elements. Even those elements very distant from the
5' end of a gene may still play a role; there is increasing evidence
that sequences at several megabases distant can be essential for
correct gene expression (11). Recently, Ovcharenko et ul. (12)
have examined gene deserts in the human, which they define as
intergenic intervals of >640 kb, the longest 3% of all intergenic
intervals. They find that the human-chicken sequence conser¬
vation in these deserts range from none to 12% and suggest that
those with 2% or more conservation may be more likely to house
long-range regulatory elements. Using the same criteria for
conservation, we find that most intervals in this deletion region
have <2% conservation.
A Site of Striking Evolutionary Rearrangement. The entire region is
homologous to human chromosome 9 but is not contiguous in
humans. There is a striking correlation between gene dcasity and
human chromosome G-banding patterns. The deserts lie within
dark G bands, and the gene-rich segments are in light bands (10).
The proximal end of the region is homologous to 9q32-33, the
distal end to 9p22-24, and an =3.5-Mb segment in the middle is
homologous to 9q21.32. The distal end of this central segment
has undergone considerable rearrangements over evolution. The
protein-coding gene, RP23-289L21.1, is =600 kb from where the
homology changes to 9p22-24. As mentioned, this gene is locally
amplified =200 kb upstream, and in the opposite orientation are
five landemly arranged, almost identical, 15-kb segments that
derive from the genomic segment encoding the gene. A further
four copies of the segment are found another 100 kb further
along the chromosome, between Rasef and Frmd3. Two pseu¬
dogenes derived from these genes are also presenting this region
(Fig. 3). Characterization of this array of highly similar sequences
required that the sequence produced for the region was high-
quality and hand-finished. Earlier drafts of the region had only
a single copy of the amplified array, which illustrates the value
of hand-finished sequence.
The chromosomal orthology breakpoint is immediately adja-
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cent to the 3' end of Frmd3, and this gene also seems to have
undergone considerable evolutionary rearrangement. In mice,
Rasef and Frmd3 are divergently transcribed from opposite
strands, whereas the human orthologues are transcribed from
the same strand (Fig. 3). The 3' portions of both human and
mouse Frmd3 are transcribed from within an intron by using an
alternative, conserved exon. In mouse, a homologue of this
shorter transcript is present in a second copy (RP23-292J1.4), in
reverse orientation (the same orientation as the human tran¬
script). There appears to have been a duplication accompanying
the inversion (Fig. 3), and the human gene orientation is
ancestral. Examination of the rat genome sequence reveals that
Frmd3 in this species has the same orientation as in mouse and
also has the duplicated 3' transcript, indicating that the rear¬
rangement occurred before the mouse and rat lineages diverged.
In rat, however, the Rasef gene is reversed compared with the
mouse, apparently a result of another gene inversion in the rat
lineage (Fig. 3). The genomic arrangement in zebrafish is
different yet again; in this case, Rasef and Frmd3 are transcribed
from opposite strands, as in mouse, but are divergent not
convergent (data not shown).
Alignment of the entire 22 Mb Tyrpl deletion region reveals
at least two other small inversions in the mouse genome with
respect to the human genome of 80 and 100 kb, but nether of
these inversions include any genes or transcripts.
Identification of Deletion Phenotypes. To accurately identify can¬
didate genes for loci previously mapped to the deletion complex,
we mapped the ends of deletion breakpoints using SNPs between
the strains oforigin of the deletion chromosomes andMusspretus
in deletion/spreriM hetero/.ygotes. We focused on those deletions
that had been used to define mutant loci. The minimal and
maximal extents of key deletion intervals are illustrated in Fig.
1. Tables 2 and 3, which are published as supporting information
on the PNAS web site, list the deletions and markers used to
define the endpoints. The relevant markers from Table 3 map on
Fig. I as the maximum and minimum extents of each deletion.
Embryonic Lethal Phenotypes. Combinations of deletions identify
three embryonic or neonatal lethal phenotypes (7, 8, 13), and
their endpoints define the locations of essential genes deleted or
mutated by them.
I4Rnl is a deletion phenotype resulting in in utero death before
El 4.5 (13). The physical map of Bell et al. (8) indicates that it lies
between the proximal end points of the Tyrpl8Pub and TyrplnPu
deletions. Tyrpl8Pub breaks within the Ptprd gene and is the most
proximal viable deletion, whereas Tyrpl"Pu breaks within the
Jmjd2c gene and is the most distal lethal deletion. l4Rnl,
therefore, lies in the 2.45-Mb interval defined by these endpoints
(Fig. 1). Despite the length of this segment, only three genes are
within the interval. We can exclude Ptprd as a candidate because
TyrplSPuh disrupts Ptprd yet does not delete !4Rnl. The remain¬
ing two candidates are Jmjd2c and an uncharacterized gene,
RP24-200F10.1, defined by the Institute of Physical and Chem¬
ical Research (Japan) (RIKEN) clone no. 3110001D03, which is
the mouse orthologue of human C9orfl23. Jmjd2c is the ortho-
logue of a characterized human gene, GASC1, which is amplified
in esophageal cancer cell lines (14). The encoded protein
contains two jumonji domains, jmjC and jmjD, which are found
together in numerous mouse proteins and may indicate function
as a transcription factor. Any potential function of the product
of the C90rfl23 orthologue is difficult to predict; the protein is
only 111 aa in length but has two potential transmembrane
domains that are conserved in humans.
Mice homozygous for l4Rn2 deletions die neonatally, and the
locus is defined by the distal end of deletion Tyrpl"R30M and the
distal end of deletion Tyrpl9"73^' (6). Our deletion mapping
indicates that this interval contains only part of only one gene,
nuclear factor FB (Nfib), encoding a transcription factor ex¬
pressed at high levels in the embryonic lung (15) (Fig. 1). Nfib
mutant pups die shortly alter birth as a result of severe pulmo¬
nary hypoplasia (16), and this phenotype is entirely consistent
with that of mice bearing homozygous deletions of l4Rn2. We
suggest deletion of Nfib is responsible for the l4Rn2 phenotype.
The final early embryonic lethal deletion locus, l4Rn3, lies
between the distal ends of the Tyrpl46UThc deletion and Tyrpl8Pub
(Fig. 1). This interval contains six genes: RP23-41 OKI9.1, which
is the Freml gene (17); the PC4 and SFRS1 interacting protein
1, Psipl; the small nuclear activating complex protein 3 (Snapc3);
basonuclin 2 (Bnc2); and two uncharacterized genes, RP23-
17021.2, encoding the cDNA 1810054D07Rik, and RP23-
311U24.5, encoding A330015D16Rik, which are the mouse or¬
thologues of human C90rf52 and C90rJ93, respectively. We can
exclude Freml as a candidate as loss-of-function mutations of
this gene result in the head blebs (heh) phenotype (17). The
SNAPC3 protein forms part of the small nuclear RNA-activating
protein complex and reduction of protein in vitro leads to
inhibition of RNA polymerase II- and Ill-mediated small nu¬
clear RNA gene transcription (18). PSIP is a nuclear protein
important for cellular protection against stress-induced apoplo-
sis in which activity is regulated by caspase-medialed cleavage
(19, 20). Neither protein has been knocked out but, given their
cellular functions, eitherwould make a good candidate for l4Rn3.
Of the two unknown function transcripts, only the C90rf93
orthologue has any recognizable protein domain, including
coiled coils and tropomyosin motifs. Very few of the brown
deletions were mapped relative to 14Rn3; we were unable to
further reduce this locus, and all five genes remain candidates.
Brown-Associated Fitness (bat). Previous studies of the deletion
complex showed that appropriate combinations of chromosomal
deletions complement the embryonic lethal phenotypes. All
complementing deletions reported result in mice with poor
growth rates, alterations in behavior, and compromised survival
(6, 7). This phenotype, termed brown-associated fitness (baf),
must result from the loss of a gene or genes very close to Tyrpl.
However, certain deletion combinations, namely TyrplIOZ with
Tyrpl37DTD and Tyrpl47UTHc with Tyrpl37DTD, Tyrpl330, or
Tyrpl'mo~'v result in phenotypically normal mice, indicating
that the gene(s) in which deletion results in baf must lie outside
these deletions (E. M. Rinchik, unpublished data). Paradoxi¬
cally, each of these deletions, in combination with others, can
produce baf mice. We must conclude that there are two genetic
elements, one on each side of Tyrpl, the deletion of either of
which gives rise to the baf phenotype (Fig. 1).
The maximum deletion interval on the proximal side that
defines baf contains a part of only one gene, Ptprd. This gene has
been mutated by gene targeting and results in mice with neu¬
rological defects that fail to thrive without ground feeding (21).
This phenotype is consistent with baf, and we conclude that the
phenotype caused by deletions proximal to Tyrpl is due to loss
of Ptprd. It is worth noting that these deletions remove a 2.5-Mb
gene desert in addition to Ptprd, yet the mice have a phenotype
no more severe than a targeted mutation of Ptprd alone. The
cause of the distal haf phenotype is less clear. Seventy kilobases
distal of Tyrpl is an uncharacterized gene RP24-318C20.1, the
orthologue of human C9Orfl50.1 Iowever, deletion of all or part
of this gene, from Tyrpl'mo~lv and Tyrpl37DTD, does not result
in the baf phenotype. Rather, the distal baf is defined hy the
endpoints of Tyrplimo~IV TyrplI73G (Fig. 1), which encompass a
180-kb segment between the C9Orfl50 orthologue and Mpdz,
containing no predicted genes or transcripts. Comparison of this
sequence with other mammalian species reveals numerous seg¬
ments with a high level of sequence identity consistent with
evolutionary conservation of regulatory element(s). It is possible
that these are long-range control element(s) necessary for the
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Fig. 4. White-based brown inversion. (A) Schematics of the C57BL/6J and Tyrp1B~w chromosomes showing the regions around the Tyrpl and Bnc2 genes, and
the intervening D4Bwg0951e gene for orientation. Arrows indicate transcriptional start sites. The gray arrowheads mark the breakpoints of the inversion, (fi)
RT-PCR showing transcription of the Tyrp1-Bnc2 fusion transcript in a range of adult tissues and in the skin of mice between 1 and 20 days postnatal (dpn).
expression otPtprd, for which the 5' end is some 3 Mb away, and
this finding would account for the consistency of phenotype
between distal and proximal baf deletions.
Characterization of White-Based Brown (Tyrp1Bw). White-based
brown (TyrplB~w) is a mutation of the brown locus that arose
spontaneously during a radiation mutagenesis experiment (22).
The TyrplB w chromosome carries a dominant mutation that
results in the absence or reduction in pigment at the base of the
hair follicle but which is also a recessive loss-of-lunetion allele of
Tyrpl. This curious phenotype has been partially explained by
preliminary molecular characterization showing that it results
from an inversion that inactivates Tyrpl by interrupting the gene
in the first intron (9, 23). It has been proposed that the dominant
pigmentation loss in the mice results from ectopic expression of
a second gene from the Tyrpl promoter, which either abrogates
pigment production or leads to melanocyte death during the
latter stages of the hair growth cycle. Short sequences bordering
the inversion breakpoints have been cloned (9), and the genome
sequence of the interval allowed us to determine the exact nature
of the rearrangement.
The proximal end of the inversion is 105 bp from the exon-2
splice acceptor site in Tyrpl intron 1 (Fig. 4/1). The other
breakpoint lies distal of the brown deletion complex, *»15-kb
upstream of the recently characterized Basonuclin 2 (Bnc2) gene
(24). RT-PCR analysis demonstrated the expression of a Tyrpl-
Bnc2 fusion transcript in several Tyrpl11'"' tissues (Fig. 4/i).
Normal Tyrpl expression is restricted to melanocytes; however,
we detect expression of the fusion transcript in several other
tissues such as the kidney, liver, ovary, and testis. This finding
indicates that enhancer elements associated with Bnc2 are
driving ectopic expression of Tyrpl in these tissues or that Tyrpl
expression is normally repressed by elements subsequently sep¬
arated from the locus by the inversion. To determine whether
melanocyte death occurred during the hair follicle cycle, we
examined expression of the fusion transcript during the first hair
cycle. Tyrpl is normally activated shortly after birth when
melanocytes begin to produce pigment during anagen, and this
expression stops by 13 days postnatal. However, we observed
persistent expression of the fusion transcript in the skin both at
birth and after 13 days postnatal, presumably as a consequence
of the ectopic expression.
We sequenced multiple RT-PCR products of the Tyrpl-Bnc2
fusion transcript. Normal splicing of Tyrpl exons 1 and 2 uses
three different donor sites (25), which were all detected in the
fusion transcripts spliced to Bnc2. We identified promiscuous
splicing of Tyrpl to splice acceptor sites in Bnc2 exons la and 2
(Fig. 4/1) of which products of splicing to la would produce
normal protein products. Because expression of the coding
region of Tyrpl at the proximal end of the inversion is not
detected (23), we propose that overexpression of Bnc2 underlies
the dominant loss of pigment in Tyrpl11-"' animals.
Other Deletion Complexes. The surprisingly low gene density of
this deletion complex may account for the viability of large
deletions encompassing Tyrpl. Certain other specific locus re¬
gions, such as 1'yr and Ednrb, also have large, viable deletions and
appear to be gene-poor. By contrast, the agouti region is
relatively gene rich, but relatively few deletions have been
recovered from the region. Once other regions of the mouse
genome are annotated at high quality, it will be interesting to
correlate gene content with the presence or absence of large
deletions that have been identified at many other chromosomal
sites following radiation mutagenesis.
Materials and Methods
BAC Contig Construction, Sequencing, and Annotation. A BACconlig
spanning the entire brown deletion complex was constructed by
using clones from RCPI-23 and -24 C57BL/6J strain mouse librar¬
ies (26). Clones containing genes known to map to the intervalwere
identified by hybridization to gridded libraries, and contigs were
extended by using probes produced by overlapping oligonucleotides
(overgos) designed to the ends of these BACs. The contig was also
extended by using BAC fingerprint data (27). Contiguous BAC
clones were sequenced by the Rosalind Franklin Centre for Ge¬
nome Research and the Sanger Institute, as described in ref. 28.
Manual annotation was performed by using established criteria and
methodologies (www.sanger.ac.uk/IIGP/havana/havana.shtml).
Detailed annotation of the complete brown deletion sequence is
available at the Vega web site (http://vega.sanger.ac.uk/index.
html). Details of phenotypes defined in the region are in the Mouse
Genome Database (www.inlormatics.jax.org).
Deletion Mapping. Deletion endpoints were mapped by using a
panel of deletion/Spreto DNAs (7). Primer pairs were predom¬
inantly designed lo amplify nonrepetitive BAC end sequences,
although in some cases were designed specifically to map genes
against deletions. Primers used for mapping key endpoints are
listed in Table 3. Additional primer sequences and their ampli¬
fication conditions are available on request.
Analysis of the B™ Inversion. The proximal end of the Bw inversion
was identified by using the short sequence known to border the
inversion (12). The genomic structure and sequence of mouse
Basonuclin 2 (Bnc2) was determined by assembling ESTs and
comparing thesewith both the Basonuclin 1 (Unci) sequence and
expanding the gene structure in the human, l'ugu, and zebrafish
genome assemblies by using GENEWISE (29). RT-PCR analysis of
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splicing between Tyrpl and llncl was performed by using a
forward primer in Tyrpl exon 1 (TCA GOG GAA AAG GAG
ACA TC) and a reverse primer in exon 3 of Snc2 (GOT GCA
GTT TAC CAA TGT GC). RNA was extracted from homog¬
enized mouse tissues by using the Total RNA Isolation System
kit (Promega) and cDNA and PGR were undertaken by using the
Access RT-PCR Kit (Promega) following the manufacturers
protocols.
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